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1Chapter 1
Introduction
2This chapter is based on: Zilhao, N. R., Boomsma, D. I., Smit, D. J. A, Cath, D. C.  Genetics 
of Obsessive-Compulsive Disorder and Tourette’s Syndrome. This chapter is (with the 
exception of the paragraphs on hoarding disorder) to be published (accepted) in: Genes, 
Brain and Emotions, Oxford University Press, eds. Klaus-Peter Lesch, Judith Homberg 
and Andre Miu; 2018.
Review: 
Genetics of Obsessive-Compulsive Disorder, 
Tourette’s Disorder and Hoarding Disorder
3Obsessive Compulsive Disorder (OCD), Tourette’s Disorder (TD) and 
Hoarding disorder (HD) are common psychiatric disorders affecting 
approximately between 1-3% of  the population. Since their first descriptions 
in the nineteenth century to today, we have witnessed considerable progress 
in the way these disorders are conceptualized, both clinically and genetically 
- from simple manifestations of  psychological disturbances to the notion of  
highly polygenic and heritable disorders. Family and twin studies have shown 
that both disorders run in families, and that this familiarity is in part due 
to genetic factors, with heritability estimates ranging between 0.26-0.60 for 
OCD, 0.25-0.54 for TD and 0.35-0.50 for HD. Over the years, advances in the 
fields of  psychiatric genetics have sought to uncover specific genetic variants 
underlying the etiology of  these disorders, and although there has been a 
steady progress, results so far remain inconclusive. In the recent decades, 
a remarkable increase in international collaborative efforts within the field 
of  psychiatric genetics has opened new possibilities of  research, with larger 
datasets and multiple sources of  genetic information available. In this chapter, 
we provide a broad overview into the genetics of  OCD, TD and HD and 
on their genetic association over the years until the present. We summarize 
historical evidence from the literature over the years, and the recent results in 
the light of  current research.
Abstract
4The first scientific descriptions of  Obsessive Compulsive disorder (OCD) 
and Tourette’s Disorder (TD) as psychiatric disorders stem from medical 
research in the nineteenth century, starting with the works of  Jean Itard (1825) 
and George Gilles de la Tourette (1885) (on tic disorders), and of  Pierre 
Janet (1900) (on OCD). Hoarding disorder (HD), has only recently sprouted 
attention within the research community. It still remains, actually, as the 
focus of  a debate of  whether it constitutes a separate mental disorder rather 
than a symptom of  OCD. Conceptualization of  these disorders over time 
reflected the evolving views regarding underlying causes and mechanisms. 
The Freudian psychogenic view prevailed for many decades, explaining both 
TD/tics and OCD symptoms as manifestations of  inner psychological or 
psychosexual conflicts as a result of  environmental adversities (predominantly 
stemming from early life traumatic events and disadvantageous upbringing). 
From the second half  of  the twentieth century onwards, advances in 
pharmacotherapeutics and new neurobiological insights (Pauls & Leckman, 
1986; Peterson et al., 1993; Shapiro, Shapiro, & Feinberg, 1988), questioned the 
psychoanalytical explanations of  tics and OC symptoms, and provided new 
insights into more neurobiological genesis of  these diseases. Developments 
within the field of  twin and family studies, following applications of  structural 
equation modelling (Martin, Eaves, & Davies, 1978), have advanced the field 
of  psychiatric genetic research. Both family-based and epidemiological twin 
studies have sought to estimate the contribution of  genetic and environmental 
influences to variation in the phenotype, often specified as the heritability of  
the liability to develop the disease. Collaborative psychiatric genetic research 
further contributed to the insight into the genetic basis of  both OCD and TD, 
as well as their shared underlying etiology (den Braber et al., 2016; Mattheisen 
et al., 2014; Scharf  et al., 2013; Stewart et al., 2013). This rapidly growing 
field now also aims at finding the genetic DNA variants that help to identify 
pathways of  disease development. These efforts, when successful will aid in 
understanding the biological mechanisms underlying the disorders. Here, we 
provide an overview of  the genetic studies into OCD,  TD and HD,  and of  
the genetic comorbidity between these disorders.
The current definition of  OCD was introduced in the 1980s in the Diagnostic 
and Statistical Manual of  Mental Disorders, third edition (American 
Psychiatric Association [APA], 1980). Until then, OCD was commonly 
referred to as “obsessive compulsive neurosis”, or psychasthenia. OCD had 
been considered a sub-dimension of  depression (World Health Organization 
Symptom Characteristics
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5[WHO], 1992). According to the fourth edition of  the Diagnostic and 
Statistical Manual of  Mental disorders (American Psychiatric Association 
[APA], 1994), OCD was classified as an anxiety disorder, characterized by 
persistent, repetitive and intrusive thoughts/images (obsessions) that cause 
anxiety and or tension, and are in >80% of  the cases followed by anxiety/
tension reducing actions and ritualized behaviours (compulsions). Relief  from 
carrying out compulsions is usually brief  and the repetitive behaviour by and 
in itself  fuels subsequent repetitive behaviour (van den Hout & Kindt, 2003), 
with the person getting caught in an on-going cycle of  fear, doubt, worry 
and distress, leading to high levels of  social impairment: Global Burden of  
Disease (GBD) estimates have found that OCD accounted for 2.2% of  all 
years lost to disability (YLD) (Ustun, 2004), placing it at the 11th position of  
causes of  non-fatal disease burden worldwide (World Health Organization 
[WHO], 2007). Whereas in DSMIV OCD was classified among the anxiety 
disorders, the new edition (DSM-5) includes OCD in its own category (‘OCD 
and related disorders’) alongside HD, excoriating disorder, body dysmorphic 
disorder and trichotillomania (American Psychiatric Association [APA], 2013).
The course of  the disease is diverse: around 50% of  cases remit with time, 
and 50% of  persons with OCD run a chronic course (Skoog & Skoog, 
1999). Recent studies from the Netherlands Twin Register showed that 
OCD diagnosis as well as symptom severity on average decreases from age 
35 onwards, with an increase after age 60 that is predominantly driven by 
checking behaviour (Cath, Nizar, & Mathews, 2016). In all, OCD is considered 
as a lifelong disorder, which varies with regard to symptomatology. The most 
frequently reported obsessions are fear of  contamination, a need for order 
and symmetry, and persistent and unwanted aggressive thoughts of  causing 
harm to oneself  or others (APA, 2013). Compulsions appear as repetitive 
behaviours or rituals in an attempt to decrease anxiety or tension as a result 
of  the obsessions. The most frequently reported compulsions include 
washing and cleaning, checking, counting, symmetry and hoarding behaviour 
(Katerberg et al., 2010; Mataix-Cols, Rosario-Campos & Leckman, 2005).
According to the 5th edition of  the DSM (2013), three categories of  tic disorders 
are recognized: TD, chronic tic disorder (motor or vocal) and provisional tic 
disorder (APA, 2013). They are classified as neurodevelopmental disorders 
according to DSMIV and DSM5, and characterized by sudden, repetitive and 
unwanted motor movements or sounds (tics) (Cath et al., 2011). Tics can 
be either motor/vocal or simple/complex. Simple motor tics include brief, 
abrupt movements, involving only single muscle groups (e.g.: eye blinking and 
rolling, nose wrinkling, head jerk/nodding, shoulder shrugs). Complex motor 
6tics are performed as a sequence of  simpler movements (e.g.: touching objects, 
hopping/jumping, squatting). Simple vocal tics include simple meaningless 
sounds and noises such as grunting, sniffing, throat clearing, coughing and 
snorting. Complex vocalizations entail words/syllables or making of  animal 
sounds, echolalia (repeating another person’s words), or coprolalia (obscene 
words) (Cath et al., 2011). 
Tics have a fluctuating course with time. Strikingly, over 70% of  TD 
children experience a decrease in tic symptoms in adolescence, starting at 
age 12, most likely as a result of  maturation of  the frontal lobes (Felling 
& Singer, 2011). Tics are usually more acute and expressive in periods of  
stress and anticipation, and tend to be reduced when the individual is mentally 
absorbed, focused and concentrated in activities. During adolescence, in up 
to 80% of  tic-affected children, symptom severity decreases to an extent that 
the individuals no longer experience any distress and run a course that is 
indistinguishable from individuals with normal development (Burd, 2001; 
Leckman et al., 1998). However, in a small number of  individuals, tics persist 
into adulthood and sometimes, even increase in severity. To what extent this 
differential course (remitting versus persistent) reflects differential genetic 
architecture, differences in environmental influences or differences in both 
has not been studied to date.
HD is defined as the pathological acquisition of  (and failure to discard) large 
amounts of  possessions and items leading to severe clutter, precluding the 
normal activities for which living spaces were designed (Frost & Hartl, 1996; 
APA, 2013). HD was for long considered a mere sub dimension of  OCD 
or one of  the criteria of  Obsessive-compulsive personality disorder (APA, 
1994). In DSM-5 HD has now been defined as a separate disorder as part of  
obsessive-compulsive spectrum disorders according to DSM5 (APA, 2013; 
Pertusa et al., 2008; Mataix-Cols et al., 2010). The arguments to grant HD 
a separate classification are based on HD clinical research showing that up 
to 80% of  HD patients is without concurrent OCD symptoms, and on HD 
potential neurobiological distinctions from OCD (Tolin et al., 2014). This 
new diagnosis has been empirically validated, and deemed clinically reliable 
(Pertusa et al., 2011), following the core characteristics described by Frost 
and Hartl (1996). These recent conceptualizations have been corroborated by 
twin-based genetic studies (Iervolino et al., 2011; Ivanov et al., 2013). 
7OCD is frequently accompanied by psychiatric comorbidities, mostly with 
concurrent major depression (31%), social or specific phobias (11%), anxiety 
disorders (25%), or bipolar disorder (7%) and 20% has co-morbid TD or tics 
(Angst et al., 2005; Canavera, Ollendick, & Pincus, 2010; Geller, 2006; Langley, 
Lewin, & Piacentini, 2010; Pallanti, Grassi, & Pellegrini, 2011; Storch, Lewin, 
& Murphy, 2010).
For people with TD, most frequently occurring co-morbid psychiatric 
disorders include ADHD and OCD (Freeman et al., 2000; Freeman et al., 
2007). Between 20-89% of  individuals with TD exhibit OC behavior (Karno, 
Golding, & Burnam, 1988; Weissman et al., 1994), and between 50-60% are 
diagnosed with ADHD (Polanczyk, de Lima, & Rohde, 2007). Furthermore, 
increased rates of  anxiety and depression have been reported in individuals 
with TD (Cath & Ludolph, 2013). Hirschtritt et al. (2015) published a 
comprehensive analysis on the characteristics of  ADHD and OCD as 
comorbid disorders in TD, reporting a mean of  2.1 comorbid disorders in 
TD patients and 1.6 when excluding OCD and ADHD (Hirschtritt et al., 
2015).
The most commonly co-occurring conditions with HD include ADHD, 
Major Depressive Disorder and Generalized Anxiety Disorder (Mataix-Cols 
et al., 2012). Regarding co-morbid rates with OCD, this is estimated to be 
between 12-20% of  HD patients (Frost et al., 2011; Ivanov et al., 2013).
Lifetime and one-year prevalence of  OCD is estimated at respectively 2.3% 
and 1.2% (Ruscio, Stein, & Kessler, 2010). Moreover, many individuals 
experience OC symptoms without the full diagnosis. Hence, the prevalence 
of  OC symptoms and of  subthreshold OCD (operationalized as having 
OC symptoms, but either less than 1 hour a day with significant suffering 
or distress, or > 1 hour per day without suffering or distress) is likely to be 
much higher (up to 6%) in the general population (Adam, Meinlschmidt, & 
Lieb, 2012; de Bruijn, Beun, & Denys, 2010; Fineberg et al., 2013). OCD 
shows a slight preponderance for women and a bimodal pattern for the age 
of  onset. Boys typically experience an onset before the age of  10 and more 
often have tic-related symptoms, while girls experience a later onset (Nestadt, 
2000; Pauls, Alsobrook, & Leckman, 1995). 
For TD, Robertson et al. (Robertson et al., 2008) suggested an overall 
prevalence estimate of  1% in the general population, and Scahill, Dalsgaard, 
Population Prevalence and Clinical Course
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8and Bradbury (2013) reported prevalence rates between 0.5-0.7% in children 
between age 6 and 18 (Scahill, Dalsgaard, & Bradbury, 2013). For tic 
disorders, prevalence rates range between 0.3% and 0.8% for chronic motor 
tic disorder, whereas for vocal tic disorder no reliable estimate is currently 
available. In adults, tic prevalence rates are considerably lower than in children. 
Males are more commonly diagnosed with TD than females in ratios of  
3-4:1 (Cavanna & Rickards, 2013; Robertson, 2000). The mean age of  onset 
of  TD is estimated at 7 years, ranging from 2 to 21 years of  age (Bloch & 
Leckman, 2009). Typically, tics start at 5-7 years of  age (range between 3 and 
8 years), and worsen at the age of  12, followed by a decline in severity during 
adolescence. By adulthood, it is estimated that roughly one-third of  children 
with TD may be tic-free. The onset of  vocal tics usually occurs around 2 years 
later than motor tics.
With respect to HD, current estimates on the population and lifetime prevalence 
of  hoarding symptoms are between 2-6% (Samuels et al., 2008; Mueller et al., 
2009, 2008; Iervolino et el., 2009; Timpano et al., 2011). HD is a condition 
typically associated with old age (Cath et al., 2016), although it is suggested 
that hoarding-specific behaviour can originate in childhood (Grisham et al., 
2006; Tolin et al., 2010). Ivanov and colleagues (2013) examined prevalence 
and heritability estimates of  hoarding symptoms associated with young 
age and gender; this study was performed in a population-based sample of  
15-year-old twins (N=3,974) in the Swedish Twin Register. It was reported 
prevalence rates of  2%, with a significantly higher preponderance for girls 
over boys, and suggested that sex-specific underlying etiological factors to 
hoarding symptoms may operate early in adolescence (Ivanov et al., 2013). 
No other study suggested quantitative or qualitative sex differences regarding 
influences from genetic vs. environmental factors in HD.  
Family studies investigate clustering of  a trait within families, i.e. in biological 
relatives, and provide a first insight into a possible contribution of  genetic 
factors to the etiology of  complex disorders. However, increased familial 
aggregation is in itself  not sufficient to prove a genetic origin of  a disorder, 
because phenotypic resemblance between family members may also be due to 
family members sharing a common environment.
The first family studies reported on OCD were based solely on family history 
data without directly interviewing the relatives of  patients themselves. Although 
these studies tend to underestimate the real disease rate within families, they 
Genetic Studies
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9have generated consistent conclusions on the familiality of  OCD (Eley et 
al., 2003; Hudziak et al., 2004; van Grootheest, Cath, & Boomsma, 2005). A 
total of  15 family study reports have appeared in the literature, of  which 8 in 
adults and 7 in children/adolescents, all using direct interviews with at least 
one family member, and in some instances combined with family history data 
(Grados et al., 2001; Horwath & Weissman, 2000; Nestadt, 2000). Overall, 
the results showed an up to 10-fold increased rate of  OCD in first-degree 
relatives of  children/adolescents with OCD, and a 2-fold increase in relatives 
of  adults with OCD. Interestingly, within families of  affected male probands, 
male relatives tend to report more tic symptoms, while female relatives more 
often present obsessive-compulsive behaviour (Pauls et al., 1995).
In contrast to family studies, twin studies can make a distinction between 
genetic and shared environmental factors by modelling the differences in 
correlations between monozygotic and dizygotic twins (Boomsma, Busjahn, 
& Peltonen, 2002). Twin studies of  OCD go back to 1929, with the first 
report on OC symptom pathology of  twins by Lange (1929). In the following 
40 years a number of  twin studies were published in OCD (for a historical 
overview, see van Grootheest et al. (2005). Two of  the largest clinical twin 
studies performed within the period of  the DSMIII diagnostic system (Carey 
& Gottesman, 1981; Skre, Onstad, & Kringlen, 1993) reported concordance 
rates for OCD of  45% in MZ pairs and 15% in DZ pairs (Carey et al. 1981), 
and of  33% in MZ pairs and 7% in DZ pairs (Skre et al. 1993) respectively, 
indicating a genetic background for OCD.
Other studies on the heritability of  OCD focused on OC symptoms 
(OCS) instead of  OC disorder. By using continuous data from self-report 
questionnaires of  a variety of  OC symptoms, and population-based 
epidemiological samples as opposed to clinically-based samples, larger twin 
samples could be recruited (Macdonald, Murray & Clifford, 1991). The 
first relatively large study performed on OC symptoms was conducted in 
an epidemiological sample of  419 twin pairs by Clifford et al. (1984). Using 
genetic structural equation modeling (SEM), the study obtained heritability 
estimates for obsessional traits and OC symptoms of  respectively, 44% and 
47%. Subsequent studies, using larger epidemiological sample sets, provided 
heritability estimates ranging between 26% and 65%, depending on age of  
the sample and sex (Eley et al., 2003; Hudziak et al., 2004; Jonnal, Gardner, 
& Kendler, 2000; van Grootheest, Bartels, & Boomsma, 2007). Bolton et 
al. (2007) estimated the heritability of  OC symptoms in a population-based 
sample of  854 6-year old twins to be 29% (Bolton, Rijsdijk, O’Connor, 
Perrin, & Eley, 2007). In recent years two studies have added a longitudinal 
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perspective to the twin design in cohorts of  children, adolescents and adults 
(Bolhuis et al., 2014; van Grootheest, Cath, & Boomsma, 2009). Stability as 
expressed by longitudinal phenotypic correlations was between 0.50-0.63, 
with substantial genetic contributions to symptom persistence (34%-56%), 
indicating not only that OC symptoms are influenced by genetic factors, 
but also that these factors are highly stable over time in adults. In children, 
stability of  OC symptoms was estimated at between 35%-51% for boys and 
between 28%-34% for girls (van Grootheest et al., 2007).
The first studies of  familial effects in TD (Shapiro et al., 1988) described an 
increased risk of  tics in families with TD probands. However, no distinction 
was made between recurrent childhood tics or newly onset adult tics in 
these reports. The first studies on newly developed tics in relatives of  TD 
probands reported increased frequencies of  tics/TD in these families when 
compared to the general population (Pauls, Cohen, & Kidd, 1981; Price, 
Kidd, & Leckman, 1985). The first large-scale family study utilizing direct 
interviews with patients and family members and employing a control group 
was published in 1991, showing a 10 to 100-fold increase among first-degree 
relatives of  affected family members (Pauls, Raymond, & Leckman, 1991). 
Further, increased prevalences of  tic disorders, ADHD, and OCD were 
found in parents and siblings of  4479 school-age children who were assessed 
for TD and tic disorders (Khalifa & von Knorring, 2005). Stewart et al. 
(2006) assessed (direct-interview) 692 relatives of  239 patients diagnosed for 
TD, ADHD/TD and ADHD, with the aim to explore familial associations 
between TD and ADHD. This case-control study found an increased risk 
of  comorbid TD and ADHD among relatives of  cases diagnosed for one 
of  these two disorders (Stewart et al., 2006). A large multi-generational 
family sample from Sweden assessed 4826 individuals for TD and chronic tic 
disorder between the periods of  1969-2009. There was an increased risk for tic 
disorders proportional to the degree of  genetic relatedness, with first-degree 
relatives having a risk of  1:18.69 (odds ratio), and heritability of  tic disorder 
estimated at 0.77 (Mataix-Cols et al., 2015). A slightly different approach 
was taken by de Haan and colleagues (de Haan et al., 2015) who estimated 
heritability of  different tic symptom factors, carrying out a factor analysis in 
a sample of  probands (N=494) and their family members (N=351). Three 
factors (complex vocal tics and obscene behavior; body tics; head/neck tics) 
formed a core etiological entity, with heritabilities between 0.19-0.25. Recent 
factor analysis studies of  symptoms tried to uncover tic-based subtypes or 
TD-related phenotypes including both tics and co-morbidities. Hirschtritt et 
al. (2016) analysed item-level data from 1191 TD probands and 2303 first-
degree relatives and identified a sub-phenotype characterized by high rates 
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of  social disinhibition, with a heritability of  0.53 (SE=0.08, P=1.7x10-18) 
(Hirschtritt et al., 2016). Darrow et al. (2016) reported similar results for 
3494 individuals assessed for TD, OCD and ADHD symptoms – two cross-
disorder (TD-related) phenotypes were identified: disinhibition (heritabilities 
0.35, SE=0.03, p= 4.2x10-34) and symmetry (heritability 0.39, SE=0.03, p= 
7.2x10-31) (Darrow et al., 2016).
Fewer twin studies have been performed in TD than in OCD. The available 
evidence points to a genetic basis of  the disorder. The largest clinical study 
(MZ twins: N=60, DZ twins: N=26) found concordance rates in MZ and DZ 
twins of  77% and 23% (Price, Kidd, Cohen, Pauls, & Leckman, 1985). Another 
clinical study analysed the concordance rates for TD and tic disorders among 
MZ pairs (N=16 pairs) in relation to intra-pair differences in birth weight. 
Results showed 56% concordance rates of  TD and 94% of  tic disorder. The 
results suggested that prenatal events could be affecting different phenotypic 
expression for TD – i.e. intra-pair birth-weight difference was found to be 
a predictor of  the intra-pair difference for tic scoring (Hyde, Aaronson, & 
Weinberger, 1992). Heritability estimates from epidemiological studies range 
between .28 and .56 (Bolton et al., 2007; Anckarsäter et al., 2011; Lichtenstein 
et al., 2010; Pinto et al., 2016). 
As a result of  hoarding disorder’s past definitions in DSM-III and IV, the 
majority of  previous published family studies on HD have used clinical 
samples of  OCD and estimated frequencies of  hoarding symptoms from 
the hoarding dimension of  OCD. With respect to those studies specifically 
targeting hoarding symptoms, the numbers of  non-OCD hoarding cases were 
usually low. Still, evidence gathered from somewhat earlier family studies has 
been suggestive towards the familiality of  HD (Pertusa et al., 2008; Seedat & 
Stein, 2002; Winsberg et al., 1999).
Equally, only a handful of  population-based heritability studies have been 
published so far. To date, a total of  seven studies have estimated the genetic 
contributions to HD, and results range between 0.33-0.50 (Iervolino et al., 
2009, 2011; Taylor et al., 2010; Ivanov et al., 2013; Nordsletten et al. 2013; 
Mathews et al., 2014). Taylor (2010) studied a Canadian-based sample of  
twin pairs (N=167 MZ; N=140 DZ) and reported heritability proportions 
of  0.42 (Taylor et al., 2010). Three studies have emerged from the TwinsUk 
twin register, analysing a sample consisting of  adult females (N=5022); 
heritability estimates were reported at around 0.50 (Iervolino et al, 2009; 
2011; Nordsletten et al., 2013). More recently, Mathews (2014) analysed a 
population-based family sample from the Netherlands Twin Register (NTR). 
This study included 7,906 twins and respective family members (totalling 
12
15,914 individuals) and heritability was estimated at 0.36. The study from 
Ivanov et al. (2013) reported heritability of  0.32 for boys only, whereas for 
girls the role of  additive genetic factors was negligible (Ivanov et al., 2013). It 
is noteworthy that these studies provided supportive evidence for the genetic 
contribution regarding HD symptomatology to be separate from OCD. The 
studies by Iervolino et al. (2009; 2011) estimated genetic correlations for 
OCD and HD at 0.45, within the range of  what is reported for any other two 
internalizing disorders (Tambs et al., 2010).
Linkage studies seek to find genetic markers co-segregating with the disease/
phenotype of  interest that are possibly ‘linked’ to the causal genetic variants. 
The linkage approach involves scanning large family pedigrees with known 
disease transmission patterns, and narrowing down regions of  the genome 
that segregate in association with the disorder. 
So far, five studies on OCD have been performed (Hanna et al., 2002, 2007; 
Shugart et al., 2006). Results implicated genomic regions on chromosomes 
1q, 3q, 6q, 6p, 6q, 7p, 9p, 10p, 11p, 14q, 15q and 19q. However, none of  these 
results reached genome-wide significance. Hanna et al. in 2002, conducted a 
study in 56 individuals from seven families scanned for childhood OCD, and 
found region 9p24 to be a candidate region with linkage (Hanna et al., 2002), a 
finding that was replicated by Willour et al. (2004). A suggestive signal (LOD 
score= 3.13 - usually the threshold for genome-wide linkage significance 
is 3.6) was reported in three Costa Rican families in region 15q14 (Ross et 
al., 2011), overlapping with findings from a previous study (Shugart et al., 
2006). The strongest signal so far (LOD score = 3.77) was recently found on 
the 1p36 region, by Mathews et al. (2012) in 33 Caucasian families (n= 245 
individuals) with childhood onset OCD (Mathews et al., 2012).
In TD, five genome-wide linkage studies have been performed with 
inconsistent results (Barr, Wigg, & Tsui, 1997; Mérette et al., 2000; Simonic, 
Gericke, & Weber, 1998; The Tourette Syndrome Association International 
Consortium for Genetics [TSAICG], 1999, 2007). In 1997, the Tourette 
Syndrome Association International Consortium for Genetics (TSAICG), 
published a linkage scan on 110 sib pairs, and found suggestive evidence 
for linkage in regions 4q and 8p (TSAICG, 1999). Simonic et al. (2001) 
studied an Afrikaner population using linkage transmission disequilibrium 
tests (TDT), and replicated previous findings for linkage in three previously 
identified regions, 2p11, 8q22, and 11q23-24 (Simonic et al., 1998; Simonic 
et al., 2001). Interestingly, for this last region (11q23-24), another study from 
Linkage Studies
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a French-Canadian population of  127 families found the marker D11S1377 
to be statistically significant for linkage (LOD score=3.18) (Mérette et al., 
2000). The largest linkage study so far, was from TSAIC (2007) within a 
collaborative effort comprising 2040 individuals from 238 nuclear families 
and 18 multigenerational families. Statistically significant linkage was found 
for marker D2S144 on chromosome 2p32.2 (TSAICG, 2007).
Zhang and colleagues (2002) performed a genome-wide scan for HD in 77 
sibling pairs diagnosed for TD, within the scope of  TSAICG  mentioned 
above. The top hits were in the regions 4q34-35 (P=.0007), 5q35.2-35.3 
(P=.000002) and 17q25 (P=.00002). Despite only nominally significant, its 
noteworthy that the 4q region had been previously identified by the same group 
as possibly linked to TD (TSAICG, 1999). Similarly, another study attempted 
to find chromosomal regions specific to compulsive hoarding, scanning a 
total of  219 families with OCD, as part of  the OCGS consortium. A region 
in chromosome 14 (marker D14S588) was found suggestively linked with 
HD (LOD=2.9) (Samuels et al., 2007) . Following this, Liang et al. suggested 
that the regions 9q (harbouring the SLC1A1 gene) and 14q interacted, 
when considering compulsive hoarding within OCD-diagnosed individuals 
(Liang et al., 2008). Importantly, a study by Mathews et al. (2007) provided 
a comprehensive analysis over a set of  11 multigenerational families with 
OCD, that had been gathered over the years. The goal was to phenotypically 
characterize this dataset regarding its power and other clinical characteristics, 
to detect linkage in the context of  HD. Indeed in this report, Mathews (2007) 
showed that the total of  92 individuals (44 with OCD) that comprised this 
dataset had a number of  characteristics (namely adequate power) to detect 
linkage within the scope of  OCD, but a higher number of  families was still 
needed for reasonably powered linkage studies in HD (Mathews et al., 2007). 
Linkage studies were the primary method for genetic analysis until the era of  
large-scale genome-wide association studies. Because linkage studies require 
large family pedigrees and several affected generations with a disease of  
interest, or large numbers of  affected sibling pairs, they became less popular 
over the years. When dense genotyping became feasible at reasonable costs, 
genome-wide association studies in unrelated subjects quickly lead to successes 
for numerous complex traits and diseases, including genetic disorders (Ripke 
et al., 2013).
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Genetic association studies can be performed at a population level, in large 
samples of  unrelated persons, and done either for candidate genes or for 
genome-wide SNP markers. Candidate gene studies require prior (biological) 
hypotheses, either from positional information of   a gene(s), or on a gene(s) 
that has a potential functional relevance to the disease under study (gathered 
either from pharmacological studies, animal/theoretical models or linkage 
studies). With the advent of  genome-wide association studies (GWAS) and 
the decreasing costs in measuring of  genetic variants, candidate gene studies 
have become less important. Here we summarize the genes found so far 
through candidate gene studies, i.e. reported more than once to be implicated 
in either OCD, TD/tic disorders or HD. Most studies searching for genes 
associated with OCD, TD and HD focused on central nervous system (CNS) 
neurotransmitters, or CNS neurodevelopmental pathways. Particularly, genes 
in the serotonergic, dopaminergic and glutamatergic systems, that are also 
often the pharmacological targets of  prescribed drugs, have been studied. 
Results have implied the glutamate transporter SLC1A1, the serotonin 
transporter SLC6A4, the MAOA gene encoding the enzyme monoamine 
oxidase A, the COMT gene encoding catechol-O-methyl transferase affecting 
dopaminergic functioning, the DRD4 gene, and the NTRK3 gene.
A de novo mutation in the serotonin transporter SLC6A4 gene has been 
implicated in OCD and comorbid disorders (anorexia nervosa, autism) in a 
study in two unrelated families (Ozaki et al., 2003). This finding was replicated 
in two family studies in OCD (Hu et al., 2006, Voyiaziakis et al., 2011). A 
recent meta-analysis of  a total of  113 genetic association studies in OCD 
identified COMT and MAO-A polymorphisms associated with OCD in 
males (Taylor et al., 2013). Still, the only consistent replication so far, has been 
associated with the glutamate transporter gene SLC1A1 (Arnold et al., 2006, 
Wendland et al., 2009, Stewart et al., 2007).
For TD, attention has largely focused on SLITRK1 gene, a member of  the 
SLIT and TRK family proteins, involved in the control of  neurite outgrowth. 
In 2005, Abelson et al. mapped an inversion and two subsequent mutations 
at 13q33.1, close to the gene SLITRK1 (13q31.1), in two patients with TD 
(Abelson et al., 2005). Subsequently, a Canadian based family study identified 
one polymorphism tagging the major haplotype of  SLITRK1, and these 
findings were later replicated (Karagiannidis et al., 2012; Miranda, Wigg, & 
Barr, 2008). With respect to the dopamine receptor gene DRD4, Liu et al. 
(2014) studied a tandem repeat polymorphism in DRD4 in a population-
Genetic Association Studies
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based Han Chinese sample. Results suggested a protective role for the 
2-repeat allele and a deleterious role for the 4-repeat allele (Liu et al., 2014). 
Lastly, a mutation in the HDC gene (involved in the neuronal histaminergic 
pathways) was described in a multi-generational linkage family-study where 
the father and all his eight children were diagnosed with TD (Ercan-Sencicek 
et al., 2010). A subsequent study in 520 nuclear families with TD, found a 
significant association of  SNPs rs854150 and rs1894236 (intronic SNPs in 
gene HDC), providing supportive evidence for the role of  this gene in the 
development of  TD (Karagiannidis et al., 2013).With respect to HD, Alonso 
et al. (2008) specifically investigated whether the NTRK3 gene increases the 
susceptibility to hoarding in OCD, by studying 52 tag SNPs in a sample of  
120 OCD patients and 342 controls. This gene was investigated following 
its implication in, both neuronal proliferation and differentiation during 
embryonic development stages, and neuronal growth and survival in the 
adult developed nervous system. This study identified the SNPs rs1017412 
(OR=2.16, P=0.001) and rs7176429 (OR=2.78; P=0.0001), in the NTRK3 
gene, associated with compulsive hoarding (Alonso et al., 2008). 
GWAS
The focus of  genetic research has recently shifted from candidate gene studies 
to GWAS that seek to establish an association between common genetic 
variants of  small effect and a trait of  interest. Through large international 
collaborations (e.g., the Obsessive-Compulsive Foundation International 
Genetic Consortium [OCF-genetics consortium], the OCD Collaborative 
Genetics Association Study Group [OCGAS consortium], the Tourette 
Syndrome Association International Consortium for Genetics [TSA genetic 
consortium], and TIC-genetics, all collated within the Psychiatric Genomics 
Consortium), and high-throughput analysis techniques, very large datasets of  
cases and controls have become available. Participants in these studies are 
genotyped, and the genotype data imputed based on a common reference set, 
allowing for meta-analyses in much larger numbers of  subjects. The genomic 
era has allowed scientists to measure and impute millions of  common genetic 
variants in the human genome, called SNPs (single nucleotide polymorphisms), 
which represent a form of  common inter-individual genetic variation across 
the human genome.
GWAS studies are largely hypothesis-free and exploratory. They entail 
scanning the entire genome for SNPs that are associated with the phenotype 
of  interest, i.e., that vary in allele frequency between cases and controls. The 
rationale behind these studies is that the collective variation embedded in 
all these SNPs can account for a statistically significant effect and play an 
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important role in the development of  disorders. The exploratory nature of  
GWAS, involving large numbers of  statistical tests, has forced a stringent 
control of  type I error rate by setting very low p-value thresholds (the generally 
accepted genome-wide threshold is 5.0x10-8, (Hoggart, Clark, & Balding, 
2008; Risch & Merikangas, 1996), prompting the need for large datasets. 
Unlike candidate gene studies, genome-wide data in GWAS additionally allow 
controlling for population stratification effects – the systematic difference 
in allele frequencies between subpopulations (or cases/controls). Here we 
briefly summarize the knowledge gathered so far in this field.
Four GWAS in total have so far been conducted for OCD, TD and HD. 
The International OCD Foundation Genetics Consortium (IOCDF-GC) 
performed a first GWAS in OCD, involving 1465 cases, 5557 controls and 
400 trios (Stewart et al., 2013). Two separate case-control analyses were 
performed with and without the trios with a total of  469,410 autosomal SNPs 
and 9657 X-chromosome SNPs. The study found two trend-significant SNPs 
(P = 2.49 x 10-6 , P = 3.44 x 10-6) located in the DLGAP1 gene in the case-
control analysis, and a significant SNP (P = 3,84 x 10-8) near the BTBD3 
gene. However, in the subsequent meta-analysis combining the trios and the 
case-control samples, no genome-wide significant SNPs were obtained. A 
second GWAS was published recently by the OCGAS, consisting of  1406 
individuals with OCD among a total sample of  5061 individuals from 1065 
families (Mattheisen et al., 2014). The authors failed to find any genome-wide 
significant result, but their follow-up gene-based analysis revealed a significant 
association of  OCD with IQCK, C16orf88 and OFC11, all protein-coding 
genes. 
In TD, one GWAS study has been performed so far, published in 2012 by 
the TSAICG, in a sample of  1285 cases and 4964 ancestry-matched controls 
(Scharf  et al., 2013). The top signal, a SNP located in the COL27A1 gene, 
did not reach genome-wide significance (P = 1.85 x 10-6), which might be 
the result of  power issues. Currently, several GWAS replication efforts are 
underway through world-wide consortia (TSAICG replication effort, EM-
TICS, TS-EUROTRAIN).
Finally, for HD one GWAS was published in 2010 in a sub-sample of  genotyped 
individuals (N=3410) from the TwinsUK, consisting of  predominantly 
female (91.8%) singletons  (Perroud et al., 2010).  Two loci showed suggestive 
evidence for association with HD, in chromosome 5 and 6. Noteworthy, these 
results remained after correcting for other OCD traits, suggesting specific 
effects of  these SNPs separate from any other OCD sub-dimensions.
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Copy Number variants (CNV) entail a form of  variation where segments 
of  DNA may be duplicated or deleted and people differ in the length of  
these segments. Following this approach, a study by Fernandez et al. (2012) 
analysed rare CNVs (population frequency <1%) in a case-control study of  
460 individuals with TD. Pathway analysis revealed the enrichment of  genes 
involved in histaminergic pathway, mapping within the region of  these rare 
CNVs. Interestingly, these rare CNVs for TD overlapped with previous 
findings for autism spectrum disorder (Fernandez et al., 2012). The first 
GWAS on copy number variants in TD was performed in an ascertained 
sample from Latin America (210 cases and 285 controls) (Nag et al., 2013). 
Results showed an increase of  large CNVs among cases compared to controls 
with four duplications and two deletions were located in the COL8A1 and 
NRXN1 gene, respectively. McGrath and colleagues performed a cross-
disorder genome-wide CNV analysis on TD and OCD (McGrath et al., 2014). 
Large CNVs (>500kb) with frequency <1% were assessed in a case-control 
design (2,699 cases; 1,789 controls), ascertained for OCD (N=1,613) and 
TD (N=1,086). A 3.3-fold increase of  large deletions was observed among 
OCD/TS cases compared to controls, mostly located in the 16p13.11 locus, a 
region previously linked to other neurodevelopmental disorders, with weaker 
evidence in the TD cases than in the OCD cases (McGrath et al., 2014). 
Bertelssen et al. (2014) screened 188 TD cases from a Danish cohort, and 
identified seven patients with intronic deletions in the IMMP2L gene, with a 
significant higher frequency (p=0.045)) when compared to both the Danish 
control population and the genotyping reference panel (Affymetrix) cohort.
SNP Heritability and Genetic Correlations
GWAS studies focus on the identification of  common genetic variants. Other 
techniques focus on the estimation of  the heritability of  a trait as a result of  
all measured and imputed SNPs (referred to as SNP-based heritability), i.e. 
the amount of  heritability explained by the joint effect of  common variants 
across the genome. This method – often referred to as Genome-Wide 
Complex Trait Analysis (GCTA) - calculates the genetic similarity between 
individuals based on the measured SNPs, and estimates how much of  this 
similarity explains their phenotypic resemblance. In the bivariate situation, 
genetic relatedness can be used to explain the genetic correlation between the 
phenotypes. In an attempt to assess the degree of  shared heritability between 
OCD and TD (Davis et al., 2013), Davis and colleagues performed GCTA 
with data were collected in the scope of  the consortia mentioned above—
TSAICG and IOCFGC. In this study SNP heritabilities for OCD and TD 
were reported at 0.37 and 0.58, respectively. Interestingly, it was found that 
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Total Heritability estimates of  OCD, TD/tic and HD disorders range between 
.27-.65 for OCD, between .25-.77 for TD and between 0.35-0.50 for HD. 
With respect to genetic factors underlying the etiology for these disorders, 
we expect the genetic liability to be highly polygenic with small effect sizes 
for the individual SNPs. With the increase in sample size and the continued 
collaborations in the field of  psychiatric genetics, we also expect that new 
genetic variants will soon be uncovered.
An open issue is the discrepancy between heritability estimates as found in 
epidemiological twin studies (between 0.25-0.37) versus clinical TD samples/ 
TD families using either SEM or SNP-based methods (between 0.25-0.56). 
Explanations might be 1) a larger amount of  measurement error in the 
epidemiological samples (as a result of  retrospective self-report measures used 
on lifetime tic occurrence). Generally, measurement error adds to inflated 
estimates of  unique environmental influence, and lower heritability estimates. 
Alternatively, 2) the discrepancy between clinical and epidemiological samples 
might reflect phenotypic differences. TD family studies might have an over-
representation of  participants with persistent TD, which might be associated 
with increased genetic load. By contrast, the epidemiological studies also 
included subjects with childhood-only tic disorders and may be genetically 
more heterogeneous, or may represent a group in which environmental 
factors play a larger role.
To conclude, we have witnessed a remarkable progress in our conceptualization 
of  TD, OCD and HD in the recent decades. By 1986 TD was conceptualized 
for TD 21% of  the heritability was explained by rare SNPs (with a frequency 
in the population of  less than .05), whereas for OCD the entire heritability 
was attributable to common SNPs. The results of  the bivariate analysis 
combining both datasets (OCD and TD) revealed a genetic correlation of  
0.41 (se=0.15, p=0.002). This reflects the genetic overlap, i.e., the degree 
of  shared heritability between these two disorders. Following on their first 
collaborative effort on GWAS in TD and OCD (Scharf  et al., 2013; Stewart 
et al., 2013), a PRS analysis was carried out in the same groups. The combined 
GWAS analysis, as described above, sought to unravel functional variants 
shared between these two disorders (Yu et al., 2014). The aggregated risk 
score in the discovery sample was then evaluated for predicting the disease 
status on the target sample. This analysis failed to detect a polygenic signal, 
and the overall conclusion from this work pointed towards specific, rather 
than shared, genetic effects underlying the etiology of  OCD and TD.
Conclusions and Directions for Future Research
19
as an autosomal dominant genetic disorder (Pauls and Leckman, 1986), with 
only a few genes with a large effect contributing to its expression. Moreover, 
within TD families co-morbid OCD was then considered as an alternate 
expression of  the same phenotype (Pauls and Leckman, 1986). It is largely 
consensual now that TD is highly heterogeneous, mediated by large numbers 
of  SNPs of  small effect, with influences of  CNVs and rare variants, and that 
TD and OCD only partly share genetic architecture. HD was diagnosed as 
mental disorder not until as recent as 2013. Current technology on genetic 
research offers interesting perspectives for new discoveries and understandings 
of  these three disorders in the near future. First, a number of  international 
consortia and collaborative efforts aim to standardize phenotyping and 
diagnostic criteria. This will allow researchers to increase sample sizes, and 
combine information from different populations worldwide while properly 
accounting for population stratification and cultural differences.
Second, we expect that OCD, TD and HD will undergo a similar scenario to 
that of  other psychiatric disorders such as schizophrenia, for which, within 
less than a decade after the first GWAS published, more than 100 loci were 
identified as a result of  huge sample sizes (n= 37,000 cases and 113,000 
controls) in collaborative GWAS meta-analytic efforts (Ripke et al., 2014). 
Shortly following this report, the involvement of  the Major histocompatibility 
complex (MHC) locus was confirmed, specifically the role of  complement 
component 4 (C4) genes in the reduced number of  synapses in the brains 
of  schizophrenic individuals (Sekar et al., 2016). These genes regulate the 
expression of  the human C4 protein, which has a central role in the Classical 
Complement pathway, part of  the innate immune system. This seems to 
confirm hypotheses that SCZ may in part be mediated by an affected immune 
system. In the near future, largely increased sample sizes due to worldwide 
consortia might equally yield results with respect to gene pathways involved 
in other disorders.
Third, the fast development of  other genetic techniques in targeting other 
genetic variation than SNPs, including CNVs, de novo mutations or rare 
variants and micro RNAs supplemented by pathway and network approaches 
suggests that new insightful results will soon be generated. There is (overall) 
consensus that the emerged paradigm of  ‘missing heritability’ should be 
interpreted as ‘hidden’ rather than ‘missing’. Part of  this (so far) un-captured 
genetic variation may indeed be obscured in other forms of  genetic variation 
than the currently measured SNPs.
Lastly, it is expected that similar developments in other fields such as 
epigenetics, animal models, systems biology (proteomics, metabolomics and 
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genomics) and imaging genetics lead to new insights. In sum, there are many 
scientific roads that can be followed in understanding how OCD, TD and HD 
develop, how genes express themselves to cause liability for these diseases, 
and possibly provide new drug targets or treatment options.
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From their early conceptions in the nineteenth century until modern times, 
the field of  Psychiatric Genetics has undergone substantial transformation. Sir 
Francis Galton, widely regarded as the founder of  twin studies and behavioral 
genetics, was the first to study variation in human populations, publishing 
his highly acclaimed essay ‘Hereditary Genius’ in 1869, ten years following 
Darwin’s revolutionary work ‘The Origin of  Species’ (Darwin, 1859; Galton, 
1869). Along the decades, advances in this field have come from renowned 
figures in science, namely Gregor Mendel (postmortem), Ronald Fisher and 
Sigmund Freud. Equally, major scientific hallmarks have impacted the field of  
(psychiatric) genetics. The most notable developments including the statistical 
methodology underlying modern Twin studies and the later emergence of  
Quantitative genetics (Martin & Eaves, 1977; Rao & Morton, 1974; Wright, 
1949). 
Fast-forwarding to today, we are now witnessing a formidable age in genetics. 
In the past two decades, the advent of  large-scale high-throughput DNA 
technologies have allowed scientists to scan through millions of  genetic 
variants in thousands of  genomes, providing us with unique insights into 
the basis of  individual differences in behavior. It is at this juncture that this 
dissertation stands. From Structural Equation Modeling and Twin studies, 
to molecular and statistical genetics, the field of  Psychiatric Genetics (and 
more broadly Behavioral Genetics) brings together these complementary but 
separate disciplines with the goal of  understanding the nature and causes 
(etiology) of  psychiatric conditions. 
The work within this dissertation focuses on obsessive-compulsive disorder 
(OCD), Tourette Disorder (TD) and tic disorders, and hoarding disorder 
(HD), conditions at the core of  obsessive-compulsive behavior. The three 
main objectives are 1) to identify the relative contributions of  genetic and 
environmental factors underlying these phenotypes; 2) to quantify the degree 
to which these factors are shared across these phenotypes and 3) characterize 
the genetic (and epigenetic) architecture underlying the etiology of  these 
phenotypes.  
This dissertation is organized as follows:
Chapters 2-4 provide a series of  genetic epidemiological analyses on these 
phenotypes based on the classical twin design. The twin method allows us 
to disentangle the relative contributions genetics and environmental factors 
to the variability of  a given phenotype, by comparing the relatedness across 
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different family members. The Netherlands Twin Register (NTR) contains a 
large population-based twin-family sample, providing a unique opportunity 
for twin studies. In particular, Chapter 2 presents longitudinal genetic 
epidemiological analyses on the stability in time of  Obsessive-compulsive 
symptoms, and the relative contribution of  environmental or genetic factors 
to this stability. To this end, we had at our disposal self-report longitudinal 
data collected at the NTR at two different time points corresponding to 
the 6th (2006) and 8th (2008) waves of  collection. Chapter 3 presents a 
comprehensive analysis on the heritabilities of  four different tic phenotypes. 
Here, the most reliable phenotype is described considering the most reliable 
heritability estimate. Four different tic phenotypes (according to DSM IV) 
were analysed with respect to the contribution of  genes, and environmental 
factors, and their impact on future genetic studies is discussed. Chapter 4 
explores the (co)-variation of  OCD, TD/tic disorders and HD, regarding 
their shared underlying genetic and environmental factors. 
Chapters 5-8 make use of  large SNP-array datasets made available from the 
field of  genetic association analysis. We explore the genetic variance captured 
within these SNP-arrays, in search for variants associated with these disorders. 
Specifically, Chapter 5 describes a series of  exploratory genetic analyses into 
the genetic basis of  OC symptoms, and the informative value of  a population-
based twin-family sample  in the context of  GWASs. In Chapter 6, a GWAS 
on TD within the NTR is described, and the results of  a meta-analysis with 
the results obtained in a GWAS performed by TSAIGC – an international 
consortium for the study of  TD, combining a population-based cohort from 
the NTR with a clinically-based sample. Chapter 7 presents the results of  a 
genetic meta-analysis for HD, the first ever published, and only the second 
ever performed GWAS on HD. Chapter 8 presents the results of  a polygenic 
risk score analysis of  OC symptoms. 
Finally, in chapter 9 an epigenome-wide association study on tic disorders is 
presented. 
In conclusion, chapter 10 summarizes and discusses these findings in concert. 
The work ends with future perspectives within the field.
. 
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Chapter 2
Genetic and Environmental Contributions to Stability 
in Adult Obsessive Compulsive Behaviour
This chapter is based on: Zilhao, N. R., Smit, D. J. A, den Braber, A., Dolan, C. V, Willemsen, 
G., Boomsma, D. I., & Cath, D. C. (2014). Genetic and Environmental Contributions to 
Stability in Adult Obsessive Compulsive Behavior. Twin Research and Human Genetics, 
18(1), 52–60.
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This study investigates the relative contribution of  genetic and environmental 
factors to the stability of  obsessive-compulsive (OC) symptoms in an adult 
population-based sample. We collected data in twin pairs and their siblings 
using the Padua Inventory Revised Abbreviated, from the population-
based Netherlands Twin Register in 2002 (n=10.134) and 2008 (n=15.720). 
Multivariate twin analyses were used to estimate the stability of  OC 
symptoms as a function of  genetic and environmental components. OC 
symptoms were found to be highly stable, with a longitudinal phenotypic 
correlation of  .63. Longitudinal broad sense heritability was found to be 
56.0%. Longitudinal correlations for genetic (r=.58 for additive, r=1 for 
non-additive genetic factors) and non-shared environment (r=.46) reflected 
stable effects, indicating that both genes and environment are influencing the 
stability of  OC symptoms in adults. For the first time evidence is reported for 
non-additive genetic effects on the stability of  OC symptoms. In conclusion, 
this study showed that OC symptoms are highly stable across time in adults, 
and that genetic effects contribute mostly to this stability, both in an additive 
and non-additive way, besides non-shared environmental factors. These data 
are informative with respect to adult sample selection for future genetic 
studies, and suggest that gene-gene interaction studies are needed to further 
understand the dominance effect found in this study.
Abstract
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Obsessive Compulsive Disorder (OCD) is characterized by intrusive, unwanted 
thoughts, and repetitive behaviours performed in a ritualized fashion (APA, 
1994). It has a lifetime prevalence of  0.5 – 2.0 % (APA, 1994), and it is, 
among all anxiety disorders, recognized by the World Health Organization 
(WHO) as a leading cause for non-fatal illness-related disability, affecting 
mostly individuals between 15 and 44 years of  age (WHO, 2007). Quality of  
life is seriously impaired in OCD, more so than for instance in depression 
(Srivastava et al., 2011).Various longitudinal clinical studies have established 
that, in contrast to children/ adolescents in whom OC symptoms seem to 
remit somewhat more often (Fernández de la Cruz et al., 2013; Leckman et al., 
2009; Micali et al., 2010; Stewart et al., 2004),  in adults OC symptoms tend to 
be more stable with respect to symptom dimensions, with probability estimates 
of  full remission between 17% and 27%, and of  partial remission of  between 
22% and 53% in course up to 40 years, depending on study methodology 
(prospective versus retrospective), and country of  origin (Alonso et al., 2001; 
Eisen et al., 2013; Mancebo et al., 2014; Orloff  et al., 1994; Reddy et al., 
2005; Skoog & Skoog, 1999; Steketee et al., 1999). Specifically in patients 
who only experience partial treatment response, symptoms recur in up to 
70% within 5 years of  follow-up (Eisen et al., 2013). Longitudinal studies on 
OC symptoms are far more scarce in epidemiological than in clinical cohorts, 
both in children and in adults (Angst et al., 2004; Fineberg et al., 2013). Only 
two studies examined OCD and OC symptoms in a community cohort. The 
Zurich community cohort study followed a group of  adolescents for 30 years 
(Angst et al., 2004; Fineberg et al., 2013). This study indicated that over these 
30 years, at age 50 in more than one third of  the sample OC symptoms 
had not remitted. Fullana et al. (2007) examined the temporal stability of  
obsessive-compulsive dimensions over a period of  2 years in undergraduate 
students, and found no significant changes in OC symptom scores between 
baseline and follow-up, except for the occurrence of  obsessions (Fullana et 
al., 2007). These data provide a longitudinal perspective on OCD and OC 
symptoms in adults, but do not address the etiology for the observed stability, 
of  which still little is known. 
Several family-based studies have indicated a familial basis for OCD, with 
increased frequencies of  OC symptoms in first degree relatives (Rosario-
Campos et al., 2005; Pauls et al., 1995). Population based twin family studies 
have shown that variation in OC symptoms is heritable (Rosario-Campos et 
al., 2005; Hudziak et al., 2004; Iervolino et al., 2011; Pauls et al., 1995) with 
somewhat lower heritabilities in adults (h2 ranging between 0.30-0.40) than in 
children (h2  between 0.45-0.58 for 12 year old twins; (Hudziak et al., 2004), 
Introduction
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and 55% for 6 year old twins (Bolton et al., 2009), and little support for 
common environment and non-additive genetic effects. 
Some recent studies have extended these findings by introducing a 
longitudinal twin design. A first longitudinal study at the Dutch Twin register 
(van Grootheest et al., 2007)  examined the stability of  OC symptoms in 
twins aged 7, 10 and 12 years old. The twins were measured on OC symptoms 
using the Obsessive Compulsive Scale of  the Child Behavior Checklist 
(CBCL-OCS). The twin design allows stability to be attributed to either 
genetic or environmental factors. Van Grootheest et al. (2007) reported an 
average phenotypic longitudinal correlation of  0.5 across a five-year period 
in children between ages 7, 10 and 12. Genetic factors explained a substantial 
part (between 35% (father ratings) and 51% (mother ratings)) of  this OC 
symptom stability. Fully in line with these findings, Bolhuis et al. (2014) used 
OC symptom data from a longitudinal cohort of  adolescent twins and siblings 
(n=2651; the Genesis 12-19 study; mean age 15yrs), and a cross-sectional 
sample of  adult twins (n=4920; mean age=55years) to explore genetic 
and environmental relationships between OC and depressive symptoms 
both cross-sectionally and longitudinally (Bolhuis et al., 2014). Within the 
adolescent sample, covariance (ß) between OC symptoms at timepoints 1 
and 2 (with mean 25 months interval between measurements) was 0.48 (CI 
between 0.42-0.56), indicating substantial stability over time.
A previous genetic epidemiological study has been conducted in adult twins 
within the Dutch Twin Register on OC symptoms (van Grootheest et al., 
2009). Twins (van Grootheest et al., 2009) (average age at baseline:  17.8 
years) were measured at four time-points between 1991 and 2002, using two 
different measurement scales—the YASR-OCS (Nelson et al., 2001) at the 
first 3 timepoints and the Padua Inventory Revised Abbreviated (PI-R ABBR; 
(Cath et al., 2008) at timepoint 4. The correlation across time ranged between 
0.39 and 0.60 between sequential measurement occasions, and the longitudinal 
heritability was calculated to be around 40%. However, the stability measures 
of  OC symptoms and the etiology of  that variance may have been obscured 
by the use of  different measurement instruments at different time-points. It 
is reasonable to expect that different scales tag different sources of  variation, 
thus leading to an underestimation of  stability and the proportion of  that 
estimation to be attributed to genetic factors. 
Therefore, the aim of  the present study was to extend the findings of  the 
van Grootheest et al. (2009) study, overcoming the methodological weakness 
of  the previous study (different instruments used at different time points 
to measure OC symptoms), moreover including siblings in the analyses, to 
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explore OC symptoms over a period of  6 years, and to determine the genetic 
and environmental contributions to stability of  OC symptoms in a large 
sample of  adult twins and their siblings. OC symptoms were measured in 
2002 and in 2008, at a subsequent wave of  collection within the Netherlands 
Twin Register (NTR) with a large proportion of  the subjects overlapping with 
the 2002 wave. 
The data for this study were collected as part of  longitudinal survey studies 
of  the NTR. Since 1991, every two to three years, twins and their families 
are assessed and receive surveys by mail, with questionnaires about health, 
personality and lifestyle. For the present analysis, we analysed the Obsessive 
Compulsive (OC) data collected at the 2002 and 2008 wave of  collection, 
corresponding to survey 6 and 8. The total sample consisted of  20.376 
individuals from 7812 different families. To survey 6, 10.134 individuals 
responded, and 15.720 responded to survey 8. Longitudinal data were available 
for 5478 individuals. Twin participants with incomplete data on zygosity 
(N=41 for complete pairs, and N=170 for incomplete pairs) were excluded 
from the analysis. This study has been approved by the Medical Ethical 
Committee of  the VU Medical Centre Amsterdam. In the genetic analysis, 
we included a maximum of  four siblings (two brothers and two sisters) per 
family. Table 1 gives an overview of  the total number of  participants. The 
number of  complete twin pairs included in the study by zygosity, is given 
in Table 2. Zygosity was assessed by a questionnaire using items on physical 
similarity, blood group and DNA polymorphisms (Willemsen et al., 2013).
Materials & Methods
Participants and Procedure
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For both survey 6 and survey 8, OC symptom scores were measured with the 
Padua Inventory abbreviated (PI-R ABBR) (Cath et al., 2008). This 12 item 
questionnaire has been derived from the Padua Inventory-Revised (PI-R), a 
widely used 41 item self-report inventory on obsessive-compulsive symptoms 
with item ratings between 0-4, and 5 subscales (washing, checking, rumination, 
precision and impulses) (Sanavio, 1988; van Oppen, 1992). The 12 item PI-R 
ABBR contains 2 items on each subscale, items have been chosen based on 
the highest factor loadings in a previous validation study (Van Oppen et al., 
1995), and one item has been added to the rumination and impulses subscales.
Table 1. Number of participants included in genetic analysis.
Phenotype Measures
Genetic epidemiological twin studies are based on comparing the different 
degrees of  family relatedness between family members, to estimate the relative 
contribution of  the genetic and the environmental components to a trait. 
Monozygotic (MZ) twins share (nearly) all their genes, whereas Dizygotic (DZ) 
twins, just like non-twin siblings, share on average half  of  their segregating 
genes. In quantitative genetics, the total phenotypic variance is decomposed 
into variance components due to genetic (G), shared environmental (C) and 
non-shared environmental (E) factors. C reflects the common environmental 
effects shared by family members and E the non-shared environmental 
Genetic Modelling and Testing
Table 2. Number of twins by zygosity.
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influences i.e. the unique environmental component for an individual. The 
genetic variance can be additive (A), reflecting the additive effect of  different 
alleles, or non-additive (dominance; D), indicating interaction between alleles. 
The comparison between MZ and DZ twin and sibling correlations provides 
a first impression to the relative contributions of  each component. The 
greater the phenotypic similarity between MZ twins when compared to DZ 
twins and non-twin siblings, the more of  the variance of  the trait is explained 
by genetic factors. An MZ correlation that is the double of  DZ correlation is 
indicative of  additive genetic influences. DZ correlations higher than half  of  
the MZ correlations indicate the role of  shared environmental factors, while 
DZ correlations that are less than half  the MZ correlations indicate genetic 
non-additive effects (dominance). All genetic analyses were carried out with 
the use of  Structural Equation Modelling as implemented in OpenMx (Boker 
et al., 2011). A saturated model (with input of  a 6 x 6 data matrix of  2 twins, 
2 brothers, and 2 sisters for questionnaire data) was used to estimate familial 
correlations, to test for sex differences and for the effect of  age on the OC 
symptom scores. Next, to evaluate the stability of  the PI-R ABBR scores 
between the two time points, a bivariate saturated model (with input of  a 12 
x 12 data matrix of  2 twins, 2 brothers and 2 sisters, each with two time-point 
measures), was fitted. These models estimate variances and co-variances 
within and between MZ and DZ twins and between twins and siblings, and 
specify all correlations between family members. Next, a genetic model (ADE 
model) was fitted to the data to estimate the relative proportion of  A, D and 
E in OC symptom scores, as the twin correlations indicated an ADE, rather 
than an ACE model. The comparison between different models (e.g. ADE 
versus AE) was done by means of  likelihood-ratio tests. The negative log 
likelihood (-2LL) of  a more restricted model is subtracted from the -2LL 
of  a more general model. This generates a statistic that is distributed as a 
Χ² distribution with degrees of  freedom (df) equal to the difference in the 
number of  estimated parameters in the two models. The more parsimonious 
constrained model is selected if  the X² yields a nonsignificant p-value. An 
alpha of  0.01 was set as threshold for significance.
Longitudinal data were available for 5478 individuals (2048 males, 3430 
females). Their average age was 33.0 years (SD = 11.5) at survey 6, and 34.7 
years (SD = 14.6) at survey 8. The correlation between the two surveys was 
0.63. The effect of  age on OC symptom scores was a drop of  0.03 per year 
for both Survey 6 and 8.
Results
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Since the distribution of  OC symptom scores was skewed (skewness =1.10 in 
survey 6, and skewness =1.22 in survey 8 (Figure 1)), scores were transformed 
using square root transformation. The graph in Figure 2 plots the distribution 
of  OC symptom scores, after transformation of  the data (skewness= -0.315 
in survey 6, and skewness= -0.254 in survey 8). 
Figure 2. Distribution of OC symptom scores in both survey 6 (left), and 8 (right), after square-
root transformation of the data.
Figure 1. Distribution of OC symptom scores, before transformation of the data, in both survey 6 
(left), and 8 (right).
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The estimates for familial correlations are given in Tables 3 and 4, for surveys 6 
and 8 respectively. These are given for MZ and DZ twins, sib-sib and twin-sib 
pairs, and conditional on sex. Monozygotic males (MZM) and monozygotic 
females (MZF) correlations are moderate, and both sib-sib and sib-twin 
correlations, at survey 8, are smaller than half  the MZ correlations. The 
observed patterns in familial correlations, when comparing MZ correlations 
with all other first-degree relatives, suggest that genetic factors may play a role 
in individual differences for OC symptoms. We observed a high stability for 
OC symptoms across time with correlations of  0.629 for within individual 
measurements. Cross Twin-Cross Time correlations (Table 5) represent the 
correlations between the scores in one twin at one time-point, and its co-twin 
at another time-point. First and second-born twin correlations are constrained 
to be equal to second-born and first-born correlations. Cross Twin-Cross Time 
correlations were estimated for males and females separately, being slightly 
higher in males (MZ CTCT: Rmale = 0.400, Rfemale = 0.359; DZ/Sibling 
CTCT: Rmale = 0.130, Rfemale = 0.084). When estimated and compared 
between MZ and DZ twin pairs, the results suggest that the stability in OC 
symptom scores is predominantly due to genetic factors.
Table 3. Familial correlations estimated from Maximum likelihood, in survey 6.
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Table 5. Cross Twin - Cross Time correlations.
Table 4. Familial correlations estimated from Maximum likelihood, in survey 8.
Model fitting analyses are displayed in Table S1 (Supplementary Table S1) for 
surveys 6 and 8. There were no differences in variances across zygosity or 
between all pairs, and no differences in variances and correlations between the 
sexes. In both surveys, for twin-sib pairs, correlations could be constrained 
to be equal; equality assumptions were tested separately for males (Table S1, 
model 3 compared to model 2), for females (Table S1, model 4 compared 
to model 3), and for opposite-sex relatives (Table S1 , model 5 compared to 
model 4). Gender differences were also tested for equality and constrained to 
be equal (Table S1, model 6 compared to model 5). The correlation between 
MZM and MZF could also be constrained to be equal, estimated at 0.398 
(95% CI = 0.371 - 0.471) for survey 6, and 0.399 (95% CI = 0.356 – 0.440), 
for survey 8 (Table S1, model 7 compared to model 6).
Working from a fully saturated model, considering all results from model 
comparisons and the correlations between MZ and DZ twins, we decided to 
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Figure 3. Standardized and unstandardized (italics) estimates of the final ADE model for OC 
symptoms at the two time-points. Rectangles represent observed variables at the two time-
points, OCS 2002 (survey 6) and OCS 2008 (survey 8). Circles represent the latent factors A 
(additive genetic influences), D (dominant genetic influences) and E (non-shared environmental 
influences). The dashed line represents a non-significant path. The values represent the loadings 
of each observed variable in the latent factors.
next fit a genetic ADE model to the data. The relative contributions D could 
not be constrained to zero (Χ²=11.464, df=3, p=0.009), and consequently the 
best fitting model was the ADE. Figure 3 shows the unstandardized estimates 
of  the ADE model. This allows to compute the relative contributions of  both 
A, D and E for each time-point, given on the diagonal of  Table 6. 
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The results show that, for both time-points, the contributions of  A and D 
to OC symptoms are around 0.2. Because the contribution of  D could not 
be dropped from the model, this results in a broad sense heritability estimate 
(both A and D component) of  0.420 and 0.418 for survey 6 and survey 8, 
respectively. For non-shared environmental influences this was around 0.58 
for both time-points. The off-diagonal estimated in Table 6 gives the results of  
the decomposition of  the phenotypic stability between the two-time points. 
The result show that 56% of  the stability for OC symptoms is due to genetic 
factors (both A and D component). Non-shared environmental factors 
had a moderate contribution to the stability of  44%. Finally, longitudinal 
correlations were calculated, indicating the relative overlap of  genetic and 
environmental effects between the two time-points. The additive genetic 
correlation was estimated at .58 from the ADE model. This value indicates a 
moderately high overlap for the genetic influences between both time-points. 
For the D component a correlation of  1 was obtained, indicating a perfect 
overlap for non-additive effects between the two time-points, and that no 
new ‘D’ is involved at a later stage. For non-shared environmental factors the 
correlation was 46.
Table 6. Relative contributions of additive genetic and non-shared environmental 
influences within time (diagonal) and across time (off-diagonal) for PI-R ABBR.
Discussion
To our knowledge, this is the first genetic epidemiological study in twin adults 
assessing the longitudinal genetic and environmental contributions to the 
stability of  OC symptoms using the PI-R ABBR questionnaire at multiple time 
points. First, in slight contrast to the previous longitudinal study in children 
(van Grootheest et al., 2007), we found no quantitative sex differences in 
average OC scores or heritability estimates in this adult sample, with the 
same additive genetic factors influencing both males and females. In line with 
previous cross-sectional studies in adolescents at different time-points and 
in adults using the YASR-OCS (van Grootheest et al., 2007) and 2008, no 
evidence for a special twin environment was found, since correlations could 
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be equated across zygosities and between twins and siblings. Heritability 
estimates at each time-point were also in line with what is described in 
the literature. The values for the broad sense heritability (both A and D 
component), at both time points, were at around 42%, and the remaining 
variance was due to unique environment. In a recent paper, addressing the 
shared genetic and environmental contributions to both OC symptoms and 
hoarding, with the same adult twin data from NTR 2008 wave of  collection 
as used in these analyses, the authors found heritabilities of  40% for OC 
symptoms (Mathews et al., 2014). In an earlier report on the 2002 wave of  
data collection, Grootheest et. al found heritability rates of  38% and 44%, for 
males and females respectively, (van Grootheest et al., 2009). All these studies 
in adults found no contribution of  shared environment. Only in one study 
in children, a small contribution of  shared environment has been found at 
age 12 (van Grootheest et al., 2008), suggesting differences in environmental 
architecture underlying stability of  OC symptoms in children versus adults.
We found the OC symptoms to be highly stable with a longitudinal phenotypic 
correlation of  0.63 across a 6 year time interval. Van Grootheest et. al (van 
Grootheest et al., 2009), using the same 2002 wave of  data collection with 
the Padua-R-ABBR in 2002 as an end point, and the 1991, 1995 and 1997 
data waves that used the Young Adult Self  Report Obsessive Compulsive 
Scale (YASR-OCS) as starting points, found longitudinal phenotypic 
correlations of  around 0.2 (for the 11-year time interval) and 0.4 (for a 5 
year time interval). These different results could be explained by the fact that 
in that study the stability of  OC symptoms was calculated across different 
measurement scales. Furthermore, the patterns in Cross Twin-Cross Time 
correlations (r=0.367 for MZ twins, r=0.119 for DZ twins/siblings) show 
that the stability is due to both genetic and non-shared environmental factors 
(Table 6). This suggests that the same genes are expressed across time, and are 
influencing OC symptoms and also, that a substantial amount of  E reflects 
stable effects. Collectively, these set of  results show that in adults, data from 
men and women, as well as twins and non-twins of  different ages, can be 
combined, which is particularly beneficial in molecular genetic studies, where 
combining data will result in an increase in power to detect underlying genetic 
effects. 
Of  interest are the results regarding the decomposition of  the longitudinal 
phenotypic variance. Previously, it was reported that for children common 
environmental influences explain part of  the stability (around 40%) (van 
Grootheest et al., 2007), unlike what happens in adult family members, who 
generally do not share the same household any more with their respective 
39
co-twin. Instead, it was shown that in adults about 70% of  the stability was 
due to additive genetic factors (van Grootheest et al., 2009). Here, we found 
no common environmental influences for the stability of  OC symptoms but 
we have, however, presented for the first time new evidence for contributions 
of  unique environmental influences in adults, and these influences correlate 
substantially across time (r=0.46, Table 11). This relatively high contribution 
of  non-shared environment to the stability of  OC symptoms (off-diagonals 
in Table 6), indicates that unstable variance such as measurement error 
(time-point specific variance) cannot account for its variation. Therefore, 
individual experiences may have a relevant impact on the stability of  OC 
symptom in adults. The detrimental influence of  a early-life experiences 
might persist and influence OC symptomatology into adulthood. One study 
specifically addressed the influence of  unique and shared environmental 
factors in developing (or protecting against) OC symptoms, by comparing 
scores between highly concordant and highly discordant MZ twins (Cath et 
al., 2008). The comparison of  highly within-discordant pairs indicated some 
important influencing life-events, among which the most relevant appeared to 
be past experiences of  sexual assault. These possible risk factors were more 
highly associated with OC symptoms in high-scoring discordant MZ pairs 
than in high-scoring concordant MZ pairs, thus pointing to the relevance 
of  individual experiences in childhood in developing OC symptomatology. 
It appears then, that, once OC symptoms are acquired in early adulthood, 
stability tends to be higher and more genetically mediated than in children. 
For the first time, we observed significant non-additive genetic effects. 
Dominant effects have not been observed before for OC symptoms, even 
in the same subject sample. Non-additive variance encompasses all forms of  
genetic factors with a non-linear effect such epistasis/gene-gene interaction 
and dominant effects (Mather, 1974). This may have unexpected consequences 
for molecular genetics approaches, because most genome-wide technologies 
such as Genome Wide Association Analysis (GWAS) and Genome-wide 
complex trait analysis (GCTA) (Yang et al., 2011),  primarily assume additive 
genetic variance. These studies may have been underpowered by not including 
dominance in the linear regression models. Random effects modelling using 
GCTA to explain phenotypic variance (Yang et al., 2010) may not be able to 
provide SNP based heritability estimates for all genetic effects and lead to 
“missing heritability”, since modelling non-additive effects requires very large 
sample sizes (Yang et al., 2013). 
In sum, although our results for the broad sense heritability estimates (all 
genetic effects involved) are in line with what has been described before for 
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narrow sense heritability (Davis et al., 2013; van Grootheest et al., 2009; van 
Grootheest et al., 2007), they do indicate that the genetic etiology of  OC 
symptoms and their stability in time may be more complex than previously 
thought, and that some differences occur with respect to its underlying 
etiologies between children and adults. Molecular and genome-wide studies 
as well as twin studies could, in the future, include dominance effects in the 
linear regression, and/or take epistatic effects/gene-gene interactions into 
account. 
The Supplementary material can be found in the online version of this manuscript
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Chapter 3
Heritability of Tic Disorders: 
A Twin-Family Study
This chapter is based on: Zilhão, N. R., Olthof, M. C., Smit, D. J. A., Cath, D. C., Ligthart, 
L., Mathews, C. A., …, Dolan, C. V. (2016). Heritability of tic disorders: a twin-family 
study. Psychological Medicine 47(6), 1085–1096.
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Genetic-epidemiological studies that estimate the contributions of  genetic 
factors to variation in tic symptoms are scarce. We estimated the extent to which 
genetic and environmental influences contribute to tics, employing various 
phenotypic definitions ranging between mild and severe symptomatology, in 
a large population-based adult twin-family sample. In an extended twin-family 
design, we analysed lifetime tic data reported by adult mono- and dizygotic 
twins (n= 8,323) and their family members (n=7,164; parents and siblings) 
from 7,311 families in the Netherlands Twin Register (NTR). We measured tics 
by the abbreviated version of  the Schedule for Tourette and Other Behavioral 
Syndromes (STOBS) (TSAICG, 2007). Heritability was estimated by genetic 
Structural Equation Modelling (SEM) for four tic disorder definitions: three 
dichotomous and one trichotomous phenotype, characterized by increasingly 
strictly defined criteria. Prevalence rates of  the different tic disorders in our 
sample varied between 0.3 and 4.5% depending on tic disorder definition. 
Tic frequencies decreased with increasing age. Heritability estimates varied 
between .25 and .37, depending on phenotypic definitions. None of  the 
phenotypes showed evidence of  assortative mating, effects of  shared 
environment, or non-additive genetic effects. Heritabilities of  mild and severe 
tic phenotypes were estimated to be moderate. Overlapping confidence 
intervals of  the heritability estimates suggest overlapping genetic liabilities 
between the various tic phenotypes. The most lenient phenotype (defined 
only by tic characteristics, excluding criteria B, C and D of  DSMIV) rendered 
sufficiently reliable heritability estimates. These findings have implications in 
phenotypic definitions for future genetic studies.
Abstract
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Tics are defined as involuntary sudden, recurrent, non-rhythmic, stereotypical 
motor movements or vocalizations (DSM-IV-TR) varying from almost 
indiscernible eye-blinking to complex motor movements involving multiple 
muscle systems. The Diagnostic and Statistical Manual of  Mental Disorders 
(DSM-IV-TR; APA 2000) distinguishes four categories of  tic disorders: 
Tourette’s Disorder, also called Tourette Syndrome (TS), Chronic Motor or 
Vocal Tic Disorder (CMT/CVT), transient tic disorder, and tic disorder not 
otherwise specified (NOS). Tic diagnosis depends on age of  onset, duration, 
and type (motor, vocal or both). Tics typically first manifest between age 4 to 
6 years, and peak in severity between 10 and 12 years (Erenberg et al. 1987). 
Over 70% of  patients experience significant reduction in tic frequency and 
intensity by adulthood (Bloch & Leckman 2009; Cath et al. 2011). 
Community-based studies have produced disparate TS prevalence estimates 
in children and adolescents – ranging from 0.5 to 38 cases per 1000 (Apter et 
al. 1993; Hirtz et al. 2007; Knight et al. 2012; Robertson et al. 2009; Scahill et 
al. 2005; Mathews et al. 2014; Miller et al. 2014). In a review study Scahill et 
al. (2013) concluded that the prevalence of  TS in children between age 6 and 
18 lies between 0.5% and 0.7%. Estimates for chronic motor tics ranged from 
0.3% to 0.8% (Kurlan et al. 2001; Khalifa 2006; Scahill et al. 2006; Kraft et al. 
2012; Cubo et al. 2011) in several studies in children. Male-to-female ratios 
varied between 3- 4 to 1, with higher prevalence rates in boys (1.06 to 4.5% in 
boys, and 0.25% to 1.7% in girls (Lichtenstein et al. 2010; Knight et al. 2012)). 
In adults, tic prevalence rates are considerably lower, with estimates of  0.05% 
to 0.1% for TS, and of  0.08% to 6.7% for any tic disorders (Knight et al. 
2012; Apter et al. 1993; Bar-Dayan et al. 2010; Eapen et al. 2001; Robertson 
et al. 1994; Schlander et al. 2011; Wenning et al. 2005; Zohar et al. 1992). A 
Swedish population-based twin study (n=21,911) found prevalence rates of  
6.7% for having any tic, and 1.4% for having TS (not taking the DSM-IV-TR 
criterion of  presence of  at least one vocal tic into account) (Pinto et al. 2016).
The causes of  individual differences in tic disorder characteristics and severity 
are poorly understood. Genetic and environmental factors contribute to 
phenotypic variation. There is some suggestion of  assortative mating (i.e., 
spousal resemblance) for tics (Hasstedt et al. 1995; Kurlan et al. 1994) but 
studies have been scarce. The presence of  parental data allows us to take 
into account assortative mating. This is important as assortative mating in the 
parental generation may in their offspring increase the genetic correlations 
between siblings including DZ twins (these are on average 0.5 under 
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random mating). This may bias the results obtained from the classical twin 
design, with underestimation of  heritability and overestimation of  shared 
environmental effects. In family studies, heritability estimates of  TS and tic 
symptoms range from .18 to .77 (Mathews & Grados 2011; Pauls et al. 1991; 
de Haan et al. 2015; Mataix-Cols et al. 2015; Hirschtritt et al. 2015). Tic risk in 
first-degree relatives of  tic sufferers is high (Mataix-Cols et al. 2015). In one 
small clinical twin study (Price et al. 1985) of  30 MZ and 13 DZ twin pairs 
concordance rates were .53 for MZ pairs and .08 for DZ pairs. When criteria 
were broadened to include any tic, concordance rates were 0.77 for MZ pairs 
and 0.23 for DZ pairs. 
Three population-based twin heritability studies have been performed in 
children or adolescents, and one in adults. (Bolton et al. 2007; Anckarsäter et 
al. 2011; Lichtenstein et al. 2010; Pinto et al., 2016). The longitudinal Child and 
Adolescent Twin Study in Sweden (CATSS) assessed tic disorders in 17,000 
twins aged 9 to 12 years. The assessment consisted of  three questions on tic 
occurrence which the parents’ twins answered during a telephone interview 
(Anckarsäter et al. 2011). Tics were further assessed using the ‘Autism — Tics, 
ADHD and other Comorbidities inventory’ (A-TAC; Hansson & Svanstro 
1994; Larson et al. 2010). Correlations for tic disorder were .38 in MZ and 
.11 in DZ twins, and heritability estimates were  .26 in girls and .39 in boys. 
The heritability estimate of  a binary TS diagnosis based on these data (3.1% 
diagnosed as affected) equalled .56 (Lichtenstein et al. 2010). Furthermore, 
the Genetic and Environmental Effects on Emotion study (GEMS) estimated 
the heritability of  tic disorders based on a binary diagnosis in 4662 4-6-year 
old twin pairs (Bolton et al. 2007). Mothers were interviewed in a two stage 
telephone screen with questions on tic occurrence in their 4-year-old twins. 
The high scoring sample from stage 1 was selected for stage 2 (n=854 pairs) 
and re-interviewed. Using a liability threshold model, the heritability estimate 
was .5. A Japanese twin study employed a liability threshold model to assess 
the heritability of  mother-rated tics in a sample of  1896 twin pairs between 3 
and 15 years (Ooki, 2005). The mothers rated their twins with respect to the 
frequency of  tic behaviors. Tic heritabilities estimates were .28 (boys) and .29 
(girls), with shared environmental effects explaining 41% of  the variance in 
boys and 32% in girls. Finally, Pinto et al (2016) studied the co-variation of  
tics, OC symptoms and ADHD in adult twins (n=20.821). The tic heritability 
estimate based on liability threshold modelling was 0.33 (Pinto et al., 2016). 
In sum, heritability estimates from epidemiological studies vary between ~.28 
and ~.56, with different tic definitions and rating methods used and most 
studies estimating tic heritability of  a single phenotypic operationalization.  
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The aim of  the present study is to examine the genetic and environmental 
contributions to tic symptoms using different DSM-IV-TR derived tic 
phenotypic definitions in a population-based adult twin-family sample. As 
different studies use different measures of  tics, it is highly useful to explore 
the influence of  these varying measurement methods on variation in tic 
heritability. In addition, for future GWAS or other studies using genetic 
variants, it seems paramount to use those phenotypic tic definitions that 
capture the most optimal heritability estimates; “most optimal” meaning a 
combination of  significant nonzero heritability and narrower CIs, reflecting 
the largest information content. 
In addition, an adult twin-family sample has the advantage that lifetime tics are 
taken into account, allowing tics to be included that develop in adolescence. 
An extended twin design was used, including twins, siblings and their parents. 
The presence of  parental data allowed us to further study the influence of  
assortative mating, a topic that has been scarcely addressed in TS (Hanna, 
Janjua, Jankovic, 1999; Kurlan, Eapen, & Robertson, 1994; McMahon et 
al., 1996). This is important as assortative mating may increase the additive 
genetic correlation among DZ twins (i.e., .5 given random mating), which 
may bias the results obtained analyzing only data from twins. Specifically 
assortative mating results in overestimation of  shared environmental effects, 
and underestimation of  genetic effects. In addition, an extended twin design 
confers greater power than the classical twin design (Posthuma & Boomsma, 
2000). Our aims were to 1) quantify the genetic contributions to the various 
tic phenotypes, using both lenient and strict phenotypic definitions of  tics and 
tic severity; 2) explore the role of  assortative mating and dominance effects; 
and 3) determine how much the heritability estimates vary with phenotypic 
definition. 
This study is part of  an ongoing longitudinal study of  twins and families 
registered in the Netherlands Twin Register (NTR), in which participants 
complete a series of  questionnaires on health and behavior every two to four 
years. A tic questionnaire was included in the 2008 survey (see Willemsen et 
al. 2013 for a more detailed description of  the data collection). Data from 
8,323 adult twins and 7,164 family members (clustered in 7,311 families) 
were available. Family members included twins, and parents and siblings of  
twins. From each family, data from two twins, two additional siblings, and 
their parents, if  available, were selected. Non-biological parents and non-
full siblings were excluded. In cases of  triplets or higher-order multiples, 
Method
Participants 
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the first- and second-born twins were included. In cases of  more twin pairs 
per family, one twin pair was included. Online Supplementary table 1 gives 
the number of  family members. Data from both twins were present in 2748 
families (38%), and data from twins as well as parents were present in 804 
(11%) of  the families. Zygosity of  same-sex twins was determined by blood 
type, DNA markers, or questionnaire (Rietveld et al. 2000). There were 2,714 
complete twin pairs with known zygosity (98.8% of  all complete twin pairs): 
388 MZ and 200 DZ male pairs, 1129 MZ and 507 DZ female pairs, and 
490 DZ pairs of  opposite sex (DOS). The age of  twins ranged from 17 
to 97 years (mean=33.1, SD=14.5), and the age of  siblings from 11 to 88 
years (mean=37.1 and SD=13.8) and of  the 5,441 parents from 37 to 94 
(mean=54.9 and SD=8.6). Ethical approval for the study was obtained from 
the Medical Ethical Committee of  the VU University Medical Centre.
Data on tics from NTR Survey 8 were collected using the abbreviated 
Schedule for Tourette and Other Behavioral Syndromes (STOBS-ABBR) that 
provides a semi-structured assessment on tics, OC, and ADHD symptoms 
(Pauls & Hurst, 1996). This scale has been used widely by the Tourette 
Syndrome Association International Consortium for Genetics (TSAICG), 
both as interview and as self-report measure. For the NTR 2008 survey, 
the STOBS was abbreviated to include 9 items on the most frequent tics 
occurring in clinical samples (Cath et al. 2011; Freeman et al. 2000); see online 
supplementary table 2 for the STOBS-ABBReviated. Participants indicated 
for each tic type whether they ever/never experienced it. When given the 
response ‘ever’, they indicated whether the tic had occurred 0-1 year ago, 1-5 
years ago, or more than 5 years ago. Subsequently, given a positive response 
on tic presence, items were filled in on age at onset, duration of  tics (<1 year 
versus >1 year), and tic frequency/severity in three additional self-report items. 
A paper version of  the questionnaire was completed by 7,028 participants 
(45%), and an online version was completed by 8,459 participants. 
Using the STOBS-ABBR, all participants were classified according to DSM-
IV-TR criteria (APA, 2000) into the following mutually exclusive categories: 
probable TS, probable chronic (motor or vocal) tic disorder, probable transient 
tic disorder, or probable tic disorder NOS (see table 1 for a summary of  tic 
definitions). We added the term “probable”, since subjects were classified 
based on self-report, whereas a tic diagnosis is usually established through 
interview and observation by experienced clinical experts, a requirement that 
we were unable to fulfill in this large population-based study. The DSM-IV-
TR requires an age at onset before 18 years to fulfill criteria for a tic disorder 
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diagnosis. However, in view of  the age at onset distributions of  our data 
(figure 1) and as used by the Tourette Syndrome Study Group (Anon 1993), 
we adopted an age of  onset≤21 years as a requirement for the definitions 
of   “probable TS”, “probable chronic (motor or vocal) tic disorder”, and 
“probable transient tic disorder”. “Probable tic disorder NOS” did not 
require the age-of-onset criterion.
Table 1. DSM-IV-TR-criteria for the different tic disorders
To classify as probable TS, the following was required: 1) positive responding 
(‘ever’) to at least two motor and one vocal tics; 2) age of  onset≤21 years; 
and 3) a tic duration of  ≥ one year. The same criteria were used to classify 
as a probable chronic tic disorder, except that either one vocal or one motor 
tic was required. These subjects were further subdivided based on the nature 
of  their tics (motor / vocal). “Probable transient tic disorder” required: 1) 
one or more motor and/or vocal tics, 2) age at onset≤21, and 3) tic duration 
of  <1 year. Participants who reported at least one tic, but without an age 
at onset≤21, and/or with a tic duration of  <1 year were categorized as a 
probable tic disorder NOS. 
For genetic modelling we classified subjects as affected or non-affected 
according to different inclusion criteria: 1) all subjects who scored any tic at 
any age of  onset for any period of  time included as affected (‘any probable 
tic’ - the most lenient phenotype); 2) subjects with “probable TS”, “probable 
chronic tic disorder--motor”, or “probable tic disorder--vocal” were classified 
as affected; 3) all subjects with probable TS and probable chronic tic--motor 
tics as were classified affected. One additional definition was considered with 
3 categories: “no tic disorder” (unaffected), “probable tic disorder NOS” 
combined with “probable transient tic disorder”(affected), and “probable 
chronic tic disorder—motor”, “probable chronic tic disorder—vocal” and 
“probable TS” (affected). 
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Figure 1. Reported age of onset of tics for participants that fulfil criteria 
of Tourette syndrome, chronic tic disorder and transient tic disorder 
(including the age of duration criterium but without the age of onset-
criterium).
Statistical Analyses
Population prevalence of  the different tic disorder definitions were estimated 
in the entire sample of  15,487 individuals. Fitting the genetic models and 
calculating correlations between family members was done by assuming that 
a normally distributed liability underlies the discrete phenotypes (Falconer, 
1965; Falconer, 1967). In the case of  a dichotomous phenotype, the threshold 
separates the two classes of  subjects, namely the “affected” and “unaffected”. 
For the trichotomous phenotype, two thresholds were estimated, separating 
three classes following the definition described above. 
To assess the significance of  covariates prior to the genetic modeling, we 
performed logistic regression; examining the covariates sex, age at filling in the 
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Prevalence rates of  STOBS-ABBR tic items are summarized in online 
supplementary table 3. Given these symptoms we derived four probable tic 
disorder diagnoses in accordance with the DSM-IV-TR (i.e.: TS, Chronic 
motor/vocal tic disorder, transient tic disorder and tic disorder NOS). 
Prevalence rates of  these disorder diagnoses varied from 0.3% (probable TS) 
to 4.5% (probable transient tic disorder; Table 2).
Genetic analyses were performed on the four tic phenotypes grouped together 
in different ways for the various genetic analyses as described above in the 
methods section. Figure 2 shows the prevalence rates for each of  these four 
(three dichotomous and one trichotomous). Depending on the strictness of  
the phenotype definition, prevalence rates varied from 1.3% (‘probable TS or 
Results
Descriptive Statistics
questionnaire, method of  reporting (paper versus internet survey) and their 
interactions. To correct for family clustering, we used generalized estimation 
equation (GEE; Dobson & Barnett 2008) with the R-package ‘GEE’ and 
the logistic link function. For all analyses and model fitting procedures the 
threshold for significance was set at alpha=.05. We obtained initial estimates 
of  familial resemblance by estimating tetrachoric and polychoric correlations 
between the liabilities of  the family members using the R-package ‘polychor’ 
(https://cran.r-project.org/web/packages/polycor/index.html).
Genetic model fitting was conducted in R-package OpenMx version 2.2.4 
(Boker et al., 2011). Parameters were estimated by raw data maximum-
information likelihood. We first tested whether parent-offspring correlations 
were equal to DZ and sibling correlations (as all share on average 50% of  their 
segregating genes). For the two strictest variable definitions, we encountered 
computational problems due to the low prevalence, giving rise to empty cells 
in the tables. We therefore excluded data from siblings and parents. Next, we 
fitted genetic variance decomposition models. These decompose variance in 
the liability to have tics into additive genetic (A), unique environmental (E), 
common environmental (C), and/or dominant genetic factors (D). Since C 
and D cannot be estimated together, we included C if  the MZ correlation 
was less than twice the DZ twin correlation. If  the MZ correlation was larger 
than twice the DZ correlation, we included D. The influence of  common 
environmental factors and of  genetic dominance was tested by comparing a 
nested AE model with either the ACE or the ADE model using likelihood-
ratio tests. The AE models are depicted in online supplementary Figure 1 and 
2. 
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probable chronic motor tic disorder’) to 12.5% (‘any probable tic’, the most 
lenient phenotype). 
Table 2. Descriptive statistics: number of participants and prevelance rate of DSM-IV 
probable tic disorders
Figure 2. Descriptive statistics: Number of unaffected (‘0’) and affected (‘1’ and ‘2’) participants, 
according to each of the four phenotypes. The fourth phenotype has two thresholds and is a 
combination of the first and second dichotomous phenotype.
52
The locations of  the thresholds and effects of  covariates are shown in online 
supplementary figure 3. In all baseline models, separate thresholds were 
estimated for offspring and parents (e.g., for the ‘any probable tic’ phenotype 
when only twins and parents were included, one threshold estimate instead of  
four resulted in a significantly worse fit: Χ²(3)=15.25, p=.002; two threshold 
estimates, one for parents and one for offspring, did not significantly reduce 
the fit: Χ²(2)=3.07, p=.22). Thus, for the ‘any probable tic’ phenotype, 
threshold estimates for parents were higher than for offspring, indicating that 
parents reported less tics. This was not seen in the more strict dichotomous 
phenotypes, indicating that the frequency of  more severe tic disorders, based 
on self-report, and after correction for age, did not differ between parents 
and offspring.
Covariate effects were similar for the dichotomous variables (with the ‘any 
probable tic’ phenotype corresponding to the lowest threshold and the 
‘probable TS or probable chronic tic disorder’ and ‘probable TS or probable 
chronic motor tic disorder’ phenotypes corresponding to the second 
threshold). Males were affected more often than females (e.g., for the ‘any 
probable tic’ dichotomous variable: b=-0.38, se=0.07, p<.001). We observed 
a decrease in the reporting of  tics with increasing age (‘any probable tic’ 
phenotype, with standardized age: b=-0.17, se=0.05, p<.001). Participants 
who answered the paper-version of  the questionnaire (instead of  the online-
version) reported more tics (using the ‘any probable tic’ phenotype: b=-
0.16, se=0.08, p=.045; for the stricter tic disorder phenotypes this was not 
significant; online supplementary table 4). The interaction between age and 
method of  reporting for the second dichotomous phenotype (probable 
chronic tic disorder and TS versus mild or no tic disorder) was found to be 
significant (b=-.33, se=0.15, p=.03). 
Thresholds and Covariate Effects
Familial Correlations and Assortative Mating
Familial correlations are shown in Table 3. MZ twin correlations were 
higher than DZ twin correlations and correlations in other first-degree 
family members. Online Supplementary Table 5 summarizes the correlations 
between other family members. Since the correlation structure among 
relatives did not provide consistent evidence for either dominant genetic or 
common environmental effects, models with both dominance (ADE) and 
common environmental effects (ACE) were considered. 
With respect to exploration of  the influence of  assortative mating: our data 
do not support evidence for assortative mating using any of  the phenotypic 
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Table 3. MZ and DZ twin polychoric correlations (and standard errors) for each 
phenotype
definitions. 
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Table 4 shows the results of  genetic model fitting, where ACE and ADE 
differ in that the first model attributes familial resemblance to additive 
genetic and common environmental factors, and the second model attributes 
resemblance to additive and non-additive  (dominance) genetic factors. In 
all models the C and D parameters were not significant: comparison with 
the more parsimonious AE model did not show a significant drop in the fit 
(e.g. for the first dichotomous phenotype, when twins, parents and siblings 
were included; AE vs. ACE: Χ²(1)<.001, p>.99, and AE vs. ADE: Χ²(1)=2.59, 
p=.11). Heritability point estimates ranged from .25 to .37. Thus, familial 
resemblance can be explained solely by additive genetic factors. The 95% 
confidence intervals were wide and all overlapping. The ‘any probable tic’ 
phenotype showed the narrowest confidence interval (0.31, 95% CI [0.23, 
0.38]).
The aim of  this study was to estimate the heritability of  increasingly strict 
phenotypic definitions of  lifetime tic disorders that were mostly in line 
with current DSMIV and DSM 5 criteria for tic disorders, in a large adult 
population-based sample Further, using an extended twin design, we estimated 
the relative contribution of  additive and non-additive genetic effects, effects 
of  common and unique rearing environment, and the role of  assortative 
mating. In line with Walkup, Ferrao, and Singer (2010), we were specifically 
interested in obtaining a clear understanding of  the core phenomenological 
features of  tics, taking one step further, i.e. by investigating whether and to 
what extent the various phenotypic definitions influence estimates of  genetic 
and environmental contributions to tics (Walkup, Ferrao, & Singer, 2010). 
The abbreviated STOBS that we used is in line with both DSMIVTR and 
DSM5 criteria of  the various tic disorders with respect to their core criteria 
of  tic characteristics, duration, and age at onset, except for criterion D (i.e.: 
the disturbance is not attributable to a medical condition). In sum, the first 
9 items of  the abbreviated STOBS asked about tic characteristics (pertaining 
to criterion A), one additional item asked about age at onset (before versus 
after age 18) and one item asked about duration of  tics (<1 year or > 1 year). 
Our prevalence rates of  a tic disorder are in the expected range (i.e. between 
0.3-4.5%). In epidemiological studies in children, prevalence rates are between 
3-8 cases per 1000 between ages 6 and 18 (Scahill et al. 2013). Our rates are 
higher than reported in most epidemiological studies in adults (0.001-0.05%), 
but in line with the other tic twin study in adults using self-reports by Pinto et 
al. (2016), who reported prevalence rates of  TS between 0.4-1.4% depending 
Genetic Model fitting
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on strictness of  phenotypic definition. Also, the prevalence rates of  the most 
lenient definition of  “any probable tic” of  12.5% in our sample is by and large 
in accordance (although somewhat higher) with the rates reported by Pinto et 
al. (2016) of  7.2% for any tic in men and 6.5% in women (Pinto et al. 2016). 
An explanation for the somewhat higher rates in our twin study and previous 
epidemiological studies (Pinto et al., 2016) might be that, using DSM-III and 
IV criteria (APA, 1994), earlier studies included an impairment/disability 
criterion for TS which has been subsequently removed from the DSM-IV-TR 
and DSM-V (APA, 2000). This may have caused a relative underestimation 
of  tic prevalence. In our cross-sectional sample self-reported tic frequencies 
tended to decrease during adolescence and throughout adulthood, which is 
fully in line with interview-based epidemiological and clinical studies across 
the lifespan indicating that self-reported tic measures can be reliably used in 
large scaled studies. The decrease in tic frequencies with age might be the 
result of  maturation of  the frontal lobes, and -as a result- increased inhibitory 
efficiency of  the cortico-striato-thalamo-cortical (CSTC) circuitry (Felling & 
Singer, 2011). However, recall bias, resulting in under-reporting of  milder tics 
with age, should also be taken into account as a contributor to decrease of  tic 
severity and frequency with age. 
In this study, (narrow-sense) heritability estimates ranged from 0.25-0.37, with 
large confidence intervals that overlapped across the phenotypic definitions 
and that were in line with the other tic twin study in adults (Pinto et al., 
2016) and somewhat lower than some family studies and twin-family studies 
in children (Bolton et al., 2007; Anckarsäter et al., 2011; Lichtenstein et al., 
2010; Mathews & Grados, 2011). Possibly, with time, unique environmental 
mediators become increasingly important in the expression of  these complex 
disorders. To conclude, in the present study heritability estimates for both 
mild and severe tic phenotypes were consistent, ranging from 0.25 to 0.37. 
However, the prevalences of  the severe tic phenotypes were low, resulting 
in relatively low power to estimate the most strict thresholds models. As 
a consequence, confidence intervals of  the heritabilities for the severe tic 
disorders are wide, and the narrow-sense heritability for severe tic disorders 
might be as large as 56% (the upper border of  the confidence interval 
when siblings are included). Family-based studies specifically ascertaining 
probands with TS corroborate the data provided by this study, and suggest 
that heritability estimates might actually be on the high end of  this estimate 
(58%-77%) (Hirschtritt et al., 2015). Interestingly, we found that heritability 
estimates of  the “any tic” definition showed the narrowest Confidence 
Intervals, yielding moderate heritability estimates. Thus, the “core” tic 
phenotype that included only DSMIVTR and 5 criterion A of  the various tic 
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disorders definitions (i.e. presence of  a tic), seems to render the most reliable 
heritability estimates. In our opinion, in line with Walkup et al., 2010, this 
pleas for a relatively clear and simple phenotypic definition of  tics in future 
data collection efforts for genetic studies, provided that the core phenotypic 
characteristics of  tic disorders have been met, i.e. presence of  tics, defined as 
“sudden, rapid, recurrent, non-rhythmic, stereotyped motor movements or 
vocalisations”.
We found no evidence for assortative mating with respect to any of  the tic 
phenotypes. In addition, we found no evidence of  a contribution of  common 
environment (C) or non-additive genetic effects (D), implying that all 
phenotypic definitions of  probable tic disorders (mild/severe) are influenced 
by additive genetic factors and unique environmental factors. The absence 
of  C is consistent with the Swedish twin study in children (Lichtenstein et 
al., 2010; Anckarsäter et al., 2011; Pinto et al., 2016). The discrepant findings 
by a Japanese twin study (Ooki, 2005) who found a large contribution of  
shared environmental effects on tics, might be due to cultural differences; i.e. 
cultural adaptations reflect differences in shared environmental contributions 
to heritability estimates in cross-groups comparisons.
The heritability estimates mentioned so far were estimated using the twin 
method. Davies et al. (2013) used SNP data from a GWAS of  clinical TS 
cases to estimate the heritability attributable to the contribution of  SNPs 
(e.g., GCTA; (Yang et al., 2011)). In contrast to our findings, Davis et al. 
found a high chip-based heritability estimate of  .58, which is remarkably 
high compared to most SNP-based studies of  complex disease (Wray & 
Maier 2014). We do not have a clear explanation for these divergent findings, 
although power issues and sample selection (clinical versus epidemiological) 
might play a role.
We did not attempt to model all phenotypic operationalizations simultaneously, 
as this is impossible due to the many empty cells in the cross tables. However, 
we assume that the variation in scoring of  the various phenotypic definitions 
has a direct bearing on the diagnostic threshold, but not on the underlying 
liability. This implies that the estimates of  the genetic and environmental 
contributions to individual differences in the liability should be equal. Our 
results are consistent with this, as the confidence intervals largely overlap 
across phenotype definitions, suggesting a continuous normally distributed 
liability for having a mild or severe tic phenotype. However, as the different 
phenotypic definitions did yield small but significantly different heritability 
estimates, this suggests that small (but significant) quantitative differences 
exist in genetic liability to tics.
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The relatively modest heritabilities as found in this study, coupled with 
relatively large contribution of  unique environmental influences, are 
consistent with the conceptualization of  TS as a complex disorder like other 
complex psychiatric disorders, such as OCD and Anxiety Disorders (Zilhao 
et al. 2014; Pauls, 2010; van Grootheest et al. 2005; Shimada-Sugimoto et 
al. 2015; Hettema et al. 2001; Van Grootheest et al. 2007). In line with this, 
various environmental factors (such as stress, fatigue and life events) have 
been found to be relevant to the expression of  tics (Findley et al. 2003; 
Swain & Leckman 2005). Importantly, this study has relevance for molecular 
genetics and GWASs. GWASs in complex traits have not been very successful 
to date, partly as a consequence of  difficulties in defining and standardizing 
phenotypes (Sabb et al., 2009; Smith et al., 2013; Wray et al., 2012; Wray 
& Maier, 2014). Our work indicates that the heritability estimates from 
multiple tic phenotypic definitions largely overlap, strongly suggesting that 
future studies may use lower thresholds for tic classification, hence taking 
advantage of  the increased power due to the higher number of  cases that can 
be included in GWASs.
Results from this study should be interpreted in light of  some limitations. 
The data collected are based on self-report measures (as this is a population-
based study) and not on clinician-administered structural interviews, which 
might have led to misclassification. Additionally, since lifetime tics have 
been reported retrospectively, recall bias might have caused inaccuracy in 
recollecting past occurrences of  tics.
In conclusion, our results indicate that genetic and unshared environmental 
factors contribute to the phenotypic variability across the full range of  tic 
disorders. No shared environmental or genetic dominance effects were 
found to contribute. Finally there was no/little evidence for assortative 
mating. Our findings replicate and extend previous work in adults (Pinto et 
al., 2016), suggesting a relatively large contribution of  environmental factors 
to the phenotype. However, these environmental influences might also 
include epigenetic or even genetic effects (private mutations). The heritability 
estimates of  the different phenotypic definitions estimates are comparable 
(considering the confidence intervals), which is consistent with the liability 
threshold model, in which alternative scoring has a bearing on the threshold(s), 
but much less on the contributions of  genetic and environmental factors to 
individual differences in the liability.
The Supplementary material can be found in the online version of this manuscript
59
60
Chapter 4
Cross-Disorder Genetic Analysis of Tic Disorders, 
Obsessive Compulsive and Hoarding Symptoms
This chapter is based on: Zilhao, N. R., Smit, D. J., Boomsma, D. I., & Cath, D. C. (2016). 
Cross-disorder genetic analysis of tic disorders, obsessive-compulsive, and hoarding 
symptoms. Frontiers in Psychiatry, 7.
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Hoarding, Obsessive-Compulsive Disorder (OCD) and Tourette’s Disorder 
(TD) are psychiatric disorders that share symptom overlap, which might 
partly be the result of  shared genetic variation. Population-based twin studies 
have found significant genetic correlations between hoarding and OCD 
symptoms, with genetic correlations varying between 0.1 and 0.45. For tic 
disorders, studies examining these correlations are lacking. Other lines of  
research including clinical samples and GWAS or CNV data to explore genetic 
relationships between tic disorders and OCD have only found very modest 
if  any shared genetic variation. Our aim was to extend current knowledge on 
the genetic structure underlying hoarding, OC symptoms (OCS) and lifetime 
tic symptoms and, in a trivariate analysis, assess the degree of  common and 
unique genetic factors contributing to the etiology of  these disorders. Data 
have been gathered from participants in the Netherlands Twin Register 
comprising a total of  5293 individuals from a sample of  adult monozygotic 
(n=2460) and dizygotic (n=2833) twin pairs (mean age 33.61 years). The data 
on Hoarding, OCS and tic symptoms were simultaneously analysed in Mplus. 
A liability threshold model was fitted to the twin data, analysing heritability of  
phenotypes and of  their co-morbidity. Following the criteria for a probable 
clinical diagnosis in all phenotypes, 6.8% of  participants had a diagnosis of  
probable hoarding disorder (HD), 6.3% of  OCS, and 12.8% of  any probable 
lifetime tic disorder. Genetic factors explained 50.4%, 70.1% and 61.1% of  
the phenotypic covariance between hoarding-OCS, hoarding-tics and OCS-
tics respectively. Substantial genetic correlations were observed between 
hoarding and OCS (0.41), hoarding and tics (0.35) and between OCS and 
tics (0.37). These results support the contribution of  genetic factors in the 
development of  these disorders, as well as their co-morbidity. Furthermore, 
tics were mostly influenced by specific environmental factors unshared with 
OCS and HD.
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Current classification systems of  psychiatric disorders are primarily based 
on consensus statements with respect to clinical symptom diagnostics by 
physicians. These classification systems, i.e. the International Classification 
of  Diseases (ICD) (“The ICD-10 Classification of  Mental and Behavioural 
Disorders,” n.d.) and the Diagnostic and Statistical Manual of  Mental 
Disorders (DSM) (APA, 2013), have rendered the separate and categorical 
entities we know as disorders – including Obsessive-Compulsive Disorder 
(OCD), Tourette’s Disorder (TD) and (starting from DSM5) Hoarding 
Disorder (HD).
More specifically, OCD, HD and tic disorders/Tourette’s Disorder are 
complex neuropsychiatric disorders all characterized by repetitive behaviours 
that show substantial co-morbidity, i.e. that co-occur more often than 
expected by chance (Frost et al., 1999; Horwath & Weissman, 2000; Scahill, 
Sukhodolsky, & Leckman, 2005; Tolin, Frost, & Fitch, 2008). OCD is a 
neurodevelopmental disorder characterized by recurrent intrusive thoughts 
(obsessions) and repetitive behaviours (compulsions) designed to relieve 
either tension or anxiety stemming from the obsessions (APA, 1994; WHO, 
2007). HD has since long been classified as a symptom dimension of  
OCD, and -to a lesser extent- as a characteristic of  Obsessive-Compulsive 
Personality disorder (APA, 1994). It was later suggested, however, that 1) HD 
presents mostly (in up to 80% of  cases) without concurrent OCD (Pertusa 
et al., 2008) and that 2) the neurological mechanisms underlying hoarding 
might be distinct from OCD (Mataix-Cols et al., 2010; Pertusa et al., 2008). 
Therefore, it was included in DSM-5 as a distinct disorder in the category 
of  OCD spectrum disorders, and characterized by the inability to discard an 
excessive amount of  items of  no significant value, combined with excessive 
acquisition and clutter to such an extent that living spaces of  an individual 
are occupied (APA, 2013). Tic disorders are characterized by recurrent motor 
and/ or vocal tics that occur in a stereotypical fashion against a background 
of  normal motor/phonic activity, with onset in childhood and tendency to 
decrease in intensity and frequency during adolescence (Cath et al., 2011). 
Prevalence rates for these disorders range between 0.1-0.8% for TD (Apter et 
al., 1993; Bar-Dayan, Arnson, & Elishkevits, 2010; Eapen, Laker, & Robertson, 
2001; Robertson, Verril, & Pauls, 1994; Scahill, Dalsgaard, & Bradbury, 2013; 
Schlander, Schwarz, & Roessner, 2011; Wenning et al., 2005; Zohar et al., 
1992), 2-6% for compulsive hoarding (Iervolino et al., 2009; Timpano et al., 
2011) and 0.5-2.0% for OCD (APA, 1994; Ayuso-mateos, 2001). 
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With respect to co-morbidity rates between HD and OCD, in clinical and 
epidemiological studies of  OCD between 18-42% of  patients report hoarding 
behaviors, depending on phenotypic definition (Frost & Hartl, 1996; Lochner 
et al., 2005; Rasmussen & Eisen, 1989; Samuels, Bienvenu, & Cullen, 2002), 
and reversely, in 12-20% of  HD patients OCD is reported (Frost, Steketee, 
& Tolin, 2011; Ivanov et al., 2013; Mathews, Delucchi, & Boomsma, 2014). 
In TD/chronic tic disorders, OCD is very common, with estimates ranging 
from 28-49% of  OCD/ OCS in TD, and reversely, of  10-20% of  tics in 
OCD (Como, LaMarsh, & O’Brien, 2005; Rosario-Campos et al., 2005). In 
sum, these comorbidity estimates are well above expected comorbidity rates 
if  the three disorders would be etiologically distinct. Finally, in tic disorders 
no studies on hoarding co-morbidity have been performed nor have studies 
been performed on tic co-morbidity in HD. 
Family studies and genetic epidemiological twin studies on each separate 
disorder have shown substantial genetic contribution to each separate 
phenotype, with heritability estimates from twin studies ranging between 
.30-.58 (OCD) (Rosario-Campos et al., 2005; Hudziak et al., 2004; Iervolino, 
Rijsdijk, & Mataix-Cols, 2011; Pauls, Alsobrook, & Leckman, 1995; Zilhao et 
al., 2014), .35-.50 (HD) (Iervolino et al., 2009, 2011; Ivanov et al., 2013), and 
.25-.58 (tic disorders) (de Haan, Delucchi, & Cath, 2015; Hirschtritt et al., 
2015; Mataix-Cols et al., 2015; Mathews & Grados, 2011; Pauls, Raymond, 
& Leckman, 1991). A next question is whether the high proportions of  
co-occurrence between the three phenotypes reflects overlap in genetic or 
environmental contributions between OCD, HD and tics. Multivariate twin/
family studies are particularly suitable for this, making use of  correlations 
between MZ and DZ twins on the various traits to partition the relative 
contribution of  shared versus unique genetic and environmental factors that 
influence multiple traits (Dongen, Slagboom, & Martin, 2012).  
Despite recent advances in psychiatric genetics, twin studies specifically 
investigating shared genetic and environmental influences between OC 
symptoms (OCS), hoarding behaviour and tics are scarce. Two studies by 
Iervolino et al. in a sample consisting predominantly of  female twins from 
the TwinsUk twin registry (4459 female twins, mean age of  55.0 years) have 
specifically examined the genetic and environmental overlap between OCS 
and HD behaviour (Iervolino et al., 2009, 2011). It was found that 45% of  
the genetic variance was shared between HD and OCS dimensions. Further, 
hoarding had the lowest loading on the common factor with only 55% of  the 
total variance in OC symptom dimensions being hoarding-specific. A recent 
twin study of  our group within the Netherlands twin Register, which overlaps 
64
with our sample, assessed the unique and shared genetic contributions for 
HD and OCS in a sample of  7567 twins (2270 males, 5297 females, mean 
age of  33.2 years) (Mathews, Delucchi, & Boomsma, 2014). The authors 
found significant genetic contributions to the co-morbidity across both 
traits, although a low genetic correlation (0.10) was found. Finally, a recently 
population-based twin family study with data from the Swedish Twin Register 
(n=20,821), specifically addressed the proportion of  shared genetic and 
environmental factors underlying the liability to chronic tics, ADHD and 
OCS (Pinto et al., 2016). Tics were broadly defined based on the number of  
total tics (‘no tic score’, ‘tic score=1’, ‘tic score > 1’). A substantial correlation 
of  0.45 between tics and OCS was found.
From another line of  research Genome-wide association study (GWAS) 
data from samples of  TD and OCD patients were analysed to find a genetic 
correlation between OCS and TD of  0.41 (Davis et al., 2013), which was 
relatively high in light of  what has been described for other complex 
disorders (Wray & Maier, 2014). However, this correlation might have been 
an overestimation, as the standard error of  this estimate was large (se=0.15) 
and, in addition, the co-occurrence between tics and OCD appeared relatively 
high (13% of  OCD had co-occurring tics/TD and reversely 43% of  TD had 
OCD) Further, in this same sample, Yu et al. (2014), sought to characterize 
common genetic variants shared among TD and OCD. Although no specific 
variants were identified, the combined GWAS signals were significantly 
enriched for functional alleles, suggesting that there is some proportion of  
TD-OCD shared genetic risk variants (Yu et al., 2014). 
So far, genetic-epidemiological twin-family studies to estimate the shared 
respective unique contributions of  genetic and environmental factors between 
tic- HD symptoms and between tic-HD-OCS are lacking, as are molecular 
genetic studies to estimate shared genetic contributions from SNPs across 
TD, OCS and HD phenotypes. 
Therefore, the main aim of  the present study was to extend the available data 
so far with respect to shared etiology between OC symptoms and hoarding 
behaviour (Mathews et al., 2014) by expanding with the tic phenotype, in a 
large population-based twin sample that includes male, female and opposite 
sex twin pairs using diagnostic methods that assess the full range of  the 
symptomatology of  these disorders to better address their shared underlying 
etiology. Specifically, we aimed at 1) replicating previous quantifications of  
shared and independent genetic contributions to OCS-hoarding behaviour; 
2) quantifying shared and independent genetic contributions to hoarding 
behaviour and tics; 3) quantifying shared and independent genetic contributions 
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to OC symptoms and tics; 4) quantifying shared and independent genetic 
contribution to OCS-hoarding behaviour and tics. 
Materials & Methods
Subjects
Participants included in this study are registered with the Netherlands Twin 
Register (NTR). Since 1991, twins and their family members receive surveys 
by mail, and are assessed with questionnaires about health, personality and 
lifestyle (Boomsma et al., 2006; Willemsen et al., 2013). For these analyses, 
we used data collected in 2008, corresponding to the survey 8 wave of  
collection, on Obsessive Compulsive Symptoms, Hoarding and tic symptoms 
(henceforth named as ‘tics’). A total of  16.930 participants from 7400 different 
families completed the questionnaires. Twins encompassed 8047 individuals 
(2511 males, 5536 females). This study has been approved by the Medical 
Ethical Committee of  the VU Medical Centre Amsterdam.
Measurements
The assessment instruments used were the Hoarding Rating Scale-Self-
Report (HRS-SR) for Hoarding, the Padua Inventory Abbreviated Revised 
(PI-ABBR) for OCS and an abbreviated self-report questionnaire (the 
Schedule for Tourette and Other Behavioral Syndromes - STOBS-ABBR) 
based on the Schedule for Tourette and Other Behavioral Syndromes 
(STOBS) for tics. The HRS-SR questionnaire consists of  five items each 
scoring on a 0-8 scale, that assess cluttering, difficulty in discarding items, 
excessive acquisition or collecting, distress derived from hoarding symptoms 
and functional impairment (Tolin, Frost, & Steketee, 2010). The distress item 
was discarded due to approval restriction on the items to be included in the 
larger questionnaire. The PI-ABBR questionnaire has been derived from the 
Padua Inventory-Revised, a 41 item self-report instrument that measures OC 
symptoms on a scale from 0-4, and 5 subsequent subscales (washing, checking, 
rumination, precision and impulses). The PI-ABBR has been abbreviated 
to 12-items that include two to three items from each of  the five OCS 
dimensions above mentioned (Cath, van Grootheest, & Boomsma, 2008). 
These subscales refer to four main factors of  obsessions and compulsions – 
‘impaired control’, ‘fear of  contamination’, ‘checking behaviour’, ‘urge/worry 
of  losing control’ (Sanavio, 1988). 
The STOBS consists of  a semi-structured assessment on tics, and has 
been widely used in data collections by the Tourette Syndrome Association 
International Consortium for Genetics (TSAICG). It consists of  36 tic items 
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(rated as: current/lifetime, not present), generating lifetime tic information 
(Pauls & Hurst, 1993). For the NTR 2008 survey, the STOBS was abbreviated 
to a 12-item tic questionnaire on the 9 most frequent tics occurring in clinical 
samples (Cath et al., 2011; Freeman et al., 2000). Additionally, 3 items were 
added on age at onset of  symptoms,  tic severity and  whether the tic persisted 
for more than a year. Using the STOBS-ABBR, a diagnosis of  probable 
chronic tic disorder was established if  the person had 1) one or more chronic 
motor or one or more vocal tic, that 2) occurred before age 21 and 3) had 
been present for >1 year. Probable TD diagnosis was established when 2 or 
more motor and 1 or more vocal tics were reported that occurred before 
age 21 and had lasted for > 1 year, and probable transient tic disorder was 
established when motor and/ or vocal tics had occurred before age 21 for 
less than one year. Participants who reported at least one tic, but without an 
age at onset≤21, and/ or with a tic duration of  <1 year were categorized as 
a probable tic disorder NOS. We use the term “probable” since tic diagnoses 
were not confirmed by a face-to-face interview by an experienced clinician. 
We fitted a liability threshold model, using for each phenotype a categorical 
variable derived from several cut points applied to the full distribution of  
sum scores (for OCS and HD), and defining the presence/absence of  a tic 
disorder (for tics). The liability threshold model assumes an un-observed 
(and not measured) liability (or risk) to disease, normally distributed in the 
population (Falconer, 1965, 1967). The categories function as a (indirect) 
measure of  this liability, representing the susceptibility to the true underlying 
distribution of  the disease. Four categories were used for both the HRS-SR 
and PI-ABBR. The HRS-SR was divided into categories that more closely 
resemble the clinical patterns of  symptomatology (no hoarding symptoms, 
mild symptoms, subclinical hoarding and clinically significant hoarding or 
probable hoarding disorder), having unequal distributions in each category 
(scores of  0, 1-5, 6-16, and ≥17) (Iervolino et al., 2009). For a probable HD 
diagnosis, we used the cut-off  proposed by Tolin to define caseness (Tolin 
et al., 2010). In this work, a receiver operating characteristic (ROC) analysis 
determined that the best threshold separating HD from non-HD cases was 
a sum-score over the cut-off  of  17 with a sensitivity and a specificity of  
0.95. The scores for PI-ABBR (0, 1-6, 7-15, and ≥16) have been previously 
described in the literature (Cath et al., 2008). In brief, ROC determined that 
the best threshold separating OCD from non-OCD cases was a sum-score 
over the cut-off  of  16 with a sensitivity of  0.74 and a specificity of  0.72. For 
tics, we derived a dichotomous variable defining the presence or absence of  
any of  the tic disorders described here-above, according to a definition of  
‘probable tic disorder’ as defined by the STOBS-ABBR. For further details 
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on the phenotype definition for tics, please refer to (Zilhao et al, 2016). 
Briefly, the probable tic disorder dichotomous variable consists of  the most 
lenient definition defined for caseness, in which lifetime probable chronic tic 
disorder, probable TD, and probable transient tic disorder are included. 
Univariate Twin Analyses
Statistical Analyses
Prevalences, means and distributions for the three phenotypes were calculated 
in the entire sample of  16.930 individuals. Performing these analysis on 
clinically defined significant symptoms has the advantage of  increasing the 
generalizability of  the results. Polychoric correlations (correlations on the 
liability scale) were calculated in Mplus (Prescott, 2004) for the PI-ABBR, 
HRS-SR, and STOBS- ABBR, both in MZ and DZ twin pairs by sex, and 
in all twins for both sexes. Data from both complete and incomplete twin 
pairs were included in the analysis. Univariate analyses for each phenotype 
were performed separately using the software OpenMx (Boker et al., 2011) 
to estimate the relative contributions from additive genetic (A), shared 
environment (C) and non-shared environment (E) to each phenotype. 
Maximum-likelihood model-fitting procedures were carried out, as is 
standard in structural equation modelling, in which the phenotype was a 
function of  the A, C and E factors and polychoric correlations, according to 
the liability threshold model described above. We investigated the potential 
influence of  twin-specific and gender-specific (sex differences) environment 
by constraining correlations across zygosity groups to be equal, for all three 
phenotypes. The effect of  covariates (age and sex) on the thresholds was 
univariately assessed for each phenotype.
Multivariate Twin  Analyses
Using the Mplus software we then fitted a Trivariate genetic model to the data 
with the weighted least square mean and variance adjusted estimation option 
(WLSMV) (Prescott, 2004), using the described liability threshold models. 
Covariances between the three phenotypes were partitioned into the relative 
contributions of  shared additive genetic (A), common environmental (C) 
and non-shared environmental (E) influences to the etiology of  the three 
phenotypes. The influence of  common environmental factors and of  genetic 
dominance were tested by comparing a nested AE model with either the ACE 
or the ADE model using the Chi-square difference test. 
Lastly, we performed a single factor analysis on the covariance matrices 
partitioned between the phenotypes. This analysis gives a representation in 
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terms of  the components shared by the three phenotypes.
The mean age of  the entire sample was 33.61 years (SD= 14.56); for males 
the mean age was 33.11 (SD=14.66) years and for females 33.84 (SD=14.51) 
years. The mean average score for HRS-SF was 5.74 (SD=5.6) and for the PI-
ABBR was 6.89 (SD=5.2). Males had on average higher scores than females 
on both the HRS-SF and the PI-ABBR. Also for tics, the prevalence rates 
were higher in males (13.0%) than in females (12.6%). Table 1 summarizes 
the demographics in males and females for the PI-ABBR, HRS-SF and 
STOBS-ABBR.
Descriptives 
Means and distributions
Results
Table1. Sample demographics for the data included in the analysis
Table 2 shows prevalence rates for the three phenotypes for MZ and DZ 
twins, as estimated according to the diagnostic criteria. Of  the entire sample, 
5.0% had clinically significant HD, 6.0% had clinically significant OCS, and 
13.5% had any probable tic disorder according to the STOBS-ABBR. The 
threshold used to determine caseness in a probable HD disorder diagnosis 
rendered population prevalence rates that closely resemble previous estimates 
for clinical HD (Iervolino et al., 2009; Timpano et al., 2011). Furthermore, 
among individuals with OCS, 18.0% had co-occurring HD and 12.1% had 
tics; among individuals with HD, 15.0% had OCS and 8.72% had tics; among 
individuals with tics, 27.1% had OCS and 23.3% had HD. Lastly, in the entire 
sample, 0.31% (n=25) of  individuals had the co-occurrence of  all three 
disorders.
Prevalence and phenotype ‘overlap’
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Table 2. Prevalence rates for HD (HRS-SR, OCS (PI-R-ABBR), and tics (YGTSS), for the 
total sample included in the analysis.
Univariate results
Twin correlations
Table 3 shows the polychoric correlations as calculated on the observed data 
for the five zygosity groups, on the HRS-SR, PI-ABBR and the STOBS-
ABBR. Overall, when comparing MZ and DZ pairs on the three phenotypes, 
an average two-fold increase for MZ twins when compared to DZ twins is 
observed. The greater similarity for MZ twins the moderate MZ correlations 
suggest the influence of  non-shared environmental factors for all three 
phenotypes. 
Specific gender/twin environments were tested univariately for each 
phenotype. As expected from the twin correlations across all zygosities, the 
fit statistics results show that correlations could be equated across twins and 
sex, with no twin-specific or sex-specific environments observed (table 4). 
Table 3. Polychoric twin correlations for observed data for HD, OCS and tics
70
The total heritability estimates were 0.33 (SE=0.05, p<0.001) for clinically 
significant HD, 0.38 (SE=0.05, p<0.001) for OCS and 0.37 for any tic disorder 
(SE=0.05, p<0.001) (off-diagonal in table 6). For non-shared environment 
the estimates were 0.67 (SE=0.05, p<0.001) for clinically significant HD, 
0.62 for OCS (SE=0.05, p<0.001) and 0.63 (SE=0.05, p<0.001) for tics. No 
evidence was found for an effect of  common environment.
Examining the cross-disorder correlations (cross-twin cross-trait) again 
suggests that genetic factors are involved in the correlations between traits 
(table 5). The MZ cross-twin cross-trait correlations were 0.14 (HD vs. OCS), 
0.12 (HD vs. tics) and 0.16 (OCS vs. tics), while the DZ correlations were 
0.07 (HD vs. OCS), 0.05 (HD vs. tics) and 0.02 (OCS vs. tics). The within-
person cross-trait correlations (phenotypic correlation) were 0.30 (HD vs. 
OCS), 0.15 (HD vs. tics) and 0.25 (OCS vs. tics) (table 5). 
A trivariate ACE model was fitted to the data in order to examine the 
relative contributions from shared genetic and environmental contributions 
to the covariance among the traits. Again, as suggested by patterns of  twin 
correlations, no evidence for common environment was found and the C 
parameter could be dropped when compared to the more parsimonious AE 
model (AE vs. ACE model: Χ² (6) =0.876, p=0.99 and AE vs. ADE model: 
Χ² (6) =2.994, p=0.81). Hence, the best fitting model to the data was one in 
which the covariation between the three phenotypes can be explained by a 
set of  common A and E factors. Table 5 and figure 1 show the estimates 
of  the relative contributions of  genes and non-shared environment factors, 
calculated from the best-fitting model. The total variance for each variable 
Heritabilities and fit statistics
Table 4. Model fit indices for the univariate models, examining the role of sex and 
zygosity of each phenotype separately.
Note: NP, Number of parameters; -2LL, -2*Log-Likelihood; df, degrees of freedom for χ2 test
Cross-disorder correlations
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Table 5. Relative contributions of additive genetic and non-shared environmental 
influences on the trait variance (diagonal) and covariance cross-trait (off-diagonal) 
for HD (HRS-SR), OCS (PI-R-ABBR) and tics (YGTSS).
Note: CTCT= cross-twin-cross-trait correlations. 
was constrained to 1, in order to estimate the proportion of  individual 
liability due to shared vs. common genetic/environmental factors. Bivariate 
heritability results (table 5), show that 50% of  the covariance between HD 
and OCS, 70% of  the covariance between HD and tics, and 61% of  the 
covariance between OCS and tics are due to genetic factors. The remaining 
variance is accounted for by non-shared environmental factors. Furthermore, 
the genetic correlations were 0.41 (HD vs. OCS), 0.35 (HD vs. tics) and 0.37 
(OCS vs. tics). Figure 1 depicts the path diagram in terms of  correlated A and 
E factors. 
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Figure 1. Path diagram for the best fitting model. Squaring these paths gives the proportion 
of variance accounted by each of the A and E components. Also indicated are the correlations 
among each A and E component for each of the three phenotypes. A indicates additive genetic 
factors; E indicates non-shared environmental factors.
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Lastly, single factor analysis for the A and E component revealed the degree 
of genetic and environmental overlap shared by the three phenotypes 
(Figure 2). As shown, between 31.5% and 43% of the total genetic 
variance of each phenotype is due to genetic factors shared among all three 
phenotypes. Specific genetic variance unshared with other phenotypes was 
60.7% (HD), 57.0% (OCS) and 68.5% (tics). Further, 43.2% and 41.8% 
of the total environmental variance is due to unique environmental factors 
shared between HD and OCS, respectively, whereas for tics this amounts 
only to 4.4% of the total environmental variance – in other words, tics had 
the lowest loading on the common factor and were mostly influenced by 
tic-specific environmental effects (Figure 2).
Figure 2. Single factor representation for the each of the A and E component for the best-fitting 
model. Numbers indicate the proportion (for both A and E components) shared by the three 
phenotypes. Ac indicates common additive genetic factors; Ec indicates common non-shared 
environmental factors.
74
In this study we sought to examine the extent to which shared genetic and 
environmental factors contribute to clinically significant OCS, HD and tic 
symptomatology. We had at our disposal the largest twin pair sample available 
to date in which these three phenotypes were measured at the same wave of  
data collection. The present results extend previous work in the same NTR 
sample on shared genetic contributions to OCS and HD (Mathews et al., 
2014).
Our univariate prevalence rates for clinical significant HD symptoms and 
OCS are in the expected range when compared to the literature (Cath et 
al., 2008; Samuels et al., 2008). For tics we note that our somewhat higher 
prevalence rates than described in the literature might be due to the fact that 
they reflect lifetime tic disorders, and therefore a somewhat lenient definition 
for caseness, reflecting our approach to generate optimal results with respect 
to phenotypic validity, in light of  the self-report measures used in the NTR. 
Our comorbidity prevalence rates - 18% of  OCS patients reported co-
occurring HD, and reversely, 15.0% of  HD patients reported co-occurring 
OCS; 12.1% of  OCS patients reported co-occurring tics, and reversely, 27.1% 
of  TD/chronic tic disorders reported co-occurring OCS), are within the 
expected range when compared with the epidemiological literature (Como et 
al., 2005; Rosario-Campos et al., 2005; Frost & Hartl, 1996; Frost et al., 2011; 
Ivanov et al., 2013; Lochner et al., 2005; Mathews et al., 2014; Rasmussen & 
Eisen, 1989; Samuels et al., 2002). For HD/tics, to the best of  our knowledge, 
we report here the first co-morbidity prevalence rate estimate – 8.72% of  HD 
individuals having co-occurring tics and 23.3% of  tic individuals having HD. 
Discussion
The univariate model fitting results
Previous results with data from the NTR, using by and large the same 
sample, have yielded heritabilities of  0.40-0.50 for OCS (Cath et al., 2008; 
van Grootheest et al., 2009), 0.36 for HD (Mathews et al., 2014) and 0.30 for 
tics (Zilhao et al., 2016). Other previous twin/family studies have rendered 
comparable estimates (0.26-0.55 for OCS, 0.35-0.50 for hoarding, and 0.28-
0.56 for tics) (Pinto et al., 2016; Taylor, Jang, & Asmundson, 2010; van 
Grootheest et al., 2005). We found no evidence for sex differences in twin 
correlations for any of  the phenotypes. Similar findings have been reported 
for OCS (Bolton et al., 2007; Hudziak et al., 2004; Iervolino et al., 2011), 
whereas for HD results have been mixed (Iervolino et al., 2009; Ivanov et al., 
2013); for tics, to the best of  our knowledge, the issue of  sex differences in 
twin correlations has not yet been addressed. Our results here show that the 
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genetic contributions to these phenotypes are consistent across both sexes.
Second, our results provide evidence for shared genetic variation between the 
phenotypes. The phenotypic correlation between OCS and HD was of  0.30. 
As expected, we observed a higher phenotypic correlation between OCS and 
tics (0.25) than between HD and tics (0.15). The genotypic correlations also 
mirrored this – there was higher shared genetic variance between OCS and 
HD (0.41), than both OCS or HD with tics (0.37 and 0.35, respectively). 
Interestingly, a relatively high proportion of  the phenotypic correlations were 
attributable to genetic factors. In other words, although the genetic overlap 
(expression of  same genes) between tics and both OCS and HD is moderate, 
a substantial proportion of  the phenotypic correlation is mediated by their 
shared genetic variance (61% and 70%, respectively). 
Importantly, Iervolino et al. (2011) recently reported a genetic correlation 
between OCS and HD of  0.45, combined with their data suggesting that HD 
was mostly influenced by specific genetic effects (54.5% specific) (Iervolino et 
al., 2011). The authors argued that this supports the notion of  these disorders 
constituting two etiologically distinct, although related, entities (Iervolino et 
al., 2009, 2011). Further, Mathews et al. reported a substantially lower genetic 
correlation of  0.10 (Mathews et al., 2014). Our current findings of  all cross 
twin cross trait genetic correlations being below 0.2, and the within person 
cross trait correlations being all below 0.35 are mostly in line with those in 
the study by Iervolino et al. (2011). Iervolino et al argue that the magnitude 
of  these genetic correlations is lower than the shared genetic variance of  
0.55 between OCD and other internalizing disorders. i.e. panic disorder, 
generalized anxiety, phobias, and PTSD (Iervolino et al., 2011; Tambs et al., 
2009). They reason that a genetic overlap just under .50 argues in favor of  
HD being a separate, but related entity as it is currently defined in DSM-5. 
Our data on the relationship between HD and OCS are in support of  this 
view.
Our estimates of  genetic correlations between OCS and tics (0.37) are 
somewhat lower than the genetic correlations (0.45) as found by Pinto et 
al. (Pinto et al., 2016). The differences in estimates might be explained by 
the different phenotypic tic definitions requiring an age of  onset before 21 
resulting in a prevalence of  13.5%, whereas their multinomial definition of  
lifetime tics into categories ‘no tic’, ‘one tic’, and ‘two or more tics’ resulted 
in prevalences of  16% at the first, and 6% at the second threshold. Further, 
our results are not fully in line with tic/ OCS enriched clinical family studies 
Bivariate analyses
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reporting very high genetic correlations between TD and OCS (genetic 
correlation= 0.92), although the standard errors in this study were high 
(se=0.42) (Mathews & Grados, 2011).
With respect to the shared genetic and environmental contributions to HD 
and tics, to our knowledge, this is the first twin- family study partitioning the 
covariance between tics and HD in its relative genetic and environmental 
components. Our moderate correlation estimate (0.35) support the argument 
of  viewing TD as distinct from HD. 
Third, the common factor model further supports the view of  shared genetic 
etiology between the three phenotypes. Neuroimaging studies have reported 
structural and functional dysfunctions in the cortico-striato-thalamo-cortical 
(CSTC) circuitries across all three disorders that have negative implications 
for motor response inhibition and interference control in these disorders, 
which might underlie the phenotypic behaviors of  all these three disorders 
(Posner, Marsh, & Simpson, 2014; Velzen, Vriend, & Heuvel, 2014; Wang et 
al., 2011). Our results raise the interesting possibility that a common genetic 
architecture defines underlying CSTC dysfunctions across the three disorders. 
Follow-up genome-wide studies may investigate whether specific genetic 
variants involved in all three disorders are differentially expressed in these 
brain areas as a result of  non-shared environmental influences. In support of  
this, interestingly, OCS and HD showed low environmental correlations with 
tics, suggesting that tic disorders have specific environmental contributors 
invoking tic symptoms.  In other words, non-familial (unique) environmental 
experiences may determine the development of  tics, separately from the 
broader obsessive-compulsive related disorders, as currently defined in DSM-
5 (APA, 2013).
Finally, our results are relevant for the field of  molecular genetics. The 
lack of  power to detect specific genetic risk variants is a recurrent issue in 
genome-wide studies. One way to overcome this limitation is to combine 
related phenotypes therefore increasing sample sizes, with consequent power 
gains. A crucial point here is the balance between power gains from increased 
sample sizes and power losses from increased heterogeneity (Manchia et al., 
2013; Wray & Maier, 2014). Our results suggest that although these disorders 
share substantial genetic overlap, a substantial proportion of  the genetic risk 
variance contributing to the liability to each disorder is independent from 
each other, and care should be taken when combining the phenotypes as 
studied in this paper. 
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The Supplementary material can be found in the online version of this manuscript
These results should be considered in the light of  some limitations, mainly 
considering the phenotypes. Because this is a population-based study, the 
data collected are based on self-report measures, rather than on clinician-
administered structural interviews. The cut-offs have been empirically derived, 
and are therefore somewhat arbitrary. The cut-offs to determine symptom 
thresholds (in the case of  OCS and HD), by considering the entire range of  
age available, may have rendered different prevalence estimates, which might 
have affected estimations of  genetic and environmental effects. We note, 
however, that although these threshold cut-offs do not represent definite 
clinical diagnoses, they do correspond to clinical significant symptoms. 
Moroever, investigation of  dimensions rather than true/false categorical 
diagnosis is consistent with the ideas forwarded in the NIMH Research 
Domain Criteria (RDoC; Patrick & Hajcak, 2016). 
To conclude, OCS, HD and tics share etiologic variance that can be explained 
by substantial genetic correlations. Tics are mostly influenced by specific 
environmental effects unshared with neither OCS or HD, suggesting that 
specific environmental stressors might cause the development of  tics separate 
from OCS and HD. Our results are in line with the literature supporting 
the current definition in DSM-5 of  separating these disorders into different, 
although related, entities.
Limitations
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Chapter 5
Obsessive-Compulsive Symptoms in a 
Large Population-Based Twin-Family Sample 
are Predicted by Clinically-Based 
Polygenic Scores and Genome-Wide SNPs
This chapter is based on: den Braber A, Zilhão NR, Fedko IO, Hottenga JJ, Pool R, Smit DJ, 
Boomsma DI. (2016). Obsessive-compulsive symptoms in a large population-based twin-
family sample are predicted by clinically based polygenic scores and by genome-wide SNPs. 
Translational Psychiatry, 6(2).
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The heritability of  Obsessive-Compulsive symptoms (OCS) is significant, but 
genetic association studies have thus far not yielded consistent findings of  
variants influencing OCS. We aimed to contribute further insights into the 
genetic basis of  OCS by performing a series of  analyses in a homogeneous, 
population-based sample from the Netherlands. First, phenotypic and genetic 
longitudinal correlations over a 6-year period were estimated by modeling of  
OCS data from twins and siblings. Second, polygenic scores (PRS) for 6931 
subjects with genotype and OCS data were calculated based on meta-analysis 
results from Stewart et al. (2013), to investigate their predictive value. Third, 
we used random-effects modeling to estimate the contribution of  measured 
SNPs to the heritability. Lastly, we performed an exploitative GWAS of  OCS, 
testing for SNP- and gene-based associations. Stability in OCS (0.63) was 
mainly explained by genetic factors. PGS obtained from a European case-
control GWAS predicted OCS in the population-based sample. Common 
genetic variants explained 14% of  OCS. GWAS showed one SNP (rs8100480), 
located within the MEF2BNB gene, to be associated with OCS (P=2.56x10-8). 
Additional gene-based testing resulted in 4 significantly associated genes, 
located in the same chromosomal region (19p13.11): RFXANK, MEF2BNB, 
MEF2BNB-MEF2B and MEF2B. Common genetic variants explained a 
significant proportion of  OCS trait variation. Genes significantly associated 
with OCS are expressed in the brain and involved in development and 
control of  immune system functions (RFXANK) and the regulation of  gene 
expression of  muscle specific genes (MEF2BNB). MEF2BNB also showed 
a suggestive association with OCD in an independent case-control study, 
suggesting a possible role for these genes in the development of  this disorder.
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Obsessive–Compulsive Disorder (OCD) is a neuropsychiatric disorder 
characterized by recurrent, persistent and intrusive anxiety-provoking thoughts 
or images (obsessions) and subsequent repetitive behaviours (compulsions) 
(APA, 2000). The lifetime prevalence of  OCD has been estimated between 
0.5-2.0%, and among all anxiety disorders, it is known as a major cause of  
social impairment and a leading cause of  non-fatal disease burden worldwide 
(Ustun, 2004).
It is clear that genetic factors are important in the etiology of  OC symptoms, 
with heritability estimated at 40% (Mathews et al., 2014; Taylor et al., 2011). 
These results did not vary with sex or symptom severity. Consistent with 
what is expected for individual SNP effect sizes in highly polygenic traits, the 
first molecular association studies for OCD have not identified large effect 
variants (Pauls, 2010; Stewart et al., 2013; Taylor, 2013). Compared to genetic 
association studies for other complex human traits, including psychiatric 
disorders, sample sizes and thus statistical power were not large. Therefore, 
Taylor and colleagues (Taylor, 2013) performed a comprehensive meta-
analysis of  the literature of  genetic association studies in OCD, including 113 
relevant studies. Their main meta-analysis showed that OCD was associated 
with serotonin-related polymorphisms (5-HTTLPR and HTR2A) and, 
in males only, with polymorphisms involved in catecholamine modulation 
(COMT and MAOA). In addition, a secondary meta-analysis by this group, 
which analysed polymorphisms that were investigated in fewer than five 
datasets, identified another 18 polymorphisms with significant odds ratios. 
These polymorphisms might be useful candidates for further investigation, 
although most included results were based on candidate gene studies and 
must be treated with great care due to the possible confounding effects of  
population stratification.  
As a first attempt to identify the genetic variation predisposing to OCD 
at genome-wide level, The international OCD foundation Genetics 
Collaborative (IOCDF-GC; Stewart et al., 2013) (Stewart et al., 2013; Taylor, 
2013), conducted an ancestry-stratified case-control genome-wide association 
(GWA) analyses, containing 1465 cases, 5557 ancestry-matched controls, 
and 400 trios, consisting of  one affected offspring with two parents. The 
trio analysis revealed a significant single nucleotide polymorphism (SNP) 
near the BTBD3 gene (rs6131295). However, this variant lost genome-wide 
significance when meta-analysed with the case-control data,. In addition, 
meta-analysis showed a significant enrichment of  methylation quantitative 
trait loci (QTLs) (P<0.001) and frontal lobe expression for the top-ranked 
Introduction
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SNPs (P<0.01). Recently, a second multinational collaboration (OCD 
Collaborative Genetics Association Study; OCGAS; Mattheisen et al., 2014) 
performed a GWAS in 1598 patients and 3473 controls. None of  the SNPs 
tested were significantly associated with OCD, with the smallest p-value 
observed for a marker near the PTPRD gene on chromosome 9. Gene-based 
testing for associations at the gene instead of  SNP level, revealed a significant 
association of  IQCK, C16orf88 and OFC11 (Mattheisen et al., 2014). These 
findings await replication.
With this study, we aim to gain further insights into the genetic basis of  
OC symptoms by performing a series of  analyses in a homogeneous, 
population based sample of  twin families, registered with the Netherlands 
Twin Registry (NTR). Well-phenotyped population cohorts may contribute 
to the understanding of  the underlying architecture of  common complex 
disorders. To ensure a sound OC symptom phenotype, we first performed 
genetic structural equation modelling (SEM) (Boker et al., 2011) to estimate 
twin–twin and twin–sibling correlations and heritability for OC symptoms 
in adults as measured with the Padua-Inventory-Revised-Abbreviated (PI-
R-ABBR) (den Braber et al., 2010). Information on the PI-R-ABBR was 
available for two time-points (2002 and 2008), which allowed calculation 
of  the stability of  OC symptoms across a six-year period. The long-term 
stability of  the phenotype puts an upper limit to heritability – i.e. reveals the 
proportion of  total variation across time that is due to differences among 
individuals, and puts genetic association studies into perspective. Next, we 
investigated whether polygenic scores (PRS) based on a GWA analysis of  
clinical OCD cases (Stewart et al., 2013) significantly predict OC symptoms 
in our population-based sample. If  so, this indicates genetic overlap between 
the two samples, and suggests that future GWA studies can benefit from the 
inclusion of  both population-based and case-control samples. We estimated 
the proportion of  phenotypic variance explained by all autosomal SNPs in a 
sample of  unrelated individuals whose Genetic Relationship Matrix (GRM) 
was obtained in the Genome-wide Complex Trait Analysis (GCTA) software. 
Further, we performed an explorative GWAS on OC symptom scores from 
6931 subjects and entered the GWAS output into a gene-based analysis, to 
test for associations at the gene rather than the single SNP level, in order to 
obtain more information on the biological meaning of  the results (Li, Gui, & 
Sham, 2011).
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Materials & Methods
Participants and measures
Study data were collected in participants of  the NTR (Boomsma et al., 2006; 
Willemsen et al., 2013). We analysed data from the PI-R-ABBR collected in 
2002 and 2008. The total sample with phenotype data from either the 2002 
and/or 2008 data collection contained 20.376 individuals from 7.812 families. 
A total of  10.134 individuals had sum scores available for the PI-R-ABBR 
collected in 2002 and 15.720 individuals had sum scores for the PI-R-ABBR 
collected in 2008. Longitudinal data were available for 5.478 individuals. 
The distribution of  the OC symptom scores, from the PI-R-ABBR 
collected in 2002 and 2008, is provided in Supplementary figure 1. For more 
information on the PI-R-ABBR OCS measures, please see supplementary 
methods “participants and measures”. The number of  participants differed 
between analyses. Table 1 gives an overview of  subjects per analysis and their 
demographic data (see also supplementary methods “Subjects entered into 
different genetic analyses” for more details and Zilhao et al. (2014)).
This study has been approved by the Central Ethics Committee on Research 
involving human subjects of  the VU University Amsterdam.
Table 1. Subjects (including age and sex) entered per analysis
Note: Table 1. PI-R-ABBR =Padua Inventory Revised Abbreviated; PI-R-ABBR 2002 = PI-R-ABBR 
collected in 2002; PI-R-ABBR 2008 = PI-R-ABBR collected in 2008; SEM = structural equation modeling; 
PRS = Polygenic score; GCTA = Genome-wide Complex Trait Analysis ; GWAS = Genome-wide association 
study.
DNA was extracted from either blood or buccal cell samples that were collected 
for various projects done by the NTR (Boomsma et al., 2006; Willemsen et 
al., 2013). For further details on genotyping, quality control and imputation 
methods see supplementary methods “genotyping and imputation”. 
Genotyping and Imputation 
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To examine shared polygenic risk at an aggregate level between two 
independent GWAS samples, we used genetic risk-score profiling as described 
by Purcell and colleagues (Purcell et al., 2009). GWAS results (SNP, effect 
allele, effect size as represented by a Beta-value and p-value) obtained from 
the analysis in the European case-control sample by Stewart et al. (2013) was 
used as a discovery dataset for calculating polygenic scores (PGS) within our 
NTR target sample in PLINK. PGS were then regressed against the OCS 
scores from the NTR dataset (n=6931) in order to calculate the proportion of  
variance in this target set explained by PGS obtained from the discovery set, 
with 15 statistical cutoffs for SNP inclusion in the score (cutoffs: p<0.00001, 
p<0.0001, p<0.001, p<0.01, p<0.05, p<0.1, p<0.2, p<0.3, p<0.4, p<0.5, 
p<0.6, p<0.7, p<0.8, p<0.9, p<=1). To correct for family relatedness in the 
NTR sample generalized estimating equations in SPSS with the exchangeable 
and robust function were used (Minica, Dolan, & Vink, 2014). For Sex, age, 
principal components to correct for the population substructure (Abdellaoui 
et al., 2013) and genotyping platform were included as covariates. As an 
additional test, we regressed the PGS on a non-psychiatric, and OCS-
uncorrelated trait (height), from the NTR (n=6715). We sought to rule out a 
possible spurious association that can arise as a consequence of  incomplete 
correction for population stratification and/or cryptic relatedness between 
the discovery and target samples. Finally, to test for concordance of  effect 
directions across both datasets, we performed Fisher’s exact statistical test 
using the online-based application SECA (SNP effect concordance analysis) 
- http://neurogenetics.qimrberghofer.edu.au/SECA/ (Nyholt, 2014). For 12 
To estimate the total contribution of  genetic factors to trait variance and to 
the longitudinal covariance, the resemblance among twins and siblings was 
compared. Monozygotic (MZ) twins share (nearly) all their genes, whereas 
Dizygotic (DZ) twins, just like non-twin siblings, share on average half  of  
their segregating genes. In quantitative genetics, this information is used 
to decompose the total variance of  a trait into additive genetic (A), non-
additive genetic (D=dominance), and unshared environmental variance (E). 
The greater the phenotypic similarity between MZ twins, when compared 
to DZ twins and non-twin siblings, the more of  the variance of  the trait is 
attributed to genetic factors. Genetic analyses were carried out by Structural 
Equation Modeling (SEM) as implemented in OpenMx (Boker et al., 2011). 
For further details on SEM analysis may be found in supplementary methods 
“SEM methods”.
Heritability Estimates from Structural Equation Modelling 
Polygenic risk scores 
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subsets of  SNPs with P < {0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.8, 0.9, 
1.0} in both datasets, Fisher’s exact tests were performed to evaluate if  there 
is an excess of  SNPs in the first dataset (European case-control study) with 
same direction of  effect in the NTR dataset across the total 144 SNP subsets. 
An empirical P-value was generated by permutations (1000) for observing the 
number of  SNP subsets with nominally significant concordance.
The variance of  OC symptoms explained by measured and imputed SNPs 
was estimated with Genome-wide Complex Trait Analysis (GCTA) using the 
Restricted Maximum Likelihood analysis procedure (Yang, Lee, & Visscher, 
2011, 2013). This method gives insight into the contribution to the additive 
genetic variance of  all SNPs tagged by all genotyped and imputed SNPs. This 
provides an upper bound on the variance that can be explained by the set of  
SNPs.  To analyse all available data we followed the method proposed by Zaitlen 
et al (2013). In this method, the SNP based and kinship-based heritability 
can be estimated simultaneously. For this, a second variance component is 
included in the model, which only considers closely related individuals for a 
certain predefined threshold of  genetic relatedness (here defined only those 
with Identity by descent values greater than 0.05). For further details on 
the method followed and quality control, refer to supplementary methods 
“estimations of  variance explained by common SNPs (GCTA)”.
Estimations of variance explained by common SNPs (GCTA)
Genome-wide association (GWA) analysis was conducted with linear 
regression under an additive model with adjustment for age, age-squared, 
principal components of  genetic ancestry, genotyping platform and sex. 
SNPs with values of  p<5.00E-08 were declared genome-wide significant. For 
further details on this analysis, refer to supplementary methods “GWAS”.
GATES, as implemented in the open-source tool Knowledge-Based Mining 
System for Genome-Wide Genetic Studies (KGG, version 3.0), was used to 
perform a gene-based genome-wide analysis (Li et al., 2011). GATES employs 
an extension of  the Simes procedure (Benjamini & Hochberg, 1997) to assess 
the significance of  a statistical association at the gene level, by combining the 
individual genotype-phenotype association tests applied at each single marker. 
In short, it sums all the individual SNP p-values, available from GWAS 
summary data, within a gene to output a gene-based p-value. The effective 
number of  independent p-values is given by appropriately controlling for the 
GWAS
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Linkage Disequilibrium structure on the specified SNPs. SNPs were allocated 
to genes including gene boundaries of  +/- 5 kb from the 5’and 3’UTR. To 
correct for multiple testing false discovery rate (FDR) was set at q<0.05.
Results
Demographics
For subjects who completed the PI-R-ABBR in 2002 and in 2008 the average 
age was 33.0 (SD=11.5), and 34.7 (SD=14.6). Retest stability for OCS scores 
over a timespan of  ~6 years was 0.63. The effect of  age on OCS scores was a 
drop of  0.03 per year for both PI-R-ABBR collected in 2002 and 2008.
Genetic Modelling (SEM)
MZ, DZ/sibling, test-retest and cross-correlations are summarized in table 2. 
Twin correlations for MZ males and MZ females were equal, as were twin/
sibling correlations for DZ males, DZ females, DZ opposite-sex twins and 
siblings. This indicates that there is no evidence for qualitative sex differences 
in the heritability of  OC symptoms and that to a large extent the same genes 
influence these symptoms in males and females. Twin correlations were 
more than twice as large in MZ as compared to DZ/sib pairs, indicating that 
phenotypic similarity is predominantly accounted for by genetic effects rather 
than shared environment. The same pattern was observed for cross-twin–
cross-time correlations, indicating that the observed stability is also mainly 
caused by genetic factors. Structural equation modelling showed a significant 
heritability (p < 1.0 x 10-10) for OC symptoms at both time points of  0.42 
(95% CI PI-R-ABBR 2002 = 0.371 – 0.467, and 95% CI PI-R-ABBR 2008 
=0.379 – 0.456). The estimation of  the bivariate (broad sense) heritability 
found that 56% (95% CI = 0.497 – 0.619) of  the stability of  OC symptom 
was due to genetic factors (both additive and dominant components), and 
the longitudinal additive genetic correlation, that is, the degree of  overlap 
between additive genetic influences at both time-points was 0.58.
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Table 2. Familial correlations estimated from Maximum likelihood for OC symptoms 
measured over 2 points in time.
Note: Table 2. MZ = monozygotic; DZ = Dizygotic.
The proportions of  variance of  OC symptoms in the NTR sample explained 
by polygenic scores obtained from the discovery set (European case 
control sample Stewart et al. 2013), using the 15 statistical cut-offs for SNP 
inclusion in the score, are summarized in figure 1. Results show that when 
including more SNPs in the analyses an increasing amount of  variance in 
OC symptoms is explained; reaching a plateau of  0.2% explained variance 
(p<0.001) at PRS12 (includes all SNPs from Stewart et al., 2013 with a p<0.7 
[N=4.288.152]). Supplementary figure 2 provides the results obtained when 
using height as the outcome phenotype for the target set for the same PGS. 
For the same 15 statistical cut-offs, no significant result was observed (p < 
0.01), i.e. the PGS did not explain any variance in height, hence excluding 
the confounding effect due to cryptic relatedness across sample sets and 
possible residual genetic stratification effects present in both populations. 
Finally, supplementary figure 3 presents the results in a heat map plot from 
analysis of  concordance using SECA. The permuted P-value for the number 
of  SNP subsets nominally significant was P=0.002 thus indicating significant 
concordance of  genetic risk across the datasets.
PRS regressed on PI-R-ABBR sum scores
Figure 1. Proportion of variance in OC symptom scores, as measured in the NTR sample, explained by 
polygenic scores (PRS) obtained from European case-control sample by Stewart et al. 2013, with a range 
of 15 statistical cut-offs for SNP inclusion in the score (PRS1; p<0.00001, PRS2; p<0.0001, PRS3; p<0.001, 
PRS4; p<0.01, PRS5; p<0.05, PRS6; p<0.1, PRS7; p<0.2, PRS8; p<0.3, PRS9; p<0.4, PRS10; p<0.5, PRS11; 
p<0.6, PRS12; p<0.7, PRS13; p<0.8, PRS14; p<0.9, PRS15; p<=1). *=p<0.05; **=p<0.01.
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SNP-based Heritability
GCTA results showed a significant SNP-based heritability estimate of  0.14 
(SE=0.05, p=0.003), and a total narrow-sense heritability of  0.338 (SE=0.02, 
p<0.001). Thus 14% of  the total phenotypic variance in OCS can be 
accounted for by the SNPs in the genotyping platform, and the total set of  
SNPs included in an additive genetic model account for 33.8% of  the total 
heritability.
Top associated variants in GWAS analysis (top 20 SNPs) are summarized 
in table 3 (a more comprehensive overview of  these results is present in 
supplementary table 1). The Manhattan plot, showing the -log(P) plotted 
against genomic location, and QQ plot of  observed versus expected 
-log(P) statistics for the OC symptom GWAS, are illustrated in figure 2 & 
supplementary figure 4, respectively. Of  the top associated variants, one SNP, 
rs8100480 (19299079, 19p13.11 (hg19), P=2.56x10-8), exceeded the threshold 
for genome-wide significance and showed a positive association with OCS. 
This SNP is located within the MEF2BNB gene. A more detailed look into 
this region is provided by the regional association plot in Supplementary 
Figure 5.
Genome-wide Association Analysis
Figure 2. Manhattan plots of all genotyped single-nucleotide polymorphisms (SNPs). Red and blue lines 
indicate significance thresholds of 5.00E-08 and 1.00E-05, respectively
88
Further, we searched in our results whether they replicate top SNPs reported 
by Stewart et al., 2013 and Mattheisen et al., 2014. Supplementary table 2 
summarizes results for the strongest associated GWAS variants from Stewart 
et al, 2013. From their table of  43 SNPs (with P<1.0x10-5), 16 were found 
to be independent (Mattheisen et al., 2014). None of  these SNPs were 
significantly replicated in our sample when correcting for multiple comparison 
(0.05/16=0.003). However, a trend (p=0.0049) for replication was found 
for rs4868342, located on chromosome 5. This SNP is located within the 
HMP19 gene. 
Supplementary table 3 summarizes results for the strongest associated GWAS 
variants from Mattheisen et al. (2014). None of  the 32 suggestive associations 
(with P<1.0x10-4) were replicated in our sample after correcting for multiple 
comparison (0.05/32=0.001). Neither were the significant results obtained in 
our study replicated in the Stewart sample (data not shown).
Table 3. Top associated variants in NTR-GWAS analysis.
Note: Table 3. Single Nucletotide Polymorphisms (SNP) listed include the top 20   P-values for the GWAS 
results. Chromosome (Chr) and base pair position (BP), based on hg19 build, are also given. The beta indicates 
the effect size, and the direction of the association is given by its positive or negative value. The location of each 
SNP is given in the last column; when located in non-intronic locus, the left and right closest flanking genes are 
additionally noted. A1 and A2 indicate the effect allele and the non-effect allele, respectively.
A total of  2.644.694 SNPs were mapped to 22.759 genes. The QQ plots 
with the observed versus expected –log(P) of  the association tests are 
presented in supplementary figure 6. Table 4 depicts all the genes with 
a significant association. Although these are all nominal significant, the 
Gene-based analysis
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Benjamin-Hochberg procedure was set to control for the q<0.05 (Benjamini 
& Hochberg, 1997). After correction, four genes remained significant, the 
regulatory factor X-associated ankyrin-containing protein (RFXANK), the 
myocyte enhancer factor 2B (MEF2B), the MEF2B neighbor (MEF2BNB), 
and the MEF2BNB-MEF2B read through (MEF2BNB-MEF2B). All these 
genes are located in the same chromosomal region (19p13.11), and they all 
share the SNP with the lowest P-value annotated to the gene (rs8100480, 
P=2.56E-08). The Manhattan plot for the gene association P-values is present 
in supplementary figure 7.
Table 4. List of all nominal significant (genes α =0.05). Genes significant 
after FDR corrections are depicted with a (*)
Note: Table 4. Genes listed include all the nominal significant genes (α= 0.05). Significant 
genes after FDR correction are depicted with (*). For each gene, the chromosome, start 
position and respective gene length (in base pairs) are given. The number of SNPs from the 
GWAS within each gene are also present. The last column represents the calculated gene-
based test P-value. 
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Discussion
This study aimed at getting a better insight into the genetic basis of  OC 
symptoms in a population-based sample. 
First, in line with previous studies, we estimated the heritability for OC 
symptoms at 0.42 (S Taylor, 2013). Stability of  OCS over a 6 year time period 
was 0.63, and cross-twin–cross-time correlations were found to be twice as 
high in MZ compared to DZ/sib pairs, indicating that the observed stability 
is mainly caused by genetic factors. Bivariate analyses showed a longitudinal 
genetic correlation of  0.58.
Second, polygenic scores based on a GWA analysis of  clinical OCD cases 
significantly predicted OC symptoms in the independent population-based 
sample. Also, analysis of  concordance results indicates that the genetic risk 
between the two datasets are concordant. This suggests a high polygenic 
contribution to the trait and indicates genetic overlap between OCD assessed 
as a categorical disorder and OC symptoms assessed as a continuous trait. 
These results indicate that future GWA studies can benefit from the inclusion 
of  both population-based and case-control studies, and by analysing OCD as 
a quantitative rather than a categorical trait. 
Third, we estimated the SNP based heritability in the sample of  genotyped 
individuals, In a previous study by Davis and colleagues (Davis et al., 2013) 
the genetic variance in OCD explained by SNPs was estimated at 0.37 In 
accordance with this, we were able to find significant explained variance at 
0.34. More importantly we were able to partition the heritability into two 
components, revealing a SNP heritability of  0.14 and the proportion of  the 
heritability not accounted for by SNPs (so called ‘missing heritability’) at 
around 0.20. These results corroborate well with our findings from our twin 
model (broad heritability at 0.42). 
Fourth, the GWAS performed on our continuous OC symptom scores 
resulted in one significant SNP (rs8100480), which is located in the 
MEF2BNB-MEF2B gene. In addition, we sought to calculate gene-based 
p-values, to determine whether there are genes with associated SNPs, which 
can collectively achieve statistical significance. Implementing a gene-based 
analysis as a follow-up complementary analysis seems to be of  additional 
value over traditional GWAS results, since gene-based analysis takes the 
number of  SNPs in each gene and gene size into account, considering genes 
as functional units informing on the underlying genetic architecture of  the 
phenotype under review. Furthermore, since for most psychiatric disorders 
we do not expect large effect causal variants, replication analysis from 
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underpowered GWAS would not reflect these findings. Gene-based tests, by 
providing an aggregated analysis, may successfully capture those combined 
effects. We found significant associations for four genes. RFXANK encodes a 
protein that belongs to the Major histocompatibility (MHC) class II molecules, 
which has an important role in the development and control of  the immune 
system. Bare lymphocyte syndrome 2, an immunodeficiency disorder, has 
been linked with mutations in this gene. Although RFXANK has not been 
identified in OCD previously, several lines of  research have indicated a 
role of  immune system alterations and of  immune system genes, including 
TNFα, and SLC1A1, in combination with cerebral immunopathological 
reactions to amongst others group A ß-hemolytic streptococcus infections 
(Swedo et al., 1998) and Bornea virus infections (D Marazziti et al., 2009; 
Marazziti et al., 1999) in the onset (and expression) of  OCD. This has led to 
the concept of  “PANDAS” and “non-PANDAS” OCD (Cappi et al., 2012; 
da Rocha, Correa, & Teixeira, 2008; Rotge et al., 2010). However, very little 
research has been performed on direct gene*gene interactions/pathways or 
on gene*environment interactions to better understand immunopathological 
pathways related to OC symptoms. MEF2B is a protein-coding gene 
belonging to the DNA binding protein family MADS/MEF2, that regulates 
gene expression, specifically in the smooth muscle tissue. Both MEF2BNB 
and MEF2BNB-MEF2B are closely related to MEF2B, and have mostly 
regulatory functions. Additional support for a relation between MEF2BNB 
and OCD comes from a gene-based analysis in a recently published GWAS of  
OCD (Mattheisen et al., 2014) where the gene was ranked 21st of  the 21.567 
genes tested (gene-based p = 8.09E-04, N.S. after correction for multiple 
testing). All four genes are overlapping between themselves, and span a region 
of  56302 bp located in the 19p13.11 cytogenetic band, on the short arm of  
chromosome 19. Perhaps the best interpretation for these results, therefore, is 
in the implication of  this genomic location (19p13.11) as a susceptibility locus 
for OC symptoms. Several SNP-trait associations have been linked to this 
locus. For example, rs1064395 (NCAN) has been reported as a susceptibility 
factor for bipolar disorder in a genome-wide association study. NCAN gene 
is located just 10095 bp at 5’ from RFXANK, and is one of  the few genetic 
variants that has been genome-wide replicated as a risk factor in both bipolar 
disorder and schizophrenia (Cichon et al., 2011; Mühleisen et al., 2012). In 
addition, a recent study focusing on the cortical thickness and folding in 
schizophrenia patients found evidence for association of  the NCAN genetic 
variant in the occipital and prefrontal cortex (Schultz et al., 2014). The SNP 
rs874628 (MPV17L2 gene), located in this locus, was implicated in multiple 
sclerosis, an inflammatory disease with disruptions in the nervous system 
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(Sawcer et al., 2012). 
Overall, our results, combined with previous genetic studies in OCD, 
suggest a possible role for the 19p13.11 region (MEF2BNB gene) in OC 
symptoms. It might be of  interest for future genetic studies to investigate 
this area in association with OCD into depth. Further, our data shows that 
well phenotyped population cohorts could contribute to the understanding 
of  the underlying architecture of  common complex disorders such as OC 
symptoms, and that these partly overlap with results from case-control 
studies. Therefore, future studies could benefit from combining case-control 
and population-based samples.
The Supplementary material can be found in the online version of this manuscript
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Chapter 6
Genome-Wide Association Study 
of Tics and Tourette Disorder Symptoms
This chapter is based on: Zilhao, N. R.,  Smit, D. J. A., Cath, D., Hottenga J. J., Boomsma, 
D. I. (2017). Genome-wide association study of tics and Tourette Disorder Symptoms. 
European Journal of Human Genetics (under review).
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Tic disorders are common neuropsychiatric diseases with a familial 
inheritance, but specific genetic causal variants remain elusive. Here, we 
present results from a genome-wide analysis on Tourette Disorder (TD) 
from a population-based family sample from the Netherlands (NTR-TD: 
N=88 cases; 6381 controls), and meta-analyzed these with those from the 
Psychiatric Genomics Consortium Tourette’s workgroup (PGC-TS: N=778 
cases; 4414 controls). NTR top-ranking SNP (rs73193806) (p=2.13e-08) is 
located in the same region (12q23) as reported among the top results from 
the PGC-TS. LD score regression rendered a SNP-based heritability of  0.146 
(se=0.066) for the NTR-TD, in line with what has been reported for tic 
phenotypes. In the meta-analysis the top SNP was rs7783290 (p=1.49e-07), 
located on chromosome 7p21.3, 600Kbp from the closest gene, NDUFA4. 
In conclusion, we estimated a SNP-based heritability of  14.6% indicating that 
a substantial part of  the total TD heritability can be attributed to SNPs that 
are relatively common. We have extended previous work on the genetics of  
TD and shown that combining clinical- and population-based samples is of  
added value.
Abstract
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Tics are defined as involuntary, sudden, recurrent, non-rhythmic and 
stereotypical motor movements or vocalizations. The Diagnostic and 
Statistical Manual of  Mental Disorders, Fifth Edition (DSM-5) (American 
Psychiatric Association, 2013), recognizes three types of  tic disorders: 
Tourette’s Disorder (TD), Chronic Motor or Vocal Tic Disorder (CMT/
CVT) and Provisional tic disorder, with the diagnosis depending on age of  
onset, duration, and tic type (motor, vocal or both). 
Both twin and family studies have indicated that TD is heritable, with first-
degree relatives of  TD-affected probands having a 5-15 fold increased risk for 
TD compared to the general population (Pauls, Raymond, & Leckman, 1991; 
Robertson, 2008). Epidemiological studies estimated heritability ranging from 
.28 to .56 (Anckarsäter et al., 2011; Bolton, Rijsdijk, & Eley, 2007; Larson et 
al., 2010). Yet, studies seeking specific genetic variants for the susceptibility 
of  this disorder have thus far rendered only suggestive results. Candidate 
gene and CNV studies in TD have mainly been positive on SLITRK1, HDC, 
DRD4 and AADAC. However, none of  these studies were followed by 
consistent replications, and were hampered by small sample sizes (Abelson et 
al., 2005; Bertelsen et al., 2014; Ercan-Sencicek et al., 2010; Liu et al., 2014). 
The only genome wide association study (GWAS) in TD so far, performed by 
the Tourette Syndrome Association International Consortium for Genetics 
(TSAICG), from a sample of  1285 cases and 4964 ancestry-matched controls 
did not identify genome-wide significant results. The top signal (rs7868992) 
was located in COL27A1 on chromosome 9q32 (p=1.85e-06) (Scharf  et al., 
2013). 
Here, we present results from a GWAS on TD in a population-based family 
study including screened controls from the Netherlands. For these results, 
we estimated SNP-based heritability using LD score regression. Finally, we 
performed a meta-analysis combining results from our study and the study 
performed by the TSAICG, to investigate the added value of  combining 
clinically-based and population-based datasets.
Introduction
Participants in this study are adults from the Netherlands twin Register (NTR) 
who completed the 8th NTR survey between 2008-2012 (Willemsen et al., 
2013). Data on tics were collected using the abbreviated Schedule for Tourette 
and Other Behavioral Syndromes (STOBS-ABBR - Supplementary Table 1), 
a self-report that contains 9 tic items and 3 additional questions on age at 
Materials & Methods
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onset, duration and tic severity, classifying participants according to DSM-IV-
TR and in line with DSM5 criteria (American Psychiatric Association, 2013). 
Individuals identified as cases were diagnosed as having either ‘probable 
CMT/CVT’ or ‘probable TD’ according to the STOBS-ABBR. These 
individuals constitute a sample of  screened controls as we only included those 
individuals with the most severe manifestation of  a tic disorder, excluding 
those classified with a milder form of  the phenotype (N=173) (Zilhão et 
al., 2016). A final total of  88 cases and 6381 controls (from 3338 different 
families,) were included in the analysis (see Supplementary Table 2 for an 
overview on the sample demographics). The study was approved by the 
Central Ethics Committee on Research involving human subjects of  the VU 
University Amsterdam. Informed Consent was obtained from all subjects.
Genotyping and genotype calling was performed on multiple array platforms, 
and respective platform specific software, for a total of  21,775,581 SNPs 
included in the analysis.  Imputation was performed from the HRC and 
1000 Genomes Project Phase 3 (v5) reference panels (for information on 
Genotype, Imputation and Quality control steps please view Supplementary 
Methods). Post-analysis quality control steps involved removing all SNPs 
with INFO imputation score < 0.8 and SNPs with MAF>0.05. From a total 
of  21,775,581 SNPs, 6,789,596 were finally included in the analyses. 
Genotyping
Association Analysis
For genetic association analyses we employed the method proposed by Chen 
et al. (Chen et al., 2016), freely available and implemented as the R-package 
GMMAT (https://www.hsph.harvard.edu/xlin/software.html). This method 
fits a generalized linear mixed model with random effects (genetic relationship 
matrix) to account for family relatedness, and subsequently performing a 
score test (Engle, 1983) for each tested genetic variant. The actual statistical 
test (score) is based on the slope of  the likelihood function under the null 
hypothesis (H0) of  no SNP effect. This slope (or ‘score’) is used to estimate 
the improvement in model fit when including the SNP of  interest, defined 
as the (expected) difference in Χ² statistic. This is done using the penalized 
quasi-likelihood (PQL) method and the average information restricted 
maximum likelihood (AI-REML) algorithm, to test for its association with 
the binary phenotype (Gilmour, Thompson, & Cullis, 1995). Importantly, the 
score test is computationally more efficient than regular statistical techniques 
that require an estimate of  the SNP effect coefficient. However, the score 
test is only valid for small effect sizes, but this is a reasonable assumption for 
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Based on the GWA results, we estimated the SNP-heritability (probable 
TD or probable CMT/CVT) using linkage disequilibrium score regression 
(LDSR; (Bulik-sullivan et al., 2015). Following this approach, we estimated 
the heritability captured by the set of  genotyped SNPs – i.e. the contribution 
to the additive genetic variance of  all genotyped SNPs on the current panel. 
This was achieved by separately estimating the true polygenic signal and the 
confounding bias (e.g. population stratification), using Linkage disequilibrium 
(LD) information from a reference set (European-ancestry) as predictors 
for the Χ² statistic from the GWAS results (https://data.broadinstitute.org/
alkesgroup/LDSCORE). The slope of  this regression is an estimator of  the 
contribution from true polygenecity to the inflation factor – heritability.
SNP Heritability
We performed a meta-analysis, combining our results with results from 
the PGC-TS using the software METAL (http://genome.sph.umich.edu/
wiki/METAL_Program). The summary statistics from the PGC-TS were 
based on the imputed dataset (N=778 cases; N=4414 controls), derived 
from a European-ancestry sub-population (Scharf  et al., 2013). Following 
METAL software’s approach, p-values (and respective effect direction) from 
both studies were transformed into signed Z-scores and weighted to their 
sample size, reflecting higher or lower disease risk. From a combined total 
of  8,144,975 SNPs, 5,103,655 were meta-analyzed (i.e. in common between 
datasets).
No single SNP reached the genome-wide significance level (p<5.0e-08); we 
note, however, that at the given sample size genome-wide significance was 
not expected. The QQ-plot (Figure 1) indicates that there is little inflation in 
the observed results, and that the model properly accounted for population 
stratification theoretically present in the data, or any systematic technical 
artifacts.
Meta-Analysis
Results & Discussion
testing SNP effects.
99
Figure 1. QQ-plot of expected vs observed –log(p-values) from the GWAS analysis (left). Manhattan plot 
for all 5595601 SNPs included in the analysis, for 88 cases and 6381 controls. Green dots represent the top 
55 SNPs from the previous published TD GWAS (Scharf 2013, Supplementary Table S2) (right).
The top SNP rs73193806 (p=2.13e-08) is located on chromosome 12q23.3, 
2055 bp from ST13P3 gene. Supplementary Table 3 shows results from the 
association analysis, with a p<1.0e-05. The top 13 SNPs span a region of  
43,236 bp and are in high LD with each other (Figure 2, right). Interestingly, 
Scharf  and colleagues reported a SNP (rs6539267, p=7.41e-06) among its top 
hits, located within the POLR3B gene in the region 12q23 (Scharf  et al., 2013). 
Our top hit, rs73193806, is located in the same region, 350kb downstream of  
POLR3B (Figure 2, right).
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Based on the NTR-TS GWA results, we estimated the SNP-based heritability 
at 0.146 (se=0.0658). Previously Davis and colleagues estimated SNP-
heritability for TD at 0.58 (Davis et al., 2013), which seems to be a high 
estimate in light of  recent genetic epidemiological work estimating TD and 
Chronic tic disorder (CTD) heritability at 0.25, based on NTR twin-family 
data (Zilhão et al., 2016). This study showed (narrow-sense) heritability 
estimates between 0.25-0.37 across a spectrum of  severity using 4 different 
definitions of  tic disorders. The lower boundary of  0.25 phenotypically (TS 
or CTD) matches our current result of  14.6% for SNP-heritability - aligning 
with the observation that most heritability estimates from twin-family studies 
are higher than from SNP-based studies (Vinkhuyzen, Wray, Yang, Goddard, 
& Visscher, 2013). However, our results originate from a population-based 
cohort, whereas Davis et al. analyzed data from a clinical cohort. The estimate 
of  0.146 indicates that roughly half  of  the total heritability can be attributed 
to SNPs that are relatively common.
Figure 3 shows the results from the meta-analysis. The QQ-plot indicates 
little inflation in the results. Among the 5,103,655 SNPs included in the 
Figure 2. Regional plots showing the regional association for selected SNPs using the tool 
LocusZoom (http://locuszoom.org/); highlighting the region flanking the top SNP obtained 
in the study by Scharf (2013). Our top SNP rs73193806 (in red) is located 345240 bp from 
POLR3B in the highlighted area.
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Meta-analysis, 2,548,950 were concordant for effect direction (1,272,166 
for increased risk, and 1,276,784 for decreased risk). The summary statistics 
we utilized included a sub-population of  European ancestry from the study 
presented by Scharf  et al (2013). The meta-analysis presented consists of  
combining a clinical sample with a non-clinical population-based sample of  
screened-controls. Shown in the Manhattan plot, the top results from the 
PGC-TS provide expected higher relative weight in the Meta-analysis (Figure 
3). The top SNP, rs7783290 located on chromosome 7, has a p-value of  
1.49e-07 and a Z-score of  -5.25. This SNP was the 3rd top ranking SNP 
in the GWAS from the PGC-TS (p=7.49e-07), and showed p=0.077 in the 
NTR-TD GWAS (Supplementary Table 4). 
Figure 3. QQ-plot of expected vs observed –log(p-values) from the Meta-analysis between the PGC-TS 
and the NTR GWAS (left). Manhattan plot for all 5,103,655 SNPs; original results from each independent 
analysis are highlighted in green (for the TD consortium) and orange (for the NTR) (right).
We presented the second GWAS on probable TD performed to date and 
meta-analyzed the results with the first GWA carried out by Scharf  (2013). We 
note that the lack of  genome wide significant results from our study and the 
meta-analysis is likely due to the low power, well in line with observations for 
other traits within this field. The SNP-heritability estimate of  0.146 provides 
positive expectations for upcoming genetic analyses in TD, for which higher 
sample sizes may help uncover causal variants underlying the genetic etiology 
of  this disease. Importantly, we show relevance of  combining clinical and 
population-based samples in context of  GWA for tic disorders.
The Supplementary material can be found in the online version of this manuscript
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Chapter 7
Genome-Wide Association Study of Hoarding Behaviour: 
A Meta-Analysis in 2 Cohorts
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Hoarding disorder (HD) is defined as disorder characterized by a pathological 
acquisition and difficulty in discarding possessions of  relatively low value. 
This leads to severe clutter and social impairment, precluding normal daily 
living and activities for which living spaces were originally designed (APA, 
2013; Frost & Hartl, 1996). For a long time, HD was considered a form of  
obsessive-compulsive disorder (OCD), and there is a debate whether HD 
constitutes a separate mental disorder rather than a symptom of  OCD. In 
both epidemiological and clinical samples, OCD and HD show comorbidity, 
with up to 16.3% OCD in individuals with suggestive HD, and reversely, 
up to 24% of  individuals with OCD scoring above the cut-point suggestive 
for HD in the general population (Frost, Steketee, & Tolin, 2011; Ivanov et 
al., 2013; Mathews et al., 2014). Interestingly, other co-occurring disorders 
with HD, i.e. ADHD, Major Depressive Disorder and Generalized Anxiety 
Disorder (between 25-50%) are more common in HD than OCD (Mataix-
Cols et al., 2010). Partly as  a consequence of  these results, in the latest version 
of  the Diagnostic and Statistical Manual of  Mental Disorders (DSM-5), HD 
is positioned as a separate disorder, at the same time being part of  obsessive-
compulsive spectrum disorders  (APA, 2013). HD has a genetic basis, as 
established by multivariate twin studies (Iervolino et al., 2011; Ivanov et al., 
2013; Mathews et al., 2014; Zilhao et al., 2016). Zilhão, et al. (2016) estimated 
the genetic correlation between OC symptoms and hoarding symptoms at 
0.41. This genetic correlation was significantly lower than 1 and corroborates 
the notion of  HD being (at least partly) distinct from OCD (Zilhao et al., 
2016).
Possibly as a consequence of  the past positioning of  HD within the 
framework of  OCD in DSM-III and IV classification systems, there has been 
a scarcity of  studies on HD as a separate disorder. With respect to the genetic 
epidemiology of  HD, current evidence points to familial transmission of  
HD (Lochner et al., 2005; Pertusa et al., 2008; Winsberg, Cassic, & Koran, 
1999), with twin studies estimating the heritability between 0.33-0.50 in adults 
(Iervolino et al., 2009; Ivanov et al., 2013; Nordsletten et al., 2013; Taylor, et 
al., 2010; Yu et al., 2014; Zilhao et al., 2016).
The first GWAS of  hoarding behavior was published in 2010, in a population 
based sample (N=3410 independent persons) from the TwinsUK study, 
consisting of  predominantly female participants (91.8%) (Perroud et al., 2011). 
Although no SNPs with genome-wide significance were reported, results 
revealed two loci with suggestive evidence for association with HD. Here, we 
present the second genetic association study, which entails a meta-analysis on 
HD, combining two population-based samples; one from the Netherlands 
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Twin Register (NTR), and the other one from the previously mentioned 
TwinsUK sample partly overlapping with the published GWAS (Spector & 
Williams, 2006; Perroud et al., 2011). In both samples, we allow data from 
related individuals to be analysed, using appropriate methods (Purcell et al., 
2007), thereby increasing the sample size for TwinsUK as compared to the 
previous GWAS. The studies included 6521 participants from NTR and 5190 
from TwinsUK, who were phenotyped by the Hoarding Rating Scale-Self-
Report (HRS-SR; (Tolin, et al., 2010) and who had genome wide genotyped 
data, imputed on the 1000G, phase 3 (v5).   
Participants in this study are adults from the Netherlands twin Register 
(NTR) who completed the 8th NTR survey between 2008-2012 (Geels et al., 
2013; Willemsen et al., 2013) and from the TwinsUK as part of  a larger wave 
of  data collection (Moayyeri, Hammond, Hart, & Spector, 2013). Data on 
hoarding were collected using the Hoarding Rating Scale-Self-Report (HRS-
SR), a self-report assessment instrument consisting of  five items each scoring 
on a 0-8 scale, producing a total score range between 0 and 40. It assesses 
cluttering, difficulty in discarding items, excessive acquisition or collecting, 
distress derived from hoarding symptoms and functional impairment (Tolin 
et al., 2010). For both samples the distress item (item 4) was discarded, due 
to approval restriction on the items to be included in the larger questionnaire 
(Cath, Nizar, & Mathews, 2017). Therefore, phenotypic scores were based on 
a 4-item scale. The GWAS analyses were performed on a continuous score 
for hoarding ranging from 0 to 32. In total, data from 6521 (N=2237 males; 
N=4284 females) individuals from NTR and 5190 from TwinsUK (N=596 
males; N=4594 females) were included in the analysis. 
Genotyping and genotype calling was performed on multiple array platforms, 
and respective platform specific software. Imputation was performed from 
the HRC and 1000 Genomes Project Phase 3 (v5) reference panels (for 
information on Genotype, Imputation and Quality control steps please view 
Supplementary Methods). After all Quality control steps were performed, a 
final total of  7,666,767 and 9,618,499 SNPs were included in the analyses. 
The GWAS analyses of  each separate cohort were carried out in PLINK 2.0 
(Purcell et al., 2007). For both analyses, age, sex and 20 principal components 
were used as covariates to correct for population stratification. A linear 
regression was used for the association analysis, and the --family option in 
PLINK was used for correcting for the family structure.
The meta-analysis was performed using the METAL software by weighting 
the effect size estimates to their inverse of  the standard errors (http://
genome.sph.umich.edu/wiki/METAL_Program). From its combined total, 
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a final set of  6,767,570 SNPs were meta-analyzed (i.e. in common between 
the two datasets). 
Figure 1 depicts the association results on the Meta-analysis. The QQ-plot 
shows that the 20 PCs included were appropriately corrected for population 
stratification. No genome-wide level of  significance was found for any of  
the SNPs under investigation. The two top SNPs from the meta-analysis 
were rs139052 (p=8.30x10-07) and rs12873866 (1.32x10-06), both with a 
protective-effect for its major allele (Supplementary Table S1 depicts the top 
results obtained in the meta-analysis). SNP rs139052 is located in the PNPLA3 
gene in 22q13.31, and the top results for chromosome 22 map to this locus 
within a span of  100kb of  high LD region. The PNPLA3 gene encodes the 
adiponutrina protein - a triacylglycerol lipase involved in balancing the usage 
and storage of  energy  in adipocytes. SNP rs12873866 is located in 13q33.1, 
a large intronic region, forming a large LD block (Figure 2). 
This study constitutes the largest sample available to date on GWAS in hoarding 
symptoms, but we realize that the lack of  genome-wide significant results in 
this study is not unexpected given the still limited sample size combined with 
the moderate heritability of  the HD trait. Only recently have we seen the first 
robust GWAS findings for e.g. schizophrenia, bipolar disorder, ADHD and 
major depression disorder (Demontis et al., 2017; Ripke et al., 2013; Ruderfer 
et al., 2014; Wray & Sullivan, 2017), as a result of  much larger samples than 
described in this meta-analysis. Similar to what has been observed for other 
traits such as height and blood lipid levels, we expect that for psychiatric traits 
there will be the critical point (varying for different disorders) in sample sizes 
above which significant findings become detectable. It is currently widely 
agreed that until reaching this ‘inflection point’ GWAS consortia should 
collaborate to detect individual signals. This study constitutes the largest 
sample available to date for hoarding symptoms. Given the observed scenario 
for other psychiatric traits, as well as the recent works dedicated to hoarding 
from the NTR and the TwinsUK, we expect future genetic studies in HD to 
gain further relevance, and these results provide a solid starting point and 
groundwork for the future studies.
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Figure 1. QQ-plot (left) and Manhattan plot (right) from the meta-analysis results from the 
NTR and the UKTwins for Hoarding Disorder.
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Figure 2. Regional plots showing the regional association for selected SNPs using the tool LocusZoom 
(http://locuszoom.org/) for the region 22q13.31 harbouring the SNP rs139052 (top), and the region 
13q33.1 harbouring the SNP rs12873866
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Chapter 8
Polygenic Risk Scores for Schizophrenia and Depression 
Linked to  Obsessive-Compulsive Disorder
This chapter is based on: Zilhao, N. R., Abdellaoui, A.,  Smit, D. J. A., Cath, D., Hottenga J. 
J., Boomsma, D. I. (2017). Polygenic prediction of obsessive compulsive symptoms. Molecular 
Psychiatry (accepted). 
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Obsessive-compulsive disorder (OCD) is a common neuropsychiatric 
disorder, causing considerable social impairment and disease burden 
worldwide (Stewart et al., 2013). OCD is characterized by the presence of  a 
heterogeneous array of  ‘clinically significant’ obsessions and compulsions, in 
a permanent uncontrollable cycle. It is widely recognized, similarly to what 
is observed for other psychiatric disorders, that individual differences in the 
susceptibility to OCD are at least partly genetic (Stewart et al., 2013). 
Twin and family studies estimate the heritability of  OCD to be between 0.27 
and 0.50. Molecular genetic studies in epidemiological samples offer evidence 
for the highly polygenic nature of  OCD, i.e., OCD is influenced by large 
numbers of  (common) genetic variants with small-effects (Stewart et al., 
2013). This polygenicity is within the expectations, considering the findings 
on the genetic architecture of  other psychiatric traits.  
Polygenic risk scores (PRS) offer an opportunity to test if  results from large 
meta-analyses for psychiatric disorders can predict OCD. PRS are a measure 
of  an individual’s genetic risk to develop a certain disorder, calculated by 
summing all genotype scores for a person after weighting them by their 
estimated effect size for a trait as obtained from a genetic association analysis. 
These scores can be used to test the predictive value of  a PRS towards the 
disorder in independent samples, or towards another disorder of  interest. 
This approach allows one to simultaneously 1) tackle the inherent culprit 
of  polygenicity surrounding complex traits – that true genetic variance is 
captured by the full set of  measured SNPs not only significant signals, and 
2) assess to which extent the individual genetic risk to a trait has predictive 
value for another trait – serving as measure of  genetic correlation between 
disorders, even in the absence of  phenotype measurements for multiple 
disorders  (Dudbridge, 2013).
Recently, large GWASs for psychiatric traits have been completed and we 
constructed polygenic scores based on the summary statistics from a series of  
disorders that are epidemiologically related to OCD, namely: Attention Deficit 
Hyperactivity Disorder (ADHD), Bipolar Disorder (BD), Schizophrenia 
(SCZ), major depressive disorder (MDD), Autism, and Migraine. In addition 
we had at our disposal summary statistics from a meta-analysis performed 
on clinically-derived OCD samples from the International OCD Foundation 
Genetic Collaborative (IOCDFGC) and OCD Collaborative Genetics 
Association Study (OCGAS) (Stewart et al., 2013; Mattheisen et al., 2014). 
We investigated the power of  each of  these scores to effectively predict 
obsessive-compulsive symptoms (OCS) in a population-based sample, 
considering different values for genetic correlations between the score and 
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OCS, following the method proposed by Dubridge (Dudbridge, 2013).
Table 1 summarizes the results. The polygenic scores for OCD, SCZ 
(p=1.4x10-6), MDD (p=5.6x10-5) and BP-SCZ combined (p=8.1x10-7) were 
significant after correcting for multiple testing (α=0.006). This last result is 
probably driven by the genetic component that Schizophrenia shares with 
BD. Overall, the polygenic scores explained between 0.38-0.79% of  the total 
variance of  OCS - in line with what is observed for most PRS analysis. The 
score ‘BD vs. Schizophrenia’ – which includes the genetic component that 
differentiates between BD and Schizophrenia, did not significantly predict 
OCS, which indicates that genetic variation unique to SCZ or BIP is not related 
to OCS. MDD scores also showed a strong genetic association with OCS. 
Among the most co-occurring disorders with OCD are major depression 
(31%) and BD (7%), whilst for schizophrenia rates for co-occurrence are 
rare. These results indicate that the reason for comorbidity partly is genetic, 
with a shared genetic liability to OCS.
These results show that population-based OCS can be predicted with the help 
of  clinically based GWASs, which in turn reveals that psychiatric genetic risk 
factors can lead to the presence of  sub-clinical OC symptoms. The risk scores 
also indicate that OCS are clinically relevant markers of  other psychiatric 
disorders related to OCD. In other words, sub-clinical OCS shares genetic 
variance that underlies OCD, Schizophrenia and MDD.
The relevance of  PRS lies within their predictive value. PRS have a better 
predictive value than the individual GWASs’ top hits. Their application may 
in many cases be clinically useful when applied to population-based samples 
(as herein shown), and predict the development of  psychiatric traits such as 
OCD. Our results regarding the predictive value of  MDD and Schizophrenia 
for OCS should be looked into in further studies.
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Table 1. Results of the generalized estimation equations (GEE) association analyses between OCS and different polygenic scores (N=6,506). The third column also indicates the proportion (in percentage of variance explained in OCS by each polygenic risk score (R2). N-GWAS gives sample size and h2 the, heritability estimates (h2 LDSC) of the GWAS summary statistics from LD score regression. The last 4 columns give the power to detect an association between OCS and the polygenic scores given a genetic correlation (rg) of .2, .4, .6, and .8. Bold font indicates significant p-values after multiple testing correction (α=0.05/9=0.006); grey colour font indicates nominally significant p-values (α=0.05). The reference for the provenance of each summary statistics is given alongside the respective score.
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Chapter 9
Epigenome-Wide Association Study of Tic Disorders
This chapter is based on: Zilhão, N. R., Padmanabhuni, S. S., Pagliaroli, L., Barta, C., Smit, 
D. J. a., Cath, D., Boomsma, D. I. (2015). Epigenome-Wide Association Study of Tic 
Disorders. Twin Research and Human Genetics, 18(6), 1–11.
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Tic disorders are moderately heritable common psychiatric disorders that can 
be highly troubling, both in childhood and in adulthood. In this study we 
report results obtained in the first epigenome-wide association study (EWAS) 
of  tic disorders. The subjects are participants in surveys at the Netherlands 
Twin Register (NTR) and the NTR biobank project. Tic disorders were 
measured with a self-report version of  the Yale Global Tic Severity Scale 
Abbreviated version (YGTSS-ABBR), included in the 8th wave NTR data 
collection (2008). DNA methylation data consisted of  411,169 autosomal 
methylation sites assessed by the Illumina Infinium HumanMethylation450 
BeadChip (HM450k array). Phenotype and DNA methylation data were 
available in 1678 subjects (mean age=41.5). No probes reached genome-wide 
significance (p<1.2 x 10-7). The strongest associated probe was cg15583738, 
located in an intergenic region on chromosome 8 (p=1.98 x 10-6). Several 
of  the top ranking probes (p < 1 x 10-4) were in or nearby genes previously 
associated with neurological disorders (e.g. GABBRI, BLM and ADAM10), 
warranting their further investigation in relation to tic disorders. The top 
significantly enriched gene ontology terms among higher-ranking methylation 
sites included anatomical structure morphogenesis (GO:0009653, p=4.6 x 
10-15) developmental process (GO:0032502, p=2.96 x 10-12), and cellular 
developmental process (GO:0048869, p=1.96 x 10-12). Overall, these results 
provide a first insight into the epigenetic mechanisms of  tic disorders. This 
first study assesses the role of  DNA methylation in tic disorders, and it lays 
the foundations for future work aiming to unravel the biological mechanisms 
underlying the architecture of  this disorder.
Abstract
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Tic disorders form a broad spectrum encompassing four different clinical 
entities: Tourette Syndrome (TS), chronic (motor or vocal) tic disorder, 
transient tic disorder and tic disorder not-otherwise specified. Tics are 
characterized by sudden, rapid, motor movements or vocalizations, performed 
in a ritualized, recurrent and stereotypical fashion (APA, 2000).
Multiple lines of  evidence suggest that both genetic and interacting 
environmental factors are causes underlying the etiology of  these phenotypes 
(Paschou, 2013). Twin and family studies have shown that the prevalence 
of  Tourette Syndrome or chronic tic disorders among first degree relatives 
of  affected individuals varies between 15% and 53% (Towbin, 2010). 
Furthermore, heritability estimates on tic disorders or TS range between 0.28 
and 0.56 (Anckarsäter et al., 2011; Bolton et al., 2007; de Haan et al., 2015; 
Lichtenstein et al., 2010; Mathews & Grados, 2011; Ooki, 2005). However, 
most genetic and clinical studies so far have been hampered by small sample 
sizes, ambiguity in phenotype definitions and difficulties to disentangle genetic 
and familial environmental effects. Thus, molecular genetic studies have thus 
far not yet yielded robust findings (Pauls et al., 2014).  
The study of  epigenetic mechanisms on a genome-wide scale in humans 
represents the bridge between disease susceptibility and gene expression 
variation. It is known that epigenetic mechanisms regulate gene expression, 
and that these epigenetic mechanisms change during life, up and down-
regulating different genes in response to external environmental conditions. 
DNA methylation at CpG dinucleotides is the most studied epigenetic 
mechanism in humans. It regulates gene expression by targeting for example 
promoters and enhancers and its pattern may change as a consequence of  
external and internal stimuli (Hackett et al., 2013). DNA methylation is also 
involved in other biological processes such as genomic imprinting where CpG 
sites are methylated based on their parental origin which are different between 
the paternal and maternal branch (Liu, Morgan, & Calhoun, 2010), and 
chromosome X inactivation where one copy of  the female X chromosome is 
inactivated (Heard, Clerc, & Avner, 1997). Genomic imprinting has also been 
suggested to be involved in TS in a study evaluating parental gender-influenced 
differences in childhood TS phenotype. Greater motor tic complexity was 
associated with maternal transmission, whereas higher frequency in vocal 
tics was associated with paternal transmission (Lichter, Jackson, & Schachter, 
1995).  
Epigenome-wide association studies (EWAS) have thus far been used to 
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reveal altered methylation patterns in several complex disorders such as 
obesity, diabetes, schizophrenia and autism (Dempster et al., 2011; Moore, 
McKnight, & O’Neill, 2014; Rakyan, Down, & Beck, 2011; Wockner et al., 
2014). This approach is becoming increasingly accessible and it is likely that 
DNA methylation is also involved in other neurological disorders. Currently 
no epigenome-wide association studies of  tic disorders have been performed. 
These studies may clarify underlying mechanisms that differentially regulate 
genes in individuals manifesting tics.
Here, we report on the first epigenome-wide association study (EWAS) of  
tic disorders performed in a population-based sample from the Netherlands 
Twin Register (NTR). 
Subjects in this study are participants in the NTR biobank Project (Willemsen 
et al., 2010; Willemsen et al., 2013). Since 1991, the NTR has been collecting 
information on a broad range of  phenotypes in twins and family members 
(Willemsen et al., 2013). In total 3264 peripheral blood samples from 3221 
NTR participants have been assessed for genome-wide methylation data. 
After quality control (QC) on the methylation data, the total final selection 
comprised 3089 samples, for a total of  3057 individuals (32 subjects had 
methylation data for two time-points). For a complete description of  the 
entire methylation dataset from the NTR, please see (van Dongen, et al., 
2016). 
In the present study we analysed tic data from the 2008 wave of  collection, 
in a subset of  individuals in whom genome-wide methylation data were 
available. A total of  1678 individuals (twins, siblings and parents) from 
1057 families were included in the analysis. Table 1 gives an overview of  the 
subjects entered in the analysis and demographics. Zygosity was assessed by 
DNA polymorphisms as described by (van Beijsterveldt et al., 2013). The 
study was approved by the Central Ethics Committee on Research involving 
human subjects of  the VU University Amsterdam.
Materials & Methods
Subject demographics
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Table 1. Number of participants included in the analysis
Abbreviations: MZ, monozygotic twins; DZ, dizygotic twins; DOS, dizygotic opposite-sex twins.
Phenotype
Tics were measured using an abbreviated 12 item self-report version of  
The Yale Global Tic Severity Scale (YGTSS-ABBR), the latter being a well 
validated interview with a high internal consistency (Cronbach’s alpha > 0.90) 
(Leckman et al., 1989). The YGTSS-abbreviated (YGTSS-ABBR) contains 
12 most frequently occurring tics, assessing their occurrence: never (0), < 
than one year ago (1), between 1-5 years ago (2) or as a child (3). Three 
additional questions are asked on age at onset, duration and severity to 
enable establishing a probable diagnosis according to DSM-IV-TR criteria 
(APA, 2000). Table 2 shows the YGTSS-abbreviated questionnaire used for 
measuring tics. A diagnosis of  probable chronic tic disorder was established 
if  the person had 1) one or more chronic motor or one or more vocal tics, 
that 2) occurred before age 21 and 3) had been present for >1 year. Probable 
TS diagnosis was established when 2 or more motor and 1 or more vocal tics 
were reported that occurred before age 21 and had lasted for > 1 year, and 
probable transient tic disorder was established when motor and/ or vocal 
tics had occurred before age 21 for less than one year. From these categories 
we derived a dichotomous variable on absence or presence of  a probable tic 
disorder diagnosis - chronic tic disorder, transient tic disorder or Tourette 
Syndrome (TS), as referenced in the Tourette Syndrome Classification Study 
Group (TSCG, 1993). An extensive genetic analysis on the heritability of  tic 
disorders has been performed (Zilhão et al., 2016). Since smoking is known to 
have an effect on DNA methylation (Lee & Pausova, 2013), we controlled for 
smoking status in the epigenome-wide association analysis. Smoking status 
was assessed at the moment of  blood draw by interview.
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DNA methylation was assessed with the Infinium HumanMethylation450 
BeadChip Kit (Illumina, Inc.) (Bibikova et al., 2011). Genomic DNA from 
whole blood (500ng) was bisulfite treated using the Zymo Research 96-
well plate using the standard protocol, by the department of  Molecular 
Epidemiology from the Leiden University Medical Center (LUMC), The 
Netherlands. Subsequent steps (i.e. sample hybridization, staining, scanning) 
were performed by the Erasmus Medical Center micro-array facility, 
Rotterdam, The Netherlands. QC and processing of  the blood methylation 
dataset has been described in detail previously (Van Dongen, et al., 2016). 
In short, a number of  sample-level and probe-level quality checks were 
performed. Sample-level QC was performed using MethylAid (van Iterson et 
al., 2014). Probes were set to missing in a sample if  they had an intensity value 
of  exactly zero, or a detection P-value > 0.01, or a bead count < 3. After these 
steps, probes that failed based on the above criteria in > 5 % of  the samples 
were excluded from all samples (only probes with a success rate >=  0.95 
were retained). Probes were also excluded from all samples if  they mapped to 
multiple locations in the genome (Chen et al., 2013), and/or had a SNP within 
the CpG site (at the C or G position) irrespective of  minor allele frequency 
in the Dutch population (Francioli et al., 2014). Only autosomal methylation 
sites were analysed in the EWAS. The methylation data were normalized with 
Functional Normalization (Fortin et al., 2014) and normalized intensity values 
were converted into beta (β)-values. The β-value represents the methylation 
level at a site, ranging from 0 to 1 and is calculated as:
Infinium HumanMethylation450 BeadChip Data
Table 2. Yale Global Tic Severity Scale abbreviated
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where M=Methylated signal, U=Unmethylated signal, and 100 represents a 
correction term to control the β –value of  probes with very low overall signal 
intensity. After QC, from an initial total of  453288 methylation sites, the final 
total selection of  methylation sites was 411,169.
Epigenome-wide association analysis (EWAS) was performed using linear 
regression under an additive model correcting for Principal Components 
(PCs) and covariates. Principal components (PCs) were calculated from the 
methylation data after QC and normalization. The PCA plot calculated can 
be seen in Supplementary Figure S2. Supplementary Figure S3 provides the 
correlation plot between the first 20 PCs and the covariates (monocyte count, 
eosinophils count, neutrophils count, array row number, smoking status, 
age and sex), in our dataset. Generalized estimation equation (GEE) models 
were used to test whether tics were associated with DNA methylation. In the 
final model, DNA methylation level was used as outcome with the following 
predictors: tics, top 5 PCs, smoking status, eosinophil percentage and 
monocyte percentage. Additional models were tested to evaluate the inflation 
factor with different covariates (Supplementary material). Sex, neutrophils 
count and age were not included due to their correlation with the top 5 PCs 
(Supplementary Figure S3). Basophil percentage was not included because 
it showed little variation between subjects, with a large number of  subjects 
having 0% of  basophils. Smoking status was coded as ‘0=non-smoker’, 
‘1=former-smoker’, ‘2=current-smoker’. GEE uses cluster robust standard 
errors with family ID as cluster variable, and thus standard errors are robust 
for the presence of  related individuals in the sample. A permuted p-value was 
calculated by random sampling of  the phenotype (n=10000), defining the 
proportion of  permutations meeting or exceeding our p-value estimate based 
on the actual data. CpGs with p-values <1.2 x 10-7 (Bonferroni correction of  
0.05/411169 – autosomal sites) were considered statistically significant.
Statistical Analysis
Enrichment of  Gene Ontology (GO) terms among methylation sites having a 
stronger association with tics was done by ranking all methylation sites based 
on the EWAS p-value and the resulting ranked gene list was supplied to the 
online software tool GOrilla (Eden, et al., 2009). The GO tool GOrilla takes 
Enrichment of Gene Ontology Terms
119
into account the rank of  the gene where by p-value cut-off  is not required 
in creating the gene list. A false Discovery Rate (FDR) q-value < 0.05 was 
considered for a GO term to be statistically significant.
Results
After QC, the final dataset consisted of  411,169 autosomal CpG sites, for 
1678 individuals (188 Cases and 1490 Controls). The variation in the data 
captured by the first two PC is shown in Figure 1. It can be seen that the main 
contributors to variation in DNA methylation are not associated with the 
phenotype. The first component represented sex and the second component 
correlated strongly with neutrophil count. Supplementary Figure S1 shows 
the distribution of  genome-wide methylation level for all individuals included 
in the analysis.
Figure 1. Two dimensional PCA plot labelled by case-control status.
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The quantile-quantile (QQ) plot based on the EWAS model is shown in 
Figure 2. The inflation factor (λ) is 1.03, indicating that the results are not 
stratified.
None of  the CpG sites passed the Bonferroni p-value threshold (p=1.2 x 10-
7) for the association with Tics. Table 3 shows all CpG sites with a p-value < 
1 x 10-4 (N=57). Permutation tests for all of  these 57 CpG sites resulted in a 
permutation p-value < 0.05 indicating that these CpG sites did not occur by 
chance. As an example, the distribution of  permutation p-values for the top 9 
CpGs is shown in Supplementary Figure S7. The Manhattan plot can be seen 
in Figure 3 with the top 57 CpG sites highlighted in green. Figure 4 shows the 
methylation level in cases and controls for our top 15 CpGs.
Figure 2. QQ plot of P-values from gee model with top 5 PCs and Covariates Tics, Smoking Status, 
Eosinophils, Monocytes and Array Row.
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Figure 3. Manhattan plot showing the p-values of genome-wide CpG sites. The red line is the genome-wide 
threshold and the blue line is the suggestive threshold (P < 1.0 x 10-4). Top CpG sites are highlighted in 
Green.
Figure 4. Boxplots of the methylation levels at the top CpGs in cases vs controls
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Abbreviations: CHR, chromosome; ∆β, Difference in mean methylation β-values between cases and controls; 
bp, base pairs.
Table 3. Top CpG sites in the EWAS with p-value < 0.0001.
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Gene ontology enrichment analysis identified a large number of  GO terms 
that were significantly enriched (Supplementary Table T1-T3). Top enriched 
GO Processes include developmental process (GO:0032502, P=3.98e-16, 
FDR q-value = 2.69e-12), cellular developmental process (GO:0048869, 
P=4.35e-16, FDR q-value = 1.96e-12), single-organism developmental 
process (GO:0044767, P=6.57e-23, FDR q-value = 2.22e-12), and other GO 
terms related to development. Brain processes, including regulation of  neuron 
projection guidance (GO:0097485, P=8.33e-11, FDR q-value = 5.11e-08), 
axon guidance (GO:0007411, P=8.33e-11, FDR q-value = 4.89e-08), and 
neuron differentiation (GO:0030182, P=1.15e-10, FDR q-value = 6.24e-08) 
were also significantly enriched. The top most enriched GO component was 
cell junction (GO:0030054, P=6.73e-09, FDR q-value = 1.09e-05), followed by 
the neuron specific GO components neuron part (GO:0097458, P=4.39*10-
07, FDR q-value = 1.78e-04), synapse part (GO: 0044456, P=5.13*10-06, FDR 
q-value = 1.39e-03), postsynaptic density (GO:0014069, P=1.67e-05, FDR 
q-value = 3.87e-03) and dendrite (GO:0030425, P=1.04e-04, FDR q-value = 
1.05e-02). GO components related to histone modification, including MOZ/
MORF histone acetyltransferase complex (GO:0070776, P=4.21e-05, FDR 
q-value = 6.20e-03) and H3 histone acetyltransferase complex (GO:0070775, 
P=4.21e-05, FDR q-value = 5.68e-03), were significantly enriched. The top 
enriched GO function was protein binding (GO:0005515, P=1.10e-17, FDR 
q-value = 4.55e-14) followed by many functions involving DNA binding.
Gene Ontology Enrichment Analysis
Discussion
In this work we present the first genome-wide epigenetic analysis on tics/tic 
disorders. Although no methylation site achieved significance at the genome-
wide threshold, gene-ontology analysis of  the top hits revealed enrichment 
in brain-specific and developmental processes. Thus, our findings provide 
interesting targets for further analysis. 
Two of  our top CpGs (cg08093277 and cg21879791, ranked 11 and 
41) are located near the GABBR1 gene (39670 bp and 39201 bp, at 5’, 
respectively), which represents a very interesting target for further analysis. 
GABBR1 encodes a subunit of  the GABA receptor, the major inhibitory 
neurotransmitter in the central nervous system. GABA acts at brain inhibitory 
synapses where it binds transmembrane receptors of  both presynaptic and 
postsynaptic neurons. Notably, GABBR1 has been previously associated with 
autism, schizophrenia, tremor, and obsessive-compulsive disorder (Fatemi, 
Folsom, & Thuras, 2009; Hegyi, 2013; Luo, Rajput, & Rajput, 2012; Richter 
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et al., 2012). 
The involvement of  GABA in TS is well documented in the extant 
neurobiological literature. Tics have been associated with reduced basal 
ganglia volume and reduced cortical thickness in motor and sensorimotor 
areas controlling the facial, orolingual and laryngeal muscles (Sowell et al., 
2008). Studies of  brain activity using PET or fMRI in TS subjects compared 
to controls have implicated dysfunctional striatum, thalamus as well as 
cortical regions. The medium-sized spiny neurons in the basal ganglia have 
GABAergic inhibitory projections to the substantia nigra and Globus Pallidus 
(Ribak, Vaughn, & Roberts, 1979). It is hypothesized that the tonic activity of  
the striatum acts to inhibit unwanted motor patterns (Albin & Mink, 2006). 
Treatment strategies have aimed at increasing GABA levels (Awaad, 1999; 
Mink, 2001) to counteract decreased inhibitory output resulting in excessive 
activity in frontal cortical areas. Although not all studies showed significant 
results, one randomized double-blind study administering a GABA ß- 
receptor agonist in Tourette syndrome resulted in reduced tic severity (Singer, 
Wendlandt, & Giuliano, 2001).
Importantly, 8 of  the top 57 associated CpG sites (p < 1 x 10-4) mapped to 
genes that have been previously associated with psychiatric or neurological 
disorders, some of  them sharing neurodevelopmental aspects with tics (OCD, 
autism, bipolar disorder, schizophrenia, some forms of  mental retardation), 
some disorders involving cortico-striatal pathways similar to tics (as in the 
case of  Parkinson’s disease), and some in which the link with tics seems less 
clear (Alzheimer’s disease)  (Supplementary table T4 summarizes the genes 
from our top list that have been previously associated with neurological 
disorders). CpG site cg06026425, located near CLINT1, has been linked to 
Schizophrenia (Leon et al., 2011; Wang, Liu, & Aragam, 2010). Moreover, 
cg01321816 located near BLM and cg00785856 located near ADAM10 
involve genes that have been associated with Alzheimer’s disease (Schrötter 
et al., 2013; Vassar, 2013). Another example is cg26548492 which is located 
near LOC153328/SLC25A48, a gene that has been proposed as candidate 
for Parkinson’s disease (Liu et al., 2011). Lastly, cg2051967 which is located 
near PLEKHG3, involves a gene that has been linked to mental retardation 
(Lehalle et al., 2014; Lybaek, Oyen, & Houge, 2008). Furthermore, some 
of  the top hits lead to genes with a brain-specific function. This is the case 
for cg25086136 located near SNTG1, which is specifically expressed in the 
central nervous system (Hafner, Obermajer, & Kos, 2010), and cg19830950 
located near SEMA4G which might play a role in cerebellar development, the 
cerebellum being a core structure involved in the precision of  motor control 
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(Maier et al., 2011). 
Histone modification might also play a role in the tic phenotype through 
the MOZ/MORF complex histone acetyltransferase complex (Klein et al., 
2014). Genes involved in histone modifications were significantly enriched in 
the gene ontology analysis. Acetylation represents one of  the most frequent 
post-translational modifications (PTM) and it is catalyzed by lysine acetyl-
transferase enzymes (KAT). It neutralizes the positive charge present on the 
amino group of  histone tails allowing the switch from a condensed structure 
to a more relaxed one which results in an enhance level of  transcription. Two 
of  the top CpGs (cg03573179 in the BRPF3 gene and cg12961733 in the 
BRD1 gene) are pointing to this MOZ/MORF complex which is formed 
by bromodomain PHD finger protein (BRPF1/2/3), inhibitor of  growth 5 
(ING5) and homolog of  Esa1-associated factor 6 (hEAE6) (Sapountzi & 
Cote, 2011). BRD1 is associated with schizophrenia and bipolar disorder 
(Christensen et al., 2012) and the MOZ/MORF complex plays a role in the 
regulation of  the dentate gyrus, which is a brain structure extremely important 
for learning and memory (You et al., 2015). BRD1, which is a component of  
the histone H3 acetyltransferase activity within the MOZ/MORF complex, 
might have a role in gene expression through acetylation of  histone H3 and 
H4 (Doyon et al., 2006). BRD1 has also been associated with schizophrenia 
and bipolar disorder (Christensen et al., 2012; Severinsen et al., 2006). BRPF3 
is another component of  the histone H3 acetyltransferase activity within the 
MOZ/MORF complex (Ullah et al., 2008). CpG site cg23066982 is located 
near the HIST1H4E gene, which is a member of  the histone 4 family and 
is a part of  the nucleosome core. It is known that nucleosomes pack DNA 
into chromatin to regulate several processes such as transcription, DNA 
replication and chromosome stability. 
These findings support a role for aberrant DNA methylation levels in tic 
disorders as part of  a broader neurodevelopmental dysregulation. It is 
important to note that our study examined DNA methylation in blood 
rather than in the central nervous system (CNS). The relationship with DNA 
methylation in CNS tissue remains unclear. However, it has been suggested 
that inter-individual variation in DNA methylation is correlated to some extent 
across blood and brain tissues (Davies et al., 2012). Also, it was observed that 
exposure to different forms of  early life traumas led to similar methylation 
changes in blood and brain cells (Klengel et al., 2013). It has been proposed 
that epigenetic changes induced early in development in particular may be 
present across many different tissues, because they are propagated through 
cell division.  (Feinberg & Irizarry, 2010; Jeffries et al., 2012; Mill & Heijmans, 
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The Supplementary material can be found in the online version of this manuscript
2013). 
Future studies might consider taking a trans-diagnostic neurodevelopmental 
approach, combining tic disorders and other neurodevelopmental disorders 
(including OCD, Autism, ADHD and childhood movement disorders), to 
disentangle common versus disorder-specific underlying methylation patterns. 
Finally, environmental factors assessed in a longitudinal study design should 
be incorporated in epigenetic studies, to investigate which environmental 
stressors / protectors at what age/ stage of  development influence DNA 
methylation.
This study provides a first step to unravel the role of  epigenetic mechanisms 
in tic disorders. It should be noted that we analysed an ‘inclusive’ tic phenotype 
definition that may obscure different underlying etiologies. Future studies of  
larger size or including clinical samples at the more extreme end of  the tic 
phenotypic spectrum are required to improve statistical power. Future studies 
should also aim to examine different phenotypic tic dimensions (de Haan 
et al., 2015). Such studies hold the promise to shed light on the complex 
interaction between environmental and genetic factors leading to development 
and persistence of  neuropsychiatric disorders.
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Chapter 10
Summary and General Discussion
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The work presented in this dissertation is largely focused on uncovering and 
quantifying the genetic factors contributing to the development of  disorders 
within the obsessive-compulsive spectrum. The two main approaches used 
to analyze data on obsessive-compulsive (OC) symptoms, tics and hoarding 
were genetic association analysis and twin studies, which intersect within 
genetic epidemiology. The findings are summarized below. 
Chapter 1 provides an overview on the genetics of  tic disorders, obsessive-
compulsive disorder (OCD), and hoarding disorder (HD). 
Chapter 2 describes a genetic epidemiological twin study on OC symptoms, 
indicating that OC symptoms are highly stable across time (a 6 year time 
period), in a population of  around 5,500 adult twins (age range between 17-
90 years). This study modelled the longitudinal phenotypic variance of  OC 
symptoms as a function of  genetic and environmental factors. It showed 
that individual differences in stability are due to a combination of  genetic 
(heritability: h2=56%) and unique environmental factors, with heritability 
estimated at 56%. Furthermore, it showed that genetic influences on OC 
symptoms are stable across time with longitudinal genetic correlations of  
rG=0.58. The longitudinal unique environmental correlation was rE=0.46. 
This suggests that measurement error alone may not be enough to explain time-
point specific variance. It also highlights the role that individual experiences, 
in childhood and adolescence, may have on OCD far into adulthood. The 
broad-sense heritability consisted of  additive genetic variance, and the 
bivariate (two time points) model also captured non-additive (dominant) 
genetic effects contributing to the phenotypic variance. Genetic dominance 
explained around 22% and additive influence around 36%. 
Chapter 3 reports on a heritability analysis using different definitions of  tic 
disorders. A sample of  8,323 mono- and dizygotic adult twins was included, 
in addition to their 7,164 family members who had been measured on lifetime 
occurrence and characteristics of  tics. This chapter explored the extent to 
which the contribution from genetic and environmental influences differed 
across different definitions of  tic disorders. The different tic definitions, 
following the current DSM-5 criteria, represented a range of  mild to severe 
tic symptoms. Heritability was estimated to contribute between 25-37% 
depending on the phenotype definition. These heritability estimates had 
overlapping confidence intervals, which suggested a similar genetic liability 
for the different tic phenotype definitions. Interestingly, the heritability of  
the most lenient tic definition (including any tic) showed the narrowest 
Summary
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confidence interval (h2=30%; 95% CI= .23-.38), indicating that the core 
phenomenological characteristics of  tics (“sudden, rapid, recurrent, non-
rhythmic, stereotyped motor movements or vocalizations”) render the highest 
heritability estimate. 
In Chapter 4 we analysed phenotypic data on OC symptoms, hoarding 
symptoms, and tics, and explored the amount of  underlying genetic and 
environmental influences shared between these three phenotypes, to 
further explore the common etiology across these three disorders. We had 
at our disposal population-based data from the NTR for which N=5,293 
individuals had phenotypic data available on all three phenotypes. This 
revealed substantial genetic correlations (between 0.35-0.41), with the highest 
genetic correlation of  0.41 to be found between OC symptoms-Hoarding 
symptoms. This specific result is of  interest in light of  the latest development 
in DSM-5, in which HD was separated from OCD as a distinct disorder and 
placed in the category of  OC spectrum disorders. Moreover, our findings 
corroborate the findings by Iervolino (2009; 2011) and Tambs (2009). These 
results suggest that the symptoms related to OCD and HD share less genetic 
variance than the shared genetic variance observed between OCD and 
internalizing disorders such as panic disorder, generalized anxiety, phobias, 
and PTSD (genetic overlap of  0.55). To conclude, HD can be considered 
a separate, albeit related, entity to OCD, in line with its current position in 
DSM-5. Lastly, the results regarding the common factor model that was 
tested point to shared genetic etiology among the three phenotypes (with 
genetic correlations between .32-.43). With respect to the total environmental 
variance, tics had a considerably smaller loading of  only 4.4% on the common 
factor. Based on these results, it can be hypothesized that commonalities 
in genetic architecture dictate underlying similarities in dysfunction at the 
structural and functional level in cortico-striato-thalamo-cortical circuitries 
– the regions so far implicated in these disorders by neuroimaging studies. 
In view of  the lower environmental correlations between tics and both OC 
symptoms and Hoarding symptoms, it seems that unique environmental 
experiences that determine the development of  tics, are by and large different 
from the unique environmental factors involved in OC spectrum disorders.
Chapter 5 introduces the use of  genome wide array-SNP data in a series 
of  exploratory analysis on the genetics of  OC symptoms. It expands the 
work performed in Chapter 2. Here, 6,931 subjects were included (twins, 
their siblings, parents and spouses), for whom genetic data were available, i.e. 
genome wide SNP data, which together with phenotype information were 
analyzed in genetic association studies (GWAS), with polygenic risk scores, 
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SNP-based heritability (GCTA), and gene-based testing. For polygenic risk 
score calculations, GWAS results from a large clinical sample of  OCD 
patients who were of  European ancestry (the OCF-GC) were used (Stewart 
et al., 2013). Polygenic scores summarize genetic effects among a large set 
of  markers that do not individually achieve significance into a single value 
per subject. These scores significantly predicted OC symptoms in the NTR 
population-based sample (with 0.2% explained). In the same sample, SNP-
based heritability was estimated at 14%. The total variance explained by 
genetics, i.e. SNP and other heritability, captured using GCTA was of  34%. 
This means that 14% of  the OCS phenotypic variance is attributable to 
genotyped SNPs, and 20% attributable to genetic variance not captured by 
the currently used genotyping SNP-arrays. The combined association analysis 
(GWAS and gene-based test) revealed a significant SNP (rs8100480), located 
within the MEF2BNB-MEF2B gene (p=2.56×10-8), and four significant 
genes (RFXANK, MEF2B, MEF2BNB, MEF2BNB-MEF2B), all located in 
the chromosomal region (19p13.11). 
Chapter 6 reports on a meta-analysis between genome-wide association 
results on tic disorders performed at the NTR (N=88 cases, using a narrowly 
defined phenotype; 6,381 controls) and results from a clinically based sample 
from the Psychiatric Genomics Consortium Tourette’s workgroup (PGC-
TS) (N=778 cases; 4,414 controls). In line with the results on OCS from 
Chapter 5, the results showed that polygenic risk scores calculated from the 
PGC-TS case-control sample significantly predicted tic disorder in the NTR 
population-based sample. In sum, this chapter showed the added value of  
combining clinically-based and population-based samples in the context of  
association analysis. Extending the results on heritability analysis on different 
tic phenotypes (Chapter 3), screened subjects from the NTR were included in 
the analysis, consisting of  88 cases diagnosed for the most severe manifestation 
of  a tic disorder (‘chronic tic disorder - motor/vocal’ or ‘Tourette Disorder’), 
and excluding 173 individuals diagnosed with a milder tic disorder (‘transient 
tic disorder’ or ‘tic disorder not otherwise-specified’). The GCTA analysis 
showed that 14.6% of  the heritability of  the tic phenotype from the NTR 
is attributable to common SNPs. The top SNP from the meta-analysis, 
rs7783290, is located on chromosome 7, with a p-value of  1.49x10-7 and a 
Z-score of  -5.25. 
In Chapter 7 the first ever-reported meta-analysis on hoarding symptoms 
is presented. Two population-based samples from the NTR (N=6,521) 
and TwinsUK (N=5,190) were combined, with genotype data imputed to 
21,775,582 and 47,072,643 SNPs, respectively. This study constitutes the 
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largest sample available to date for hoarding symptoms, and a good solid 
groundwork for future studies. The two top SNPs from the meta-analysis were 
rs139052 (p=8.30x10-7) and rs12873866 (1.32x10-6), both with a protective-
effect for its major allele. The SNP rs139052 is located in the PNPLA3 gene 
in 22q13.31, and the SNP rs12873866 is located in 13q33.1, a large intronic 
region of  high LD. Given the observed scenario for other psychiatric traits, 
future genetic studies in HD will gain further relevance.
Chapter 8 presents a polygenic dissection of  OC symptoms, based on data used 
for the work described in Chapter 5. Building on the recent and ever-growing 
availability of  data from large-scale GWASs, polygenic scores were built for a 
set of  clinically-derived phenotypes chosen for their epidemiological relation 
to OCS, i.e., Attention Deficit Hyperactivity Disorder (ADHD), Bipolar 
Disorder (BD), Schizophrenia (SCZ), major depressive disorder (MDD), 
Autism and Migraine. PRS were also built for clinically-derived OCD samples 
from the International OCD Foundation Genetic Collaborative (IOCDFGC) 
and OCD Collaborative Genetics Association Study (OCGAS). A genetic risk 
score was calculated on these scores and tested for its predictive value for OC 
symptom. The polygenic scores for OCD (p=3.0x10-4), SCZ (p=1.4x10-6), 
MDD (p=5.6x10-5) and BP-SCZ combined (p=8.1x10-7) significantly 
predicted OC symptoms in the population-based sample, accounting for 
between 0.38-0.79% of  its total variance. Following on the increasing value of  
PRS, these findings show the presence of  sub-clinical OC symptoms based on 
psychiatric genetic risk factors, therefore strengthening the usefulness of  using 
a phenotype derived from clinically significant symptoms. It further extends 
the work in Chapter 5 in illustrating the polygenicity of  OC symptoms and 
its complex etiology. The growing availability of  PRS renders it with a higher 
predictive value than GWASs, for which epidemiologically-based phenotypes 
seem to be equally suitable as disorder-based phenotypes. 
In Chapter 9 the first Epigenome-wide association study (EWAS) of  tics 
is presented. This study was conducted on 411,169 autosomal methylation 
sites for 1,678 individuals measured for tic disorders. Of  these, all individuals 
within the NTR with current or retrospectively reported tics (‘any probable 
lifetime tic’ as defined in Chapter 3) were included as a case in the analysis 
for a total of  188 Cases and 1,490 Controls. Gene-ontology analyses for 
the higher-ranking methylation sites found that the following sites were 
involved: a methylation site involving anatomical structure morphogenesis 
(GO:0009653, p=4.6x10-15), one involving developmental process 
(GO:0032502, p=2.96x10-12), and one involving cellular developmental 
process (GO:0048869, p=1.96x10-12).
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The notion that differences in psychopathology are under genetic control is 
fundamental to psychiatric genetics. The key component is to understand the 
genetic basis of  individual differences in normal and abnormal behaviour 
and, with relevance to this dissertation - in the etiology of  mental diseases 
and disorders. 
In many aspects, neuropsychiatric disorders still lack acknowledgement as 
to its importance from the overall society. In Europe, they constitute the 
third leading cause of  disability-adjusted life years (DALYs), following 
cardiovascular diseases and malignant carcinomas - accounting for around 
15.2% of  DALYs. Other estimates place neuropsychiatric disorders as the 
leading cause of  years lived with disability (YLD), accounting for 36.1% of  all 
YLD. In recent years, large-scale collaborative research and interdisciplinary 
training has been carried out worldwide within psychiatry. The work herein 
presented was developed within the scope of  a large scale European Grant 
obtained in 2013 - the Marie Curie Initial Training Network, funded by the 
European Union, and motivated by the lack of  collaborative infrastructure 
for the study of  psychiatric/neurodevelopmental disorders. Goals were set 
to unravel the genetic, environmental and neurological basis of  Tourette’s 
Disorder and its comorbid disorders such as Obsessive-Compulsive Disorder, 
using a multidisciplinary perspective, under the guidance of  leading experts 
across Europe. 
This dissertation largely focused on uncovering and quantifying the genetic 
factors playing a role in developmental disorders in the obsessive and 
impulsive spectrum. The remarkable increase in sample sizes as well as the 
development of  a wide range of  techniques within the field of  genetics have 
contributed to a deeper understanding of  these disorders – presenting, first 
and foremost, a solid and robust foundation for future studies. In the research 
within this thesis, we have used some of  the newest tools in large-scale DNA 
data analysis. Below, the findings are discussed in the context of  the larger 
field of  psychiatric genetics. 
General Discussion
Insights from the Classical Twin Design
The application of  the twin design was an integral part of  this dissertation. 
Going back to almost a century ago, the twin design is based on the 
observation that comparing phenotypic resemblance between monozygotic 
(MZ) and dizygotic (DZ) twins can inform on the relative contributions from 
environmental and genetic factors to the variability within a phenotype – 
heritability. This relevance of  the twin method evolved in parallel to the notion 
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that many human traits did not follow the monogenic and Mendelian pattern 
of  transmission. Early gene-finding methods – linkage and candidate gene 
studies, fell short in uncovering causal genetic variation. This reflects a long-
standing debate in genetics, traced back as far as 1900s, between Mendelian 
and Quantitative genetics, that still somewhat endures today. For decades, 
twin studies played a key role in showing that variation within the human 
genome was partially responsible for developing psychological and psychiatric 
traits. In fact, the applicability of  twin studies has extended far beyond that of  
estimating heritability. Within this range is included: assessing the stability of  
genetic and environmental etiology underlying the development (or change) 
of  behavioural traits, the genetic correlations among multiple phenotypes, 
direction of  causality between different traits, phenotypic assortment, and 
assessing qualitative and quantitative gender differences in the contribution 
of  genes and environment to psychopathological traits. Being almost a 
century old, it is remarkable to observe the trust for twin studies emerging 
anew, prompted by the growing availability of  ever-increasing datasets. It is 
now possible to gather questionnaire data from self-reports, and assess the 
symptoms distributed at the level of  the population, which allows insights 
into true phenotypic variation underlying the liability to diseases. 
As a result of  these developments there has been a remarkable paradigm 
shift regarding how most psychiatric disorders are being conceptualized. 
Particularly, TD went from being widely viewed as a monogenetic disorder 
with an autosomal dominant mode of  transmission (Pauls et al., 1986) to a 
highly complex and genetically and phenotypically heterogeneous disorder 
as it is regarded nowadays, being in fact, within the same range as any other 
complex trait – schizophrenia, autism and cardiovascular disease, among 
many more. The work presented in Chapter 3 provides important conclusions 
on this matter, where TD, conceptualized as the most severe manifestation 
of  tic disorders, was found to represent genetic variability overlapping with 
other tic disorders; this suggests that a common genetic architecture underlies 
the core phenomenological aspects of  all tic disorders. Moreover, another 
point derived from Chapter 3 is the added value of  using twin studies from 
a population-based sample, a point which Twin Registers (such as the NTR) 
are at a unique position to address. Twin Registers also contribute with the 
extensive collection of  longitudinal phenotypic data. All complex disorders 
are age dependent, and equally the genetic factors underlying them. In 
Chapter 2 we explored this, and found that the genetic factors contributing to 
OC symptoms were only moderately stable in time. 
As attested for by countless lines written in scientific publications heritability 
135
has undeniably been a crucial parameter in genetics. However, some 
misconceptions need to be addressed. Heritability can be defined in its 
simpler form as a ratio of  variances – specifically, of  genetic variance to total 
phenotypic population variance. In this way, it constitutes a “measurement”. 
It is merely a descriptive statistic (in its true sense) with no de facto intrinsic 
value. These are implications that follow from the very definition of  
heritability, which are outlined below.
Heritability is a parameter of  a population and hence specific to the population 
it derives from. This implies two things. Firstly, that it renders no interpretation 
on the individual level. Secondly, that heritability does not constitute an 
immutable property in time. These interpretations are consequential of  
heritability being a proportion of  a variance. A further element that must 
be grasped is that while being a composite value, heritability refers to non-
monomorphic loci, which segregate within a specific population. Formally 
put, considering the ratio formulating heritability: an (environmental) effect 
on the mean value of  a trait (pertaining to the denominator in the ratio 
formula) will influence (to greater or lesser extent) that ratio - the statistic 
value describing heritability. The noteworthy element here is the degree to 
which this environmental effect can change across time or across populations. 
This change across time or across populations of  an environmental effect 
pertains to the non-immutability of  heritability. Human height stands as 
one of  the clearest example to this: having a very high estimated heritability 
(around 80%), the observed steady increase in human height across 
populations around the world reflects improved conditions of  nutrition 
and medical care (environmental factors). This serves as an example of  a 
change in environmental factors with no implications in heritability estimate. 
Heritability, as estimated in a particular population cannot be generalized - 
to another population, or to a different point in time - in which a higher 
variability in an environmental effect (e.g. different standards of  access to 
medical care) can render a higher relative proportion in predicting the total 
trait variability. Still relating to this point, heritability, having in mind that it 
refers to inter-individual differences, renders no interpretation on the absolute 
value of  a trait, but rather, is constrained by it. In the example of  height  – 
the steady increase (over the years) of  the absolute trait value has not been 
followed by a change in heritability. Moreover, we have the uninformative 
element of  heritability towards specific genes. Heritability can only inform on 
relative contributions from segregating genes within that same population, 
therefore ignoring fixed effect alleles that, notwithstanding, are causal for the 
same trait under study. A further consideration is in the following example 
of  blood pressure: the effect of  a gene or a set of  genes on blood pressure 
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in a population consuming a homogeneous diet can be much higher than in 
a population with diverse dietary habits. This example reflects a situation in 
which the relative effect of  a gene in the variation of  a trait is dependent on 
other (environmental) causes. 
It can be argued that the debate on heritability represents two sides of  the 
same coin. On one side, from the standpoint of  geneticists it could be argued 
that as a predictive value heritability estimates performs best when having 
controlled for known ‘fixed’ effects within a population, and hence informing 
on the relative genetic risk to disease independent of  known environmental 
risk factors. Falconer and Mackay (1996) elegantly showed this in their work 
on how heritability estimates can predict the response to selection (Falconer 
& Mackay, 1996). On the other side, an evolutionary perspective would state 
that fixed effects, in its strict sense, are an erroneous assumption. Natural 
selection acts as environmental pressures on a trait. It does so across the 
full spectrum of  factors influencing inter-individual differences - we are 
interested in understanding the response to these environmental pressures 
that shape the totality of  a variability of  a trait.
In conclusion, with heritability being an aggregate measure, it is uninformative 
towards individual genes. Heritability is an observational measure, a statistic to 
be interpreted within specific contextual boundaries. It is descriptive, but not 
fundamental. The implications, specifically in the study of  psychiatric traits, 
are of  particular relevance for its interpretations, for it is not uncommon for 
such interpretations to be made somewhat blindly. With some of  these crucial 
properties of  heritability in mind – non-immutability, change over time, 
population- and gene-specific, and dependency on environmental effects, 
examining the oldest standing question in genetics – ‘How does genetic 
variation contribute to phenotypic variation?’, one wonders on the implications 
of  heritability findings. The answer is the corollary to everything discussed in 
this section: understanding the effect that prevalent environmental conditions 
have on the value of  a trait. These environmental conditions stand as potential 
modifiable risk factors, as opposed to potentially more difficult modifications 
of  biological causes. For the purpose of  psychiatric genetics, this teaches us at 
minimum that environmental interventions can be as successful (if  not more) 
as genetic ones. It may be that there within lies the key to disease prevention, 
realizing that a less heritable trait is not (necessarily) easier to intervene in than 
a more heritable one (Haworth & Davis, 2014). Perhaps then, the best lesson 
from years of  genetic research into the nature of  psychiatric disorders will 
be that the key to disease prevention actually lies in managing environmental 
factors. Ultimately, heritability estimates will reveal the point where all genes 
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that contribute to a trait have been found. As a final note, the importance of  
finding heritable influences for psychiatric disorders for patients and their 
families must be mentioned. Understanding the causes of  disorders, even 
without this understanding leading to immediate treatment, can raise social 
and personal awareness and lift the stigma often attached to these disorders. 
The Role of Genetics in Psychiatric Disorders
The development and contribution from the field of  genome-wide data 
to psychiatric genetics has been extensively outlined in this dissertation. 
Although this growth is relatively recent, its origins can be traced back to 
the work of  R.A. Fisher, published in 1918, and the so-called “infinitesimal 
model” (Fisher, 1918). In a nutshell, this model postulates that a quantitative 
trait will be affected by an ever-decreasing allele effect size, in function of  
an ever-increasing number of  sampled alleles. In other words, a polygenic 
trait will always be a continuous and normally distributed phenotype given 
a random sampling of  alleles in that population. Proponents of  quantitative 
genetics endorsed this assumption advocating that Mendelian genetics was 
insufficient to explain the observed normal distribution of  several of  the 
studied human traits. Enters the polygenic era in genetics. In fact, the advent 
of  the genome-wide period since 2006 allowed the validation of  the polygenic 
model, whereas before validating the polygenic model could only be done by 
the use of  twin and family studies. 
Although the infinitesimal model has largely dominated the view during 
the past century, and despite its successes, some limitations have surfaced 
over time. One of  the widely-discussed topics in relation to these emerging 
limitations is the matter of  ‘missing heritability’. It was first described and 
named in 2008, after the realization that most findings brought forward 
by the Human Genome Project did not stand up for replication (Maher, 
2008). Most importantly, the observation that the collective proportion of  
variance explained by significantly associated findings across more and more 
published studies, still fell short (largely) to the estimates provided by the 
standard genetic methods of  twin- and family-based studies. Several essays 
have delved into the possible causes and explanations for this so-called 
paradox. Truly, the discussion around this topic has been evolving during 
the past decade. Although this seems an over-analyzed topic, it really is the 
culprit underlying psychiatric genetic research undermining all reflections 
within it. In summation, the likely reasons put forward to explain the ‘missing 
heritability’ have been 1) a possible over-estimation of  heritability from twin 
and family studies, 2) possible genetic variants not tagged by the current 
genotyping arrays (such as rare and structural variants), 3) lack of  power 
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on current GWASs to capture very small effect sizes from highly polygenic 
phenotypes, 4) genetic variance hidden as epigenetic variance and possibly 
not captured in GWAS studies, and lastly 5) issues pertaining to the definition 
of  the phenotype. Following the fast turnaround in this field, this so called 
‘mystery’ has somewhat diminished. The advent of  GCTA (Yang et al., 
2010) offered strong support to the idea that the highly polygenic nature 
of  most complex traits was the true cause of  ‘missing heritability’. Their 
results undeniably showed that – collectively - SNPs explained a substantial 
proportion of  trait variation, but did not, however,  explain all of  the heritable 
variance. The imprecision to detect the already inherently small effect SNPs, 
would be accentuated by the lack of  power due to small sample sizes of  the 
ongoing GWASs. This is precisely what we did in Chapter 5, by partitioning 
the heritability into SNP-heritability and heritability not tagged by the SNP-
chip genotyping platform, using the method proposed by Zaitlen (Zaitlen et 
al., 2013). This premise, although not fully answering the question of  missing 
heritability, did show that part of  the heritability had been hidden, rather 
than missing. The work in Chapter 8 stands on this current prevailing view: 
polygenic scores seem to offer better predictive value than individual genetic 
variants obtained in GWASs. Its extensive use, especially in the past 5 years is 
proof  of  it. This offers the possibility that, in the near future, genetic datasets 
with a larger and better tagging variance will offer good hopes for explaining 
larger proportions of  phenotypic variance. In light of  the ever-growing 
notion of  the intrinsic complexity of  most of  these disorders, it is perhaps 
a better strategy to apply polygenic scores that reflect the cumulative genetic 
variation underlying several phenotypes (Plomin, Haworth, & Davis, 2009). 
Henceforth, two aspects are of  relevance. First, the issue of  sample sizes 
- inherently related to statistical power. On this, there is a clear consensus: 
larger sample sizes will render higher statistical power. The findings from 
the Schizophrenia working group within the PGC finally provided the long-
awaited breakthrough - the identification of  108 loci, and of  the C4 gene, has 
been regarded as proof-of-concept within the genetic community (Ripke et al., 
2014; Sekar et al., 2016). The noteworthy point on this is the noticed ‘inflection 
point’ in sample size (N~15,000), after which there is a linear relationship 
between sample size increase and newly discovered loci (estimated at around 
4 new SNPs per additional 1,000 cases (Levinson et al., 2014). A number of  
other complex traits have been following (and verifying) this trend, such as 
Crohn’s Disease, height, Bipolar Disorder, type 2 Diabetes, major depressive 
disorder, and ADHD (Demontis et al., 2017; Wray & Sullivan, 2017). With 
this prediction in mind, a similar inflection point is to be expected for TS, 
OCD and HD. Second, it is increasing likely that effects from genetic variants 
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not tagged by the current platforms remain to be found. This refers to not 
only SNPs currently not tagged under LD-based information, but also other 
forms of  genetic variation, including rare variants and structural variants. 
Rare variants usually refer to rare deleterious mutations of  larger effect sizes, 
and structural variation takes the form of  CNVs, tandem repeats, indels 
(insertions or deletions), duplications and translocations. The advent of  Next 
Generation Sequencing (NGS) technology and Whole Exome Sequencing 
(WES) offers new windows of  possibility in the near future, when the 
contribution from lower-frequency variants to additive genetic variance are 
explicitly estimated. 
On the long road leading to disease prevention, the role of  genetics is to inform 
translational research. Probably the biggest challenge of  today’s medical 
genetics is to demonstrate functional relevance and mechanistic interpretation 
for genetic variation. This follows on a further paradigm that emerged within 
the last years of  genetic research - the fact that most GWAS findings map 
to non-coding areas of  the genome. This has motivated other works that 
have dedicated extensive analysis on bridging the gap between biology and 
GWASs, which, despite being outside the scope of  this dissertation, are worth 
mentioning – PrediXcan, ENCODE, Epigenome RoadMap, REMC, GTEx, 
fQTL-SCAN, among more (Boyle, Li, & Pritchard, 2017; Gamazon et al., 
2015). The rationale underlying these works has been to target the genome 
for functionally relevant elements that are prioritized from biologically 
informed frameworks – microRNA expression, gene expression (tissue-
dependent), and epigenetic data. On this note, epigenetics processes refer to 
changes in gene expression levels (rather than protein function directly) by 
means of  modifications to the DNA strand, histones, or the chromatin. DNA 
methylation is a form of  epigenetic modification at level of  the DNA strand, 
associated with both increased and decreased gene expression via methyl-
binding proteins. It is currently understood that different epigenomic profiles 
can influence (silencing or activation) gene expression in aberrant manners. 
It is therefore unsurprising that the use of  quantitative molecular traits has 
become increasingly popular – expression quantitative trait loci (eQTL) or 
methylation quantitative trait loci (mQTL). Quantitative trait loci (QTLs) are 
regions of  the DNA associated with variation in a quantitative trait (Lander & 
Botstein, 1989). These mQTLs or eQTLs refer to genomic loci that influence 
DNA methylation or mRNA expression, respectively. With the advent of  
high-throughput DNA technology this has become a growingly popular 
approach. In chapter 9 we took a first step in attempting to characterize DNA 
methylation profiles in association with tic disorders.
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Notably, on the issue of  bridging the gap between biology and GWASs, 
a recent paper by the group of  Pritchard (Boyle et al., 2017) suggested an 
‘Omnigenic model’ of  disease. It proposes that there exists a core set of  
genes with regulatory variants that invariably will affect disease risk, but are 
vastly outnumbered by peripheral genes that harbour the greater proportion 
of  tagged genetic variance - bringing us to the last point in this section: genetic 
pleiotropy. As Pritchard et al. elegantly put it, there is strong evidence that 
several genetic causal variants are the same for different diseases (pleiotropy). 
This is so when simultaneously in light of  Fisher’s ‘infinitesimal model’, 
and considering that the variation in the human genome is de facto finite 
(albeit large). Further, the evidence points to a widespread pleiotropy across 
the human genome. Again, the relevant implications from this is that it is a 
preferred approach to study diseases in combination, rather than as isolated 
entities assuming simplistic models of  gene->pathway->disease. Leading us, 
once more, to the use of  polygenic scores. Besides its predictive value, a major 
contribution from this method is that establishes causality and correlations 
between different diseases.
Interestingly, this provides an opportunity for twin studies in this ‘omics era’. 
First, with respect to the topic of  pleiotropy: the two main reasons that can 
exemplify pleiotropy are genetic correlation and response to selection. In 
other words, genetic and phenotypic correlations generated by pleiotropy can 
dictate the response to selection. However, a genetic correlation between two 
disorders can arise both from pleiotropy or other reasons such as heterogeneity 
– referring to misclassification of  cases from one disease as another. Further, 
a phenotypic correlation between two disorders is not by itself  evidence of  
pleiotropy as this correlation can be due to environmental factors affecting 
both disorders. As it has been reviewed in this dissertation, twin studies 
are uniquely suited to answer these questions. Second, on the topic of  the 
use of  molecular traits: the continuing technological advances now make it 
possible to assess individual differences at the molecular level. This allows 
us to investigate to what extent these differences (or resemblances) at the 
molecular level underlie phenotypic similarity for two disorders of  interest 
(van Dongen, Slagboom, Draisma, & Martin, 2012). 
Psychiatry: perspectives from genetic epidemiology
Pertaining to all questions in (psychiatric) genetics is the issue that concerns 
measurement, i.e. the definition and operationalization of  the phenotype. 
This question, though simple is far from trivial. From the perspective of  
genetics, the definition of  the phenotype is of  utmost importance, not only 
for the study design, but also for its interpretation. 
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It is important to note that most disorders we study were defined in a pre-
genetics and pre-neuroscience period; on many occasions this process 
followed an observational basis and was empirically derived. With time, 
psychiatry has adopted structured and standardized diagnostic criteria to 
attempt to surpass some limitations. Published works such as the DSM, for 
instance, have provided a greater ease of  communication amongst clinicians. 
Following this standardization psychiatric disorders became conceptualized 
as syndromes, which in the past decades have rapidly increased in number 
with each successive edition of  the DSM. This has undoubtedly provided 
advantages in both clinical practice and clinical research. However, the 
progress made in the fields of  neuroscience and molecular biology provided 
for the first time the possibility in psychiatry to have a bottom-up approach in 
conceptualizing disorders. We now understand that, if  on one hand the origin 
of  some disorders is hidden in the functioning of  a highly complex circuitry 
in the mental apparatus, this functioning is, in turn, constrained by all of  
the genomic machinery preceding it. The term endophenotypes was coined 
attempting to fill this gap. It is used to describe the search for phenotypes 
that underlie and precede behavior, and that furthermore can have a stable 
and clearer genetic relation with the phenotype. The idea is to seek for the 
neurological underpinnings behind complex disorders. When considering 
that these biological phenomena are an inheritance from millions of  years of  
evolution framing human behaviour in a continuum along the evolutionary 
history, it only takes one more step to define evolutionary psychiatry as a 
field of  study, that tries to explain psychiatric disorders through the evolving 
functional change in the human brain. For the field of  genetics, this posed as 
an additional argument in favour of  ‘infinitesimally’ small effect sizes of  some 
causal genetic variants that avoid being selected against, and thus remain in 
the population (van Dongen et al., 2013). Indeed, this has put forward the 
hypothesis that most evolutionary change in complex traits acts through 
polygenic adaptation. 
Realizing the limits of  this dissertation for such philosophical endeavours, 
the relevance of  enumerating these topics is to illustrate that at present time, 
the research approach into the nature of  human behaviour and the nature 
for its inter-individual differences are vastly multidisciplinary. It is within 
this context, that attempts are already in place to offer a new perspective 
into the understanding and definition of  mental disorders. The Research 
Domain Criteria (RdoC) project has been such an initiative (Cuthbert, 2015). 
Presenting itself  as a research framework, it attempts to provide a biologically 
informed approach “by bringing the power of  modern research approaches 
in genetics, neuroscience, and behavioural science to the problem of  mental 
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The field of  Psychiatric genetics has seen a remarkable progress over the 
last decades. Several genetic variants have only recently been identified 
and robustly associated with disease risk. Technological advances brought 
computational power, and investments in international collaborations created 
new frameworks in which these studies are conducted. It is clear that genetics 
is now living its golden age. One would struggle finding any other domain 
within our societies that has witnessed the same decrease in cost for the same 
period of  time (Mardis, 2011). Still, in parallel to answers, new questions have 
arisen. These emerging questions dictate what we can expect for the future 
of  the field. 
The steep growth in generating genetic data will most likely continue. On 
this point, even a conservative prediction would state that the limitation 
will not be the availability of  data, but rather the manpower to analyse it. 
This extends to other forms of  genetic data. It is expected that in the near 
future we will be able to answer questions such as ‘how many distinct genetic 
variants contribute to this trait’s variation’? - or in other words, explain the 
totality of  a trait’s additive genetic variation. The increasing interest in rare 
variants will likely bring about an anew focus on linkage studies, for which 
the contribution from the classic twin design is unique – e.g. genome-wide 
linkage scans in DZ twins pairs. 
We are still far from incorporating knowledge from the proteome and 
transcriptome into GWAS findings. Likely, the technological advances and 
increase in data size will also affect how research is conducted, becoming 
Future Perspectives
illness” (Walter, 2017). As mentioned above, the diagnostics and definitions 
in use today have largely been proposed in an era when knowledge from 
neuroscience, genetics, and molecular biology was null. The work in this 
dissertation supports a future translational approach into mental disorders.
The use of  genome-wide SNP data within this dissertation has by-and-
large supported the polygenic approach - as was more specifically described 
in Chapters 5 and 8. This greatly contributes to conceptualizing TD/tic 
disorders, OCD and HD as highly heterogeneous and complex entities. On 
the other hand however, the genetic overlap showed in Chapter 4, is evidence 
of  pleiotropy, and evidences the limitations of  attempting to find causal links 
between genetic variants and specific clinically-derived syndromes, that as 
herein suggested are multifaceted and show substantial overlap - both genetic 
and phenotypic. 
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increasingly data-driven (as opposed to model-based approaches). Invariably 
this means a better integration of  different fields within biology. We still 
see developments in our understanding of  how cellular networks mediate 
disease-causing genetic variants, and how different cell types (and different 
tissues) influence gene expression with effect on disease risk. Likely, advances 
in algorithm development for multivariate genetic data analysis will be to 
incorporate additional data from the phenome - transcriptome regulation, 
post-translation modifications, proteome regulation and cell signalling. In 
particular machine learning algorithms - that can learn and improve with 
experience, are already being developed, and are especially promising. Such 
technologies will assist humans in the analysis of  large and highly complex 
datasets. Although the decrease in cost of  DNA-technology and larger 
sample sizes are impacting the way research is conducted, the better approach 
may still lie at the phenotyping level. Samples that are phenotypically more 
informative will maximize gene-discovery. This is to say that the technological 
advances within DNA-technology cannot invalidate the necessary progress 
within psychiatry. If  we say that genotyping will no longer be a limiting factor, 
the same is not true for phenotyping. A better understanding on how several 
disorders are conceptualized is fundamental to our capability to unravel the 
true genetic architecture of  psychiatric disorders. 
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